Abstract

Prof. Dr. Wilhelm K. Aicher Prof. Dr. Herwig Brunner Prof. Dr. Claus D. Claussen Dr. Michael Doser Dr. Klaus Eichenberg Prof. Dr. Hugo Hämmerle Prof. Dr. Jürgen Hescheler Dr. Steffen Hüttner Dr. Ralf Kindervater Prof. Dr. Gerd Klein Prof. Dr. Konrad Kohler Prof. Dr. Heike Mertsching Prof. Dr. Oliver Rennekampff Dr. Richard Schäfer Prof. Dr. Burkhard Schloßhauer Prof. Dr. Thomas Skutella Website: www.biostar-congress.de
Scientific Committee
Plenary Lectures and Oral Presentations
Plenary opening lecture
OP 01 How about Therapeutic and Research Potential of Human Stem Cells
There has been significant interest in the therapeutic and scientific potential of stem cells since reconstitution of the haematopoietic system was first realized by bone marrow transplantation in the 1960s. The isolation of tissue‐specific, multipotent stem cells from adult organs and the derivation of pluripotent human embryonic stem cells offer the potential for regeneration of a number of different tissues and organs susceptible to age‐related degenerative conditions and traumatic injury. In the not‐too‐distant future, it will be possible to repair heart tissue damaged by myocardial infarction, to replace neuronal cells lost in Parkinson's and Alzheimer's diseases, to transplant new insulin producing cells for diabetics and myelinating cells for individuals afflicted with multiple sclerosis, and to replace bone and cartilage lost through aging and inflammatory disease. In addition, the generation of specific populations of defined subtypes of human cells has tremendous potential to revolutionize the fields of drug discovery and investigation into the cellular bases of human disease. The newly emerging field of Regenerative Medicine will fundamentally alter clinical medicine and significantly influence our perceptions of aging, health and disease, with a myriad of consequences for society at large.
Session I: Regenerative Biology Keynote Lecture
OP 02 Genetic Insights and Therapeutic Potential of the Neuro‐Vascular Link: Consequences for Tissue Regeneration
Understanding the molecular basis of the formation of blood vessels (angiogenesis) and nerves (neurogenesis) is of great medical relevance. It is well known that disregulation of angiogenesis leads to tissue ischemia, cancer, inflammation and other disorders, while a dysfunction of the nerve system contributes to motorneuron disorders like amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The observations of Andreas Vesalius ‐Belgian anatomist of the 16th century ‐ that patterning of vessels and nerves show more than remarkable similarities, are currently revisited in exciting studies. This neuro‐vascular link is not only critical for development, but, when deregulated, contributes to the pathogenesis of medically relevant diseases. Studying the molecular nature of this link thus promises to accelerate the discovery of new pathogenetic insights and therapeutic strategies for the treatment of both vascular and neurological diseases.
Often, vessels and nerves track alongside each other. Recent genetic studies revealed that vessels and nerves share many more common principles and signals for navigation, proliferation and survival than previously suspected. For instance, gene inactivation studies in mice and zebrafish showed that axon guidance signals regulate vessel navigation. Conversely, prototypic angiogenic factors such as VEGF control neurogenesis and regulate axon and neuron guidance, independently of their angiogenic activity. The next coming years promise to become an exciting journey to further unravel the molecular basis and explore the therapeutic potential of the neuro‐vascular link. Novel approaches to revascularize ischemic tissues or promote post‐infarction repair using angiogenic factors or progenitor cells offer great promise.
OP 03 Transdifferentiation of Pancreatic Cells to Hepatocytes
The development of a suitable source of hepatocytes for transplantation into patients with liver failure constitutes an important goal in regenerative medicine. However, there is a serious limitation to the treatment of liver diseases with hepatocytes and that is the shortage of organ donors. One way forward is to augment the supply for transplantation by producing hepatocytes in vitro. Alternative sources of hepatocytes include: hepatic progenitor cells, embryonic or adult stem cells but the work is currently at an early stage. Our approach is based on the production of hepatocytes from pancreatic cells by a process known as transdifferentiation (the conversion of one cell type to another). We have developed models for the transdifferentiation of pancreatic cells to hepatocytes. These models include the rat pancreatic cell line AR42J‐B13, mouse embryonic pancreatic tissue and human pancreatic cells. All the models are based on the addition of the synthetic glucocorticoid dexamethasone. We have characterised the transdifferentiated hepatocytes and these cells express many of the properties of normal hepatocytes. For example, the transdifferentiated hepatocytes: produce albumin and urea, respond to xenobiotics and replicate Hepatitis B virus. The conversion from a pancreatic to hepatic phenotype is also associated with the induction of the liver enriched transcription factor, C/EBPbeta. Overexpression of C/EBPbeta can provoke transdifferentiation, conversely overexpression of a dominant‐negative form of C/EBPbeta can inhibit the process. The production of hepatocytes from pancreatic cells represents an alternative source of cells for transplantation as well as an in vitro model for studying liver function.
OP 04 Cardiac Tissue Engineering
Endogenous repair mechanisms do not suffice to reconstitute relevant heart muscle after a cardiac insult. We have, consequently, developed a novel technology to generate Engineered Heart Tissue (EHT) with structural and functional properties of native myocardium to be used as surrogate heart tissue. Subsequent in vivo studies in a rat model of myocardial infarction did indeed confirm that EHTs may indeed be utilized to at least partially repair infarcted hearts. Yet, numerous hurdles remain to be overcome to advance our experimental technology into a clinically applicable treatment modality. One main issue will be to identify a suitable cell source for human cardiac tissue engineering. Primary cardiomyocytes are naturally post‐mitotic and are therefore not suitable for clinically relevant heart muscle repair. This is why cardiogenic stem cells have attracted significant attention. We have recently been able to apply murine and human embryonic stem cells to generate EHT with functional and structural properties of native myocardium. Implantation studies demonstrated survival and vascularization of human EHT grafts in immune suppressed rats. To address immunological concerns potentially autologous cardiomyocyte sources are presently tested in myocardial tissue engineering. They include therapeutic cloning derived stem cells, reprogrammed somatic cells, parthenogenetic stem cells, or germ line stem cells. Despite the prospect of having the right and ideally autologous human cell in hand, we are still facing compelling caveats, including the risk of tumor formation, imperfect cell integration into recipient myocardium, arrhythmia induction, and reaching a clinically relevant scale.
OP 05 Articular Motion Induces PRG4 in Chondrocyte‐seeded Scaffolds: Link between Joint Motion and Joint Lubrication?
Articular cartilage is characterized by zone differences in morphology, cell metabolism, and matrix composition. The superficial zone serves as a gliding surface for the joint. A novel bioreactor has been designed to closely simulate the movements and surface motion characteristics of natural joints. The new system, which provides joint specific biomechanical stimuli, aims to promote the formation of cartilaginous tissue with a functional surface. The present study investigated the effect of applied axial compression and articular motion on the gene expression of hyaluronan synthases (HASs) and on the synthesis of SZP/lubricin and hyaluronan (HA), macromolecules that provide the synovial fluid with lubricating property and high viscosity necessary for the frictionless articulation of diarthrodial joints.
Indeed, SZP/lubricin was immunodetected in conditioned media of constructs subjected to compression and rotation, but not in media of constructs subjected to compression alone or of free swelling constructs. In addition, applied surface motion significantly elevated HAS1 and HAS2 mRNA expression of the cells. The release of HA into the culture medium was also significantly enhanced by applied surface motion. Our findings that applied surface motion regulates both the synthesis of SZP/lubricin, an important boundary layer lubricant, and HA, a key component of the hydrodynamic aspect of joint fluid, suggest that application of specific stimuli that mimic the kinematics of natural joints may promote the development of a functional articular surface ‐ synovial interface. This may therefore be beneficial for tissue engineering of cartilage constructs as well as to better define rehabilitation protocols following cartilage repair.
OP 06 Cell Biological Approaches to Clinical Spinal Cord Repair
Lesion scarring is a common response to spinal cord injury (SCI). Recently, we have demonstrated that the collagenous basement membrane‐rich fibrous scar in SCI is a major impediment for axon regeneration, acting as a physiological barrier due to accumulation of axon‐growth inhibitory molecules. To overcome this regeneration barrier we have developed a novel treatment to suppress scarring by local application of iron chelators and cAMP which resulted in long‐distance regenerative axon growth in different animal models of CNS injury. Axons regenerated through both grey and white matter and developed terminal arborizations in grey matter regions. In contrast to controls, injured animals receiving this treatment showed significant functional recovery in various locomotor tasks. The treatment further showed a strong neuroprotective influence that retrogradely rescued primary motoneurons in cortical layer V projecting into the descending corticospinal tract that normally die (30%) after axotomy. Local neuroprotective functions of the treatment are indicated by significantly reduced protein oxidation and lipid peroxidation in SCI as well as by specific changes in the gene expression profile in sensorimotor cortex including downregulation of proapoptotic genes and upregulation of antiapoptotic genes.
The scar suppressing treatment is currently under preclinical development with SCT Spinal Cord Therapeutics (formerly Neuraxo Biopharmaceuticals), a spin off company of our laboratory. The pharmacological approach for spinal cord repair as described here is compatible with most, if not all, other therapeutic strategies known so far.
Session II: Regenerative Therapies Keynote Lecture
OP 07 Injectable Photocuring Biomaterial Shaping 3D Cell Delivery
Cell delivery‐based strategies in regenerative medicine often face low efficiency problems. The biomaterial‐assisted cell delivery was found as an attractive procedure to overcome some of the major limitations of the simple cell injection. Among different possibilities, the use of photocuring biomaterials, and in particular hydrogels, posses intrinsic properties related to the in vivo control of the cell micro‐environment.
The chemico‐physical and the mechanical properties, the morphology and the in vitro degradation rate of the cross‐linked hydrogel can be specifically designed for supporting cell delivery in vivo. All these parameters can be tuned by adjusting the light exposure time, the polymer concentration and the media properties.
An example of the feasible use of a photocurable hydrogel as cell carrier was investigated through in vivo experiments on muscle satellite cells. The results not only confirmed the hydrogel biocompatibility and biodegradability but also showed its potential in highly improving tissue regeneration.
OP 08 Cell‐based Therapy for the Treatment of Avascular Necrosis of the Femoral Head
The goal of the therapy for avascular necrosis of the femoral head is the preservation of the femoral head and, therefore, avoidance of total joint replacement. Core decompression is known to reduce the intraosseous pressure and additionally provides the opportunity to introduce bioactive materials, substances and cells into the core tract. These include vascularized and non‐vascularized bone grafts, allogenic and synthetic bone substitutes, osteogenic and angiogenic growth factors, as well as different progenitor cells. Especially, the use of cell‐based strategies is thought to have great therapeutic potential and could play an important role in the future treatment of femoral head necrosis. In this presentation the existing clinical experience of cell‐based strategies for the treatment of femoral head necrosis is discussed and clinical data concerning our own therapeutical approach will be presented. In particular, three patients have been treated with a core decompression (doubled drilling technique, 2 × 10 mm) followed by the implantation of bone marrow stromal cells (TRCs: “tissue repair cells”, Aastrom Inc.) in combination with a β‐TCP matrix. All patients had a necrosis stage ARCO II without a subchondral bone fracture. After a follow up of 2 years all patients showed a significant increase of the HHS, the Womac, and the SF 36 score. Furthermore, none of the patients showed a progression to a subchondral bone fracture. The results are encouraging and are currently evaluated in a prospective randomized controlled study.
OP 09 New Developments in Diagnostic Imaging
Progress in whole‐body imaging technologies in the last decades have provided a deep understanding of normal anatomy and pathologic changes of the human body. The fast acceleration of improving and refinement of therapeutic strategies as well as social demands, however, have pushed the requirements from organ‐defined towards systemic / disease focused imaging. With the latest developments in MRI technology, whole‐body imaging without compromising image quality and therefore diagnostic accuracy can now be provided within reasonable examination time. For early disease detection and therapy monitoring, however, imaging of morphologic changes has demonstrated to be limited. MRI can also reveal functional impairment of organs, for example diffusion weighted imaging can be used for evaluation of cell density and therefore sensitive tumor detection, contrast media enhanced perfusion imaging can display the integrity of blood vessels and be used as a therapy marker and finally, with MR spectroscopy an indirect view into the metabolism of a tissue can be provided. But for a deeper and more specific insight into the molecular pathways of pathologies, metabolic imaging is required. Positron emission tomography (PET) in combination with disease‐specific customized tracers represents the imaging modality of choice for this purpose; but what is essential for a deeper understanding of pathologies and therefore prerequisite for an effective and individualized therapy regime, is the combination of information provided by metabolic, functional and anatomical imaging. The latest developments in imaging technologies are therefore focused on combining PET and MRI in a human whole‐body hybrid system.
OP 10 Platelets in Regenerative Medicine
Stem and progenitor cells have evolved as the central cell type in regenerative medicine. This focussed approach may, however, sometimes narrow the point of view. Recently, platelets have been shown to strongly influence progenitor cell biology and to serve as regenerative cells themselves. Platelets secrete chemokines and cytokines that mediate vascular inflammation and are in turn activated by substances released from cells of the vascular wall. These interactions represent positive and negative feedback loops, which in case of dysregulation may lead to development and progression of various diseases. Furthermore, platelet adhesion to the endothelium is critical for the initiation of atherosclerotic lesion formation.
On the other hand, increasing evidence indicates that platelets mediate regenerative mechanisms. Platelets recruit circulating progenitor cells to sites of vascular injury and influence their biological activity and maturation. For example, they modulate progenitor cell chemotaxis, migration and differentiation. Platelets are crucial for the regeneration of parenchymatous organs such as the liver. Moreover, in the clinical setting, platelets are already applied for the restoration of connective and bone tissue. However, also adverse effects can be mediated by platelets and progenitor cells exposed to platelets, including the induction of pro‐inflammatory processes. This talk will highlight the role of platelets themselves as a potential effector cell for tissue regeneration and their impact on progenitor cell biology.
OP 11 Sprayed Cultured Epithelial Autografts for Deep Dermal Burns of the Face and Neck
Session III: Interfaces Keynote Lecture
OP 12 Heart Muscle Tissue Engineering: A Profound Challenge for Regenerative Medicine
Heart disease caused 1,000,000+ USA deaths in 2004 and is the leading cause of death in the developed world. Myocardial infarction often progresses to congestive heart failure. The economic/social consequence of heart disease justifies the development of therapies that can have huge impact on health and life quality. A University of Washington‐NIH Bioengineering Research Partnership (BRP) has embraced the challenging goal to tissue engineer heart muscle for reparative surgery. Specific challenges are (1) cardiomyocytes have lost the ability to replicate, (2) heart muscle is highly vascularized, (3) muscle tissue is aligned and mechanically appropriate (4) innervation is needed and (5) how will we address this therapy surgically? An interdisciplinary BRP team, in a coordinated research effort, is addressing these challenges. Two particularly pressing challenges that must be addressed are cell source (cardiomyocytes) and oxygen demands (angiogenesis). Individual investigator projects are addressing these problems: (1) unique porous gels prepared by microsphere templating that rapidly stimulate angiogenesis have been developed, (2) we invented new biodegradable polymers with degradation kinetics timed to heart muscle development, (3) a templating technology allows parallel channels for cardiomyocytes within the angiogenesis‐stimulating gels, (4) we can isolate of cardiomyocytes from human embryonic stem cells and have developed conditions permitting ongoing cell proliferation. Cardiomyocytes were injected into a nude rat heart and found to survive to one month or more. Cardiomyocytes survive well within templated hydrogel materials in vitro and in vivo.
OP 13 Rational Control of Cell and Tissue Model Shape
Mechanophysical cues emerge as important decision factors governing cell and tissue differentiation. Geometry can switch cell fate from proliferation to apoptosis and the shape of tissue models results in spatially inhomogeneous growth. Here we use a model driven approach to study shape determinants across cell and tissue scales.
Surprisingly on both scales we find experimentally that non‐adherent edges form circular arcs with an adhesion distance dependent curvature. We explain this finding in the framework of a generalized Laplace law of competing line and surface tension. Model fitting in combination with acto‐myosin inhibition experiments further reveal that cells control shape by actively modulating motor tension and contour elasticity. This study sets the biophysical foundation for a quantitative understanding of biological shape determinants that will facilitate rational cell and tissue engineering applications and suggests that similar strategies might be employed on both scales.
OP 14 Bridging the Gap ‐ Skeletal Regeneration Using Skeletal Populations at the Interdisciplinary Interface
Tissue engineering strategies have sought to repair skeletal defects resulting from trauma and disease with the application of cells, typically isolated from the patients themselves, in combination with porous biomaterials or scaffolds. Skeletal or mesenchymal stem cells are defined as multipotent progenitor cells with the ability to generate cartilage, bone, muscle, tendon, ligament and fat. These primitive progenitors exist postnatally and exhibit stem cell characteristics, namely low incidence and extensive renewal potential. However, to date, relatively little is known concerning the skeletal stem cell, whether from a morphological or biochemical standpoint or direct in vivo confirmation, nevertheless, strategies harnessing tissue engineering approaches offer much promise for skeletal regeneration using skeletal populations. Key to the success of these strategies is the application of an interdisciplinary strategy to understand evaluate how that the cells first need to fully populate the porous scaffold and subsequently differentiate into the appropriate cell type to form the new functional tissue matrix. This critical combination of cell ingrowth and appropriate cell differentiation depends on a wide variety of factors (cell type/population, growth dynamics) as well as structural parameters of the scaffold as well as an ability to generate a functional microvascular network within engineered constructs to provide oxygen and nutrients that facilitates growth, differentiation, and tissue. To achieve this goal of skeletal regeneration, it will be necessary to harness the skills set from a variety of disciplines with we believe a need for close interactions between modelers, physical scientists, tissue engineers and clinicians.
OP 15 Bulk and Interface Investigations of a Si‐TCP/HA Porous Ceramic Scaffold and Tissue Engineered Bone by X‐ray Microtomy and X‐ray Microdiffraction
Resorbable porous ceramic constructs, based on silicon‐stabilized tricalcium phosphate, were implanted in critical‐size defects of sheep tibias, either alone or after seeding with bone marrow stromal cells (BMSC). Only BMSC‐loaded ceramics displayed a progressive scaffold resorption, coincident with new bone deposition. To investigate the coupled mechanisms of bone formation and scaffold resorption, X‐ray computed microtomography with synchrotron radiation (μCT) was performed on BMSC‐seeded ceramic cubes. These were analyzed before and after implantation in immunodeficient mice for 2 or 6 months. With increasing implantation time, scaffold thickness significantly decreased while bone thickness increased. The μCT data evidenced that all scaffolds showed a uniform density distribution before implantation. Areas of different segregated densities were instead observed, in the same scaffolds, once seeded with cells and implanted in vivo. A detailed μX‐ray diffraction analysis revealed that only in the contact areas between deposited bone and scaffold, the TCP component of the biomaterial decreased much faster than the HA component, highlighting coupling and cell‐dependency of the resorption and matrix deposition mechanisms. Moreover, in scaffolds implanted without cells the TCP:HA ratio remained unchanged with respect to the pre‐implantation analysis.
OP 16 Micro‐ and Nanoscale Pattern of Proteins for Control Over Neuronal Outgrowth and Polarity
Culturing neuronal cells under appropriate conditions preserve a variety of native neuronal network properties including the development of synaptic connectivity and signal processing. Such systems, distinctive from individually isolated neurons, are both applicable and in many aspects advantageous for physiological studies and pharmacological characterization.
The creation of protein patterns require methods which take into account the complexity and fragility of these biomolecules. A number of strategies for the patterning of proteins have been developed. Microcontact printing (μCP) emerged as a simple and efficient method for surface patterning of proteins which can be applied like ink to the surface of an elastomeric stamp and transferred to the substrate by printing. The main advantage of this method is its versatility, as a wide range of biomolecules (in particular cell adhesion proteins) can be printed onto a variety of different background materials.
We will present an in vitro system which allows guiding neurite outgrowth along the lines of a micro‐ or nanopatterned surface. This surface consists of a cell repellent background of polystyrene or polyethyleneglycol onto which an adhesive grid pattern consisting of e.g. extracellular matrix molecules is applied. Neuronal network formation on the level of individual cell‐cell contacts on a micropatterned surface could be demonstrated and investigated. Further, the presented methods are used to control the development of neuronal polarity and synaptogenesis.
OP 17 Autologous Endothelial Vascular Grafts
The approach of static endothelialization of the inner ePTFE graft surface to avoid direct contact between biomaterial and blood did not consider the influence of shear stress on modifying endothelial cell adherence and thrombogeneity. Static endothelialization of grafts cannot avoid shedding of endothelial cells after insetting perfusion. Our novel approach consists in seeding a sub‐confluent number of endothelial cells onto the inner graft surface, and allowing the cells to grow up to confluence under permanent influence of increasing shear stress up to physiologic values.
In vitro, high shear stress did not lead to a disruption of the confluent cell layer in grafts endothelialized under perfusion. Therefore, a low shear stress was sufficient to wash most of cells off grafts cultured under static conditions.
In an animal testing, the control group received uncoated grafts, whereas the treatment group – grafts coated with autologous endothelial cells under defined shear stress. When removed after 6 weeks, treated grafts revealed a confluent endothelial cell monolayer on the inner graft surface. Control grafts were completely blocked by organized thrombus.
Blood perfusion rates measured directly after implantation of the processed graft group showed similar perfusion rates compared to those measured prior explantation. No perfusion could be measured in grafts implanted without endothelial cell lining.
In summary, the endothelial cell layer integrity formed in vitro under defined flow conditions is comparable to that of native endothelium as demonstrated by first in vivo data.
Session IV: Medical Biology
OP 18 Recent Advances in Liver Regeneration Imaging and Surgical Risk Analysis
In adult living donor liver transplantation, the donor operation involves either a right or a left hepatectomy leaving the middle hepatic vein (MHV) in the donor or preserving it for the recipient. In performing the resection, tributaries of the MHV will be ligated and thus induce the risk of a potentially congested area leading to reduced or even insufficient functional liver volume. For preoperative risk analysis, the graft or remnant volume is decreased by the volume of these tributaries.
In a regeneration study of follow‐up computed tomography (CT) data of donors, we analyzed global and local liver growth and the formation of venous collaterals. These vascular connections are not visible in CT data directly after transplantation and it remained unclear if they can substitute a potential venous congestion and avoid liver dysfunction in the critical postoperative phase. The study of local liver growth showed that the regeneration of territories with venous congestion is decreased compared to normally drained areas.
To further study the influence of outflow obstruction on liver regeneration and function, we investigated animal models. With a dedicated resection model of the rodent's liver and examinations of microvascular flow and the analysis of histological sections, we could show that (a) sinusoids in the zone between congested and normal zone were dilated and remodelled to vascular canals, and (b) regeneration is delayed and transient necrosis developed in the risk areas.
In conclusion, we could confirm that outflow obstructed territories should be excluded from the functional liver mass during risk assessment.
OP 19 Stem Cells and Cell Banking
Umbilical cord blood (CB) transplantation (UCBT) has extended the availability of hematopoietic stem cell transplantation to patients who would otherwise not be eligible for this curative approach. More than 10,000 patients have received allogeneic CB. During the last three years, the number of adults transplanted with cord blood cells has surpassed the number of UCBT performed in children. It is evident that CB has several advantages over donations from adults, such as rapid availability and immunological naivety. Progress in the field of CB transplantation was only possible on the basis of well‐standardized cord blood banks and products. The Düsseldorf José Carreras CB Bank started unrelated and related directed CB banking in 1992/1993. Hitherto (July 2008) a total of 14,020 CB samples have been cryopreserved and 518 CB units have been provided for transplantation. In addition our group was able to identify a multipotent cell, termed USSC (Unrestricted Somatic Stem Cells) in cord blood. USSC have the potential to differentiate into cell types of all three germ layers. They can be obtained from 35‐45% of fresh cord blood‐depending on the culture conditions. Due to difficulties in the generation of USSC from cryopreserved material, therapeutic application of USSC will rely probably on the establishment of USSC cell banks, with USSC generated from fresh CB. Cord blood banking was supported by grants from the German José‐Carreras‐Foundation (grant DJCLS‐R03/06; DJCLS‐R07/05v) and the EUROCORD III (grant QLRT‐2001‐01918). Also, the research on the USSC was supported by the Deutsche Forschungsgemeinschaft (DFG; research group FOR717 project Ko2119/6‐1).
OP 20 Nondestructive Imaging of Cells and Scaffolds
With recent advances in regenerative biology and medicine there is a strong need for quantitative imaging of three‐dimensional (3D) biological structures and scaffolds. Microcomputed tomography (μCT) allows to do so in a nondestructive and noninvasive way. It provides the data for detailed 3D quantification of scaffold and bone, from their microarchitecture down to the cell level. This methodology is useful for the quality control of scaffold fabrication processes, to quantify scaffold degradation kinetics, as well as to assess bone tissue response, its structure and its competence. In combination with bioreactors or in vivo animal models, μCT allows to qualitatively and quantitatively assess the spatial and temporal mineralization of bone tissue formation in scaffolds; such longitudinal studies improve the assessment of bone response due to scaffold architecture. Computational models will be helpful in further analyses of these data in order to improve our understanding of mechanical and biochemical stimuli on bone formation, and are likely to provide valuable knowledge to optimize scaffold design.
OP 21 Recombinant Human Laminin‐511 Enables Self‐Renewal of Human and Mouse Embryonic Stem Cells In Vitro
One of the major challenges of human cell therapy is to develop xenofree and feeder‐cell free conditions for maintaining embryonic stem cells (ESC) in pluripotent form and controllable differentiation pathways for ESCs. Basement membranes (BM) are the first extracellular matrix (ECM) that are in contact with early embryonic cells, and BM proteins, such as laminins, are thought to have a major role in differentiation of embryonic cells during morphogenesis. There exist at least 15 different laminin isoforms in vivo, but these proteins are difficult to isolate from tissues in native forms. We have produced recombinant human laminins to explore their potential usefulness for culturing and differentiating mouse and human ESCs. We cultured mouse ESCs on laminin‐111, recombinant human laminins‐332, −411, −511, and Matrigel in media free of any differentiation inhibitors, except mitogenic factor bFGF 10 ng/ml. Only ESCs cultured on recombinant laminin‐511 maintained pluripotency for at least 145 days (27 passages) and were able to form germline competent chimeric mice. Expression of main pluripotency markers, as well as proliferation rate, remained stable. Interestingly, adhesion of ESC to laminins correlated with the proliferation rate of the cells. Similar results have been obtained with human ESCs. Using human recombinant laminin‐511 as coating material, we developed a completely defined xeno‐free system for sustained maintenance of human ESCs in pluripotent state. Some other laminins cause differentiation. Use of recombinant human laminins could be a significant step forward in making ESC technologies feasible for clinical applications such as human cell therapies and regenerative medicine.
OP 22 Maintenance of Chondrocytes and Intervertebral Disc Cells in Gelatine Hydrogels
Novel regenerative approaches to intervertebral disc repair are in part based on cell therapy. Hydrogels may represent suitable cell carriers especially if they are polymerized at the site of damage or degeneration. Cells embedded in such hydrogels may be administered by a minimally invasive procedure, saving costs and minimizing patient stress. Herniated discs may represent a target tissue. In the current study we investigated to which extent disc cells and articular chondrocytes can be maintained in such hydrogels and continue to display discogenic or chondrogenic features. Cells were embedded into gelatine together with culture medium. Gels were polymerized at 37 °C and cultured for two weeks. A live‐dead staining was used to analyze cell viability. Quantitative RT‐PCR and a colorimetric assay to quantify glycosaminoglycans were used to determine cellular phenotype and metabolic activity. The gelatine hydrogel formulation used in the present study allows for the cultivation and maintenance of disc cells and articular chondrocytes. Cells cultured in hydrogels remained viable (>90%) for at least two weeks and produced tissue‐specific mRNA for collagens and aggrecan. Due to the fact that the formulation was developed for the treatment of intervertebral discs, the gel supports the phenotype of disc cells more than that of articular chondrocytes. The presented hydrogel can be administered minimally invasive and seems to be a suitable cell carrier for regenerative approaches. Disc cells embedded into the hydrogel and injected into a herniated disc might therefore contribute to the tissue regeneration process.
Session V: Stem Cell Niches Keynote Lecture
OP 23 Dormant and Activated Stem Cells during Homeostasis Injury and Cancer
Somatic stem are required to maintain highly regenerative tissues such as the skin, the intestinal epithelium and the hematopoietic system. Mouse hematopoietic stem cells (HSCs) are the most well characterized somatic stem cell to date, and serve as a model for understanding other adult stem cells present in the mammalian body. Using two types of label‐retaining assays we have identified a long‐term dormant population within the most primitive HSCs (Lin‐Sca1 + cKit + CD150 + CD48‐CD34‐). These dormant HSCs appear to have higher repopulation activity compared to actively self‐renewing stem cells. They are not involved in the maintenance of homeostasis, but are activated and driven into a self‐renewing program in response to injury signals. After homeostasis is re‐established proliferating HSCs return to dormancy, suggesting that HSCs reversibly switch from a dormant to a self‐renewing phase under conditions of hematopoietic stress. One of the reasons cancer stem cells are thought to escape anti‐proliferative chemotherapy is their relative dormancy1. I will provide evidence that treatment of mice with a member of the Interferon (IFN) family leads to the activation and proliferation of dormant HSCs in vivo, thus sensitizing them to chemotherapy drugs. The implications of these results for the design of strategies to target dormant CML stem cells not targetable by imatinib alone will be discussed.
1Wilson et al, (2008). Hematopoietic stem cells reversibly switch from dormancy to self‐renewal during homeostasis and repair. Cell, Dec. issue, in press.
OP 24 The Role of Specific Adhesion Proteins for Maintenance of Hematopoietic Progenitor Xells upon Co‐Culture with Stromal Cells
The importance of interaction between hematopoietic progenitor cells (HPC) and their cellular microenvironment for maintenance of “stemness” has been demonstrated. Mesenchymal stromal cells (MSC) from human bone marrow serve as a surrogate model for the niche. Here, we have analyzed the role of various adhesion and signalling proteins in this interaction. Expression of specific proteins was knocked down by siRNA. The hematopoiesis supportive activity was then analyzed after 7 days of co‐culture with regard on proliferation, maintenance of a slow dividing fraction and of a primitive CD34+CD38− immunophenotype. The effect of siRNA treatment was either verified by qRT‐PCR (integrin beta 1 (ITGB1), vascular cell adhesion molecule 1 (V‐CAM1), stromal cell‐derived factor‐1‐alpha (SDF‐1) and its receptor CXCR4) or on protein level by western blot (N‐cadherin, cadherin‐11, mitogen activated protein kinase 1 (MAPK1), CD44, ITGB1). Knockdown of the cell‐cell adhesion proteins N‐cadherin and cadherin‐11 impaired cell‐cell adhesion between MSC and CD34+ cells but it did not affect maintenance of primitive HPC. In contrast knockdown of ITGB1 and CD44, that have previously been demonstrated to mediate adhesion of HPC to extracellular matrix, resulted in a significantly higher fraction of primitive CD34+CD38− cells (p < 0.005). Our results indicate that MSC from human bone marrow represent a suitable model system to analyze molecular mechanisms of the stem cell niche. An orchestra of junction proteins regulates this specific interaction by activating or counteracting of the supportive function of MSC.
OP 25 Towards an Artificial Stem Cell Niche: Impact of Biofunctionalized Nanopatterns and Matrix Stiffness on Hematopoietic Stem Cells
In the hematopoietic stem cell (HSC) niche HSCs find the essential ligands, which are arranged in the optimal nanoscale geometry on a substrate with a defined elasticity. Since to date HSCs cannot be expanded in vitro without differentiation, the aim of our research is to model an artificial stem cell niche with the optimal ligands, nanostructure and substrate elasticity. Nanopatterns were biofunctionalized with peptides from the laminin alpha4 and 5 chains. The strongest attachment of the HSC‐like cell lines KG1a and TF1 was observed for a peptide from the laminin alpha4 chain at interparticle distances below 60 nm. To date, nothing is known about the influence of matrix elasticity on HSCs. However, osteoblasts flatten during HSC mobilization upon adrenergic stimulation. To examine if flat and high osteoblasts differ in their elasticities, the osteosarcoma cell line CAL‐72 was treated with the adrenergic agonist clenbuterol. Upon stimulation the cell monolayer flattened. The change in elasticity is determined by atomic force microscopy. To investigate the influence of substrate elasticity on HSCs, KG1a and TF1 cells were seeded onto fibronectin coated hydrogels with different elastic properties. Adhesion could be observed on all gels. But whereas the cells keep their round shape on soft gels (7‐15 kPa), up to 15% of the cells displayed an elongated morphology on hard gels (40 kPa). In conclusion, we could show that nanopatterns as well as substrate elasticity can influence HSC‐like cells. The next step will be to combine the optimal ligand, nanostructure and substrate elasticity within one system.
OP 26 Integrin α9 Contributes to Adhesion and Differentiation of Stem and Progenitor Cells in the Human Hematopoietic Stem Cell Niche
Human hematopoietic stem and progenitor cells (HSPCs) are mainly located in the bone marrow in specific stem cell niches. These niches compose unique microenvironments that allow the maintenance and self‐renewal of stem cells. Current knowledge suggests that the integrin subunits α4 and α6 expressed on stem cells have distinct roles in retaining these cells in the bone marrow. The aim of our study was to gain insight into expression and functions of the integrin subunits αα‐α11 within the osteoblastic bone marrow niche.
To mimic the situation in the osteoblastic niche, we isolated and cultured human osteoblasts from hip joint bone and purified human HSPCs with the stem and progenitor cell marker CD34. By RT‐PCR, we found transcripts for the integrins α7‐α11 in primary osteoblasts. Highly purified CD34+ HSPCs, however, expressed only the integrin subunits α7 and α9. Flow cytometric analysis verified extracellular expression of integrin α9 on HSPCs. To elucidate a potential role for integrin α9 in cell adhesion, we performed cell‐cell adhesion assays with primary osteoblasts and dye‐labeled CD34+ HSPCs. Addition of function‐blocking antibodies against integrin α9 drastically reduced the binding of HSPCs to osteoblasts. Furthermore, addition of anti‐integrin α9 antibodies significantly inhibited the proliferation and differentiation of CD34+ HSPCs in vitro as shown with cell proliferation assays and colony‐forming unit assays.
In conclusion, we could show the expression of integrin α9 on early hematopoietic stem and progenitor cells. Our results strongly suggest that integrin α9 contributes to adhesion and differentiation of HSPCs in the osteoblastic stem cell niche.
OP 27 The Influence of Mesenchymal Stem Cells on Development of Erythropoiesis in Co‐Culture
OP 28 Sfrp1 Regulates Immature Adult Hematopoiesis
Two stromal cell lines: EL08‐1D2 and UG26‐1B6 were identified to maintain hematopoiesis in non‐contact cultures (Stem Cells. 2005;23:842‐51). We identified the Wnt inhibitor Sfrp1 as overexpressed in both EL08‐1D2 and UG26‐1B6. The role of Sfrp1 in early hematopoiesis, was studied in Sfrp1 knockout mice in vivo (Sfrp1‐/‐, Satoh et al., Development. 2006;133:989‐99). Sfrp1‐/‐ mice had elevated number of HSC (CD34‐LSK), in their bone marrow, whereas common lymphoid (CLP), or multipotent myeloid (MPP) were unchanged with regard to wild‐type controls. Cell cycle analyses revealed an increase in the G0/G1 compartment in both LSK and MPP of BrdU‐treated Sfrp1‐/‐ mice. To understand the underlying mechanisms, we found that in Sfrp1‐/‐ mice, Ctnnb1 levels are severely decreased in Sfrp1‐/‐ LSK cells, whereas Jnk is not affected. Lower catenin levels were associated with a decrease in catenin targets Lef1 and Myc in Sfrp‐/‐ 34‐LSK cells. Whether the effects we found were related to the lack of Sfrp1 in the bone marrow niche was investigated in transplantation experiments. Wild‐type HSC showed an increase in engraftment into Sfrp1‐/‐ recipients, with increased myeloid engraftment. But, this behavior was not normalized by transplantation into secondary wild‐type recipients. Instead, we found an almost complete loss of early progenitors (LSK and MPP), with concomitant increase in lymphoid engraftment. In conclusion, our results support a model in which Sfrp1 regulates immature adult hematopoiesis mainly by extrinsically regulating HSC self‐renewal through Ctnnb1 stability, thus challenging the role of Sfrp1 as an inhibitor of canonical Wnt‐signaling.
OP 29 Interaction of Different Precursor Cells under Reduced Oxygen Tension
Bone marrow mesenchymal stem cells (MSC) provide necessary microenvironment for hematopoietic stem cells (HSC) due to both direct cell‐to‐cell contacts and hematopoietic growth factors secretion. It was shown that hematopoiesis and HSC differentiation as well as MSC proliferation is activated by low oxygen tension. Though there are little data on HSC functional activity and their interaction with MSC under hypoxia. The aim of this study was to evaluate MSC structural and functional characteristics including their ability to maintain hematopoiesis using its co‐cultures with umbilical cord mononuclear cells in normoxia (20% O2) or hypoxia (5% O2). MSC phenotype was assessed by flow cytometry. MSC adipogenic and osteogenic differentiation were analyzed using specific staining procedures. Umbilical cord HSC colony forming ability was evaluated after the cultivation of HSC with MSC in methyl cellulose medium containing growth factors during 7 and 14 days. It was shown that MSC kept their phenotype and differentiation potential at 5% O2. MSC and HSC co‐cultivation at low oxygen resulted in more intensive HSC proliferation and formation of so called “cobblestone areas” corresponding to immature hematopoietic progenitor cells clusters which are active hematopoiesis sites. Intensive proliferation of HSC within colonies was observed under both normoxic and hypoxic conditions. The results demonstrated the role of MSC as active environment for HSC with local regulation of hematopoiesis under low oxygen tension.
OP 30 Critical Role of Type 2 Ryanodine Receptor in Differentiating Cardiomyocytes and Neuronal Cells from Embryonic Stem Cells
Embryonic stem cells (ESCs), one possible source of transplantable cells, have an unlimited potential to proliferate in vitro and differentiate into derivatives of all three primary germ layers, including cardiomyocytes and neuronal cells. It has been well documented that the proper function of these cells is tightly controlled by intracellular Ca2+ signaling, however, the significance of intracellular free calcium concentration ([Ca2+]i) regulated by Ca2+ release from endoplasmic reticulum (ER) during early developmental stage of myocytes and neuronal cells has not yet been fully understood. It is believed that ER‐function is rudimentary in the fetal heart and ESC‐derived cardiomyocytes (ESCMs). Also it remains unclear whether intracellular Ca2+ mobilization from type 2 ryanodine receptor (RyR2) is required during neurogenesis. Using murine wild‐type and RyR2 null ESCs as an in vitro model of cardiomyogenesis and neurogenesis, we reveal that Ca2+ release through RyR2 plays critical roles in mediating contractile activity in myocytes and in activity‐dependent neurogenesis via amplifying intracellular Ca2+ signaling triggered by activation of L‐type Ca2+ channels through autocrine and/or paracine released GABA (Grants: National National Basic Research Program of China (2006CB0F0900; 2007CB947900); NSFC (30671045).
Key Words: murine embryonic stem cells; calcium signaling; cardiomyogenesis; neurogenesis; endoplasmic reticulum; type 2 ryanodine receptor
Session VI: Reprogramming and Differentation Keynote Lecture
OP 31 Induced Pluripotent Stem Cells: How Far Are We from Clinical Application?
So far, development of many cellular therapies aiming at regeneration or replacement of damaged, lost or malformed tissue was hampered by the lack of suitable cell sources. The recent reprogramming of adult somatic cells into induced pluripotent stem (iPS) cells now offers an autologous pluripotent cell source with theoretically unlimited expansion potential. The lecture will give an overview on the current state of the art concerning technological and mechanistical aspects of iPS generation and their differentiation potential.
This will include own data on generation and cardiac differentiation of murine and human iPS cells. Finally, remaining risks and hurdles with respect to clinical application, as well as the role of iPS cells as a novel tool in medical research and drug screening will be discussed.
OP 32 Tumor Stromal Cells Shift the Phenotype of In Vitro Cocultured Keratinocytes toward Their Stemness
Severe skin defects represent serious medical, economical and social problem. Epidermal stem cells play a key role in epidermis self‐renewal and healing. Hair follicle or epidermal basal layer are supposed to be possible sites for epidermal stem cells. In our previous works we ascertained that feeder cells are able to effect the phenotype of cocultured keratinocytes. In this study, we used different types of feeder cells – normal and cancer associated fibroblasts as well as fibroblastoid cells prepared by transfection of murine lung epithelial cells by E6/7 HPV genes. We investgated influence of these cells on interfolicular and hair‐follicle originated keratinocytes. To characterize the phenotype of cocultured keratinocytes we detected a panel of keratins, nucleostemin, vimentin, Snail, Nanog and Oct‐4. Depending up the type of feeder, cocultured keratinocytes formed rather various colonies concerning their shape and size. Furthermore, we found a significant difference between interfollicular and hair follicle‐derived keratinocytes concerning their phenotype including maintaining the stem‐like pattern, mainly under the influence of cancer associated fibroblasts. These results indicate the possibility of the employment of specific feeder for cultivation of kerationocytes for tissue engineering. This study was supported by Ministry of Education Youth and Sport of the Czech Republic, projects No. MSM0021620806 and No. 1M0021620803 and by EC Marie Curie Research Training Network grant (contract No. MRTN‐CT‐2005‐01956).
OP 33 Chemokines Fused to a Fractalkine Backbone and a GPI‐anchor Attract Embryonic EPCs to the Site of Injury
Medizinische Poliklinik‐Innenstadt, University of Munich, Germany
Recruitment of endothelial progenitor cells to ischemic tissue is a prerequisite for efficient neovascularization. Chemokines play a major role in this recruitment of EPCs, a mechanism fading in chronic ischemia. To overcome this limitation, we constructed an artificial adhesion molecule consisting of a GPI‐anchor, a fractalkine‐backbone and an SDF‐1 head (SDF‐1‐fra‐GPI), which was applied for enhanced recruitment of embryonic EPCs.
We demonstrate that in animals pretreated with SDF‐1‐Fra‐GPI, the angiogenetic effect of 2 × 106 eEPCs exceeds the effect of 5 × 106 eEPCs in untreated animals. We conclude that recruitment of EPCs may benefit from pre‐treatment of the vasculature with SDF‐1‐Fra‐GPI. This approach might be valuable for therapeutic neovascularization of chronic ischemic syndromes.
OP 34 Rat Sciatic Nerve Repair Using a Microstructured Nerve Guide: A Histomorphological Study
OP 35 Characterization of Early Cardiac‐Specific Transcripts in Embryonic Stem Cell‐Derived Progenitors ‐ A Transcriptional Profiling
During in vitro differentiation, embryonic stem (ES) cells recapitulate cellular developmental processes and gene expression patterns of early embryogenesis. Here, we characterize early stages of cardiac differentiation of mouse ES cells. ES cells were cultured as embryoid bodies (EBs) for 5 days (d). After plating EBs were spontaneously differentiated for 9d into a multilineage progenitor population representing cells of all three primary germ layers including early cardiomyocytes. To investigate this stage of multilineage progenitors and of early cardiac cell types at the transcript level, microarray analysis was performed using Affymetrix chips comparing undifferentiated ES cells and 5 + 9d progenitors followed by RT‐PCR analysis. Transcript levels of transcriptional regulators (e.g. Tbx20, GATA4, Pitx2), extra‐cellular matrix components (e.g. procollagens I, III, IV, MMPs), and cytoskeletal proteins (troponins T2 and C, cardiac alpha actin) involved in cardiac differentiation and function were found to be up regulated. Specifically, we detected a subset of up regulated transcripts of genes known to be expressed in the cardiac neural crest or its derivatives. mRNA levels of transcription factors Hand1 and Hand2, known to control cardiomyocyte‐specific gene expression through interaction with other transcription factors, and the neural crest‐specific genes Mef2c, Id2, Lbx1, Efnb1, and Sema3c were clearly up regulated at this early stage of cardiogenesis. Also, the presence of the neural crest marker, Mab 4E9R in this population suggests the involvement of neural crest‐specific genes and proteins at an early stage of cardiac differentiation. Immunocytochemistry is presently performed to analyse the potential role of cardiac neural crest cells in early ES‐derived cardiogenesis.
OP 36 Hyperglycaemia Regulates ESC Differentiation into Bone Cells
Hyperglycaemia caused by Diabetes mellitus can lead to osteoporosis in the adult, which may eventually cause a reduction in the mobility of the patient. Osteoporosis is characterized by low bone mass and develops, when either the osteoblasts, which normally secrete the bone matrix, or the osteoclasts, which digest the matrix proteins, do not function properly. Several groups have already proposed that differentiation of bone‐derived progenitor cells into mature osteoblasts is influenced by high glucose levels in vitro. However, these studies are limited by the fact that they only explore osteoblast development. Due to their pluripotent potential, embryonic stem cells (ESCs) can be differentiated into both osteoblasts and osteoclasts [1] and are therefore a useful model to study the interaction of both cell types in vitro.
In order to better understand the effect of glucose on bone tissue development, ESCs were differentiated in media containing either low (1.0 g/l) or high D‐Glucose (4.5 g/l). The expression level of pluripotency, lineage and tissue‐specific markers was determined at distinct time points of differentiation by RT‐PCR. To check whether there is a difference in the mineralization of the matrix generated by the differentiating ESCs, the calcification level was analyzed. Beside this, the activities of alkaline phosphatase (ALP, osteoblasts) and tartrate resistant acidic phosphatase (TRAP, osteoclasts) were measured at determined time points of differentiation.
Ultimately, our observations provide evidence for the possible involvement of high glucose concentrations in the differentiation of ESCs into mature bone cells. [1] zur Nieden et al. (2003). Differentiation
OP 37 Bone Marrow Stromal Cells Recuperate Hepatocyte Functions in an Acute Liver Injury Model 2
Allyl alcohol (AA) has been used in food flavorings and causes a periportal‐specific hepatocellular lesion in animal livers. Bone marrow contains certain progenitors with the ability to differentiate into multiple mesenchymal cell lineages. To identify any differentiation plasticity of adult bone marrow mesenchymal stem cells (MSCs), we used AA treated rabbits for an acute liver failure model.
The MSCs were aspired and expanded to a cellular concentration of 1x108/4ml. The rabbits were injected AA intraperitoneally. Three days after the injection, the MSCs were injected via portal vein. The control group rabbits were injected with 4 ml of normal saline under the same condition. The postoperative recovery was closely monitored by hepatic function markers.
Within one week, in the experimental group, the AST, A LP, Billirubin and rGT were reduced significantly. The ALT and albumin level recovered two weeks after. The BUN was better off one week later. The MSCs were traced by different marks and turned out to be engrafted in portal areas.
Whether extracorporeal devices or the transplantation of primary hepatocytes, stem cells or cells genetically engineered to over‐express key metabolic functions to meeting these demanding challenges. The MSCs may as well have some roles in acute live injury by bridging patients to liver transplantation.
Poster Presentations
Embryonal Stem Cells
PP 01 Effective Cryopreservation Protocol For Human Embryonic Stem Cells Using Controlled‐Rate Freezing
Human embryonic stem cells (hESC) hold tremendous potential in the newly emerging field of regenerative medicine. However, an essential prerequisite for the future human therapeutic widespread application of hES cells is the development of efficient cryopreservation protocols to facilitate their large‐scale storage and transportation. A significant obstacle to using human embryonic stem cells arises from very poor survival after freezing. Better colony survival recovery was obtained using vitrification cryopreservation technique, but the associated aseptic challenge doesn't make it the method of choice for clinical applications. The aim of the present study was to optimize cryopreservation for hESC cells; we utilized cryopreservation of H9 clusters in cryovials, in presence of DMSO as the cryo‐preservative‐agent and slow freezing–rapid thawing in a computer‐programmable freezer. A recovery of 16% of colony survival was achieved in comparison to 1% by the standard WiCell method; this optimization was due to the temperature profile (e.g. Start/end/gradient temperature). The colonies recovered using this method were similar in morphology and showed the expression of pluripotent markers (SSEA‐4, Tra1‐60 and Tra1‐81) comparable to the unfrozen hESC colonies, additionally, the surviving colonies possessed undifferentiated morphology similar to the unfrozen groups. CONCLUSION: A colony survival of 16% after thawing of cryopreserved H9 hESC was achieved using our protocol and the surviving colonies retained the properties of pluripotent cells.
Acknowledgment: This work is funded by the E U under project name CRYSTAL http://www.crystal‐eu.org
PP 02 Isolation of ES cell derived cardiomyocytes via TBX5‐Promoter based Magnetic Cell Sorting
Authors contributed equally to this work.
PP 03 Investigation of zebrafish homologues to specifically upregulated TUFs in cardiomyocytes derived from murine embryonic stem cell
Corresponding authors
Heart failure due to the loss of functional cardiomyocytes is one of the most frequent cardiovascular diseases. Understanding the genetic network that leads to functional cardiomyocytes is the first step to develop future therapies. A global transcriptome analysis yielded up‐regulated genes in cardiomyocytes, which were derived from murine embryonic stem cells (Doss et al., 2007). We were interested in a fast screen for the functional role of transcripts with unknown function (TUFs) for an intact activity of the heart. Therefore we searched for homologous in the zebrafish genome and performed a morpholino‐based knockdown approach. We tested 5 TUFs of the zebrafish and found most of them to be expressed in the cardiovascular system. Morpholino‐oligonucleotide injections caused highly specific cardiovascular defects in the majority of them such as altering of heart morphology, vasculature defects or accumulation of blood cells to a different extent and penetrance. This pilot approach thus shows the potential of the zebrafish to identify TUFs in the cardiovascular system.
PP 04 Role of NKG2D‐ligands and ICAM‐1 in NK cell‐Mediated lysis of murine embryonic stem cells and embryonic stem cell‐Derived cardio
The transplantation of cardiomyocytes derived from embryonic stem (ES) cells into infarcted heart has been shown to improve heart function in animal models. However, immune rejection of transplanted cells may hamper the clinical application of this approach. Natural killer (NK) cells could play an important role in this process both in autologous and allogeneic settings by eliminating cells expressing low levels of MHC class I molecules. Here we characterize ES cell‐derived cardiomyocytes (ESCM) in terms of their sensitivity to NK cells. We show that despite expression of very low levels of MHC class I molecules murine ESCM were neither recognized nor lyzed by activated NK cells in vitro. In contrast, undifferentiated ES cells expressing similarly low levels of MHC class I molecules as ESCM were recognized and lyzed by NK cells. This differential susceptibility results from the differential expression of ligands for the major activating NK cell receptor NKG2D and the adhesion molecule ICAM‐1 on ES cells versus ESCM. NKG2D ligands and ICAM‐1 were expressed on ES cells but were absent from ESCM. Undifferentiated ES cells were lyzed by NK cells in a perforin‐dependent manner. However, simultaneous blockade of NKG2D and ICAM‐1 by antibodies inhibited this killing. These data suggest that in the course of differentiation ESCM acquire resistance to NK cell‐mediated lysis by down‐regulating the expression of ligands required for activation of NK cell cytotoxicity. Therefore, NK cells may play a role in eliminating undifferentiated ES cells but not ESCM after transplantation in vivo.
PP 05 Disruption of fibronectin‐Beta1integrin interactions results in a delayed chondrogenic differentiation of embryonic stem cells
Chondrogenic differentiation of embryonic stem (ES) cells is a complex process that is influenced by a multitude of factors, notably soluble growth factors and extracellular matrix molecules. A crucial step in chondrogenesis is the early formation of mesenchymal condensations by aggregation of precursor cells. The matrix molecule fibronectin is involved in cellular processes such as migration and adhesion by interaction with surrounding cells through the alpha5beta1‐receptor. We analyzed fibronectin expression during chondrogenic differentiation of murine ES cells by immunofluorescence staining and RT‐PCR analysis and found that it is highly expressed throughout early steps of cartilage formation in vitro. This suggests a predominant role in the cartilage condensation process rather than in the concurring terminal differentiation. To further prove this hypothesis, we disrupted fibronectin‐beta1integrin‐interactions by treatment of ES cell cultures during an early differentiation stage with specific peptides containing an RGD‐sequence identical to the beta1integrin‐binding module in fibronectin. RGD‐treated ES cells showed a delayed chondrogenic differentiation as demonstrated by a decrease in the number of chondrogenic nodules. Currently, we investigate ES cells with a homozygous knock out of fibronectin to confirm the functional role of this extracellular matrix molecule during early chondrogenic differentiation in vitro.
PP 06 Employment of Genetic selection to the implementation of stem cell based in vitro models for toxicology
Embryonic stem cells (ESC) are immortal cells derived from blastocysts that can differentiate into any cell type in the human body. Any defect in the cell cycle will lead to apoptosis (programmed cell death), which contributes to many diseases, including pathologies associated with cell loss, and disorders characterized by a failure to eliminate harmful cells, like cancer. Apoptosis is caused by activation of intracellular proteases, known as caspases, which are responsible directly or indirectly for the morphological and biochemical events that characterize the apoptotic cell. The embryonic stem cell test (EST) represents a scientifically validated in vitro system for the classification of compounds according to their teratogenic potential. Embryotoxic drugs are also known to cause cell death and little is explored of their effects on the ESC. Knowledge of the molecular details of apoptosis regulation, and the toxicity markers constituting the apoptosis core machinery has revealed new strategies for identifying drug targets that could one day yield more effective in treatment for a wide variety of illnesses.
Since the molecular basis of the action of these drugs ESC is limitedly understood, thus identification of factors involved in ESC is one of the most important tasks in ESC research. We examined cytotoxic effects of embryotoxic category of drugs on the ESC. The aim of this study is to profile toxicological markers for embryotoxic drugs and in turn to explore the molecular mechanism of these drugs.
PP 07 A comparison of the phenotype and differentiation potential of placenta‐Derived human fetal and maternal mesenchymal stroma cells (pMSC)
PP 08 Derivation of trophoblast‐Like cells from non‐Human Primate Embryonic Stem Cells
Besides their ability to differentiate into derivatives of all the three germ layers, embryonic stem cells (ESCs) of mouse and human origin have been shown to be able to transdifferentiate into trophoectodermal cells. ESC‐derived trophoblast cells represent an useful in vitro model to investigate placental development and function as well as embryonic‐maternal interaction during pregnancy. Aim of our study was to investigate, whether monkey ES cells similar to human and mouse ESCs are able to form functional trophoectodermal cells in vitro.
ESCs were maintained and passaged using standard protocols. The differentiation was initiated via embryoid body (EB) formation in suspension. After 2d of suspension culture, the EBs were plated onto tissue culture plates. In the course of 2‐3 weeks, differentiated ESC cultures were analyzed by means of semi‐quantitative RT‐PCR and immunofluorescence for the expression of trophoblast markers, and by electron microscopy.
Using our EB‐based approach, effective differentiation into trophoblast‐like cells firstly became evident by morphological appearance of cystic structures. Semi‐quantitative RT‐PCR analyses showed the expression of cell type specific trophoblast marker genes as well as markers for more differentiated trophoblast subtypes. Immunfluorescence staining confirmed these results. The ultra structural analysis showed a microvillus morphology. More detailed analyses of the gene expression, the immunological properties and functional testing are ongoing.
This is the first study demonstrating the differentiation of non‐human primate ESCs towards cells of the trophoblast lineage. These ESC‐derived trophoblasts represent a valuable tool to investigate placental morphogenesis and implantation events of early trophoblasts in vitro.
PP 09 Influence of acetylcholinesterase on neuronal differentiation of murine embryonic stem cells
The primary role of acetylcholinesterase (AChE) is to terminate neurotransmission by fast hydrolysis of its substrate acetylcholine (ACh) at cholinergic synapses and neuromuscular junctions. However, it has long been acknowledged that AChE also displays a large set of non‐cholinergic functions. These functions have been attributed to both developmental and degenerative processes. Our previous gene and protein expression studies demonstrated that AChE and other components of the cholinergic system are expressed in murine embryonic stem cells (ESCs). This paper presents further work on the functions of AChE in stem cells. In order to investigate a possible contribution of AChE to cell differentiation, we stably transfected the CGR8 and D3‐cell lines with a plasmid encoding mouse AChE. Cells from the same passage were also stably transfected with GFP and used as experimental control. We examined at the stem cell stage parameters as cell vitality, proliferation and apoptosis. AChE overexpression led to a significant decrease of cell proliferation, but didn't affect cell vitality and apoptosis. Stably transfected cells were differentiated toward a neuronal phenotype following an ITSF protocol and their differentiation was compared with GFP‐transfected cells. Expression of stem cell and neuronal markers was examined by RT‐PCR, qPCR and immunohistochemistry. We found that AChE stimulated a more efficient differentiation of stem cells into neuronal cell type, by comparing expression of nestin, MAP‐2, N‐CAM. With these results we could show that AChE expression at early developmental stages is not related to synaptic transmission, but to developmental processes.
PP 10 Influence of microRNA‐1 on cardiac differentiation of rhesus monkey embryonic stem cells
Although contribution of microRNAs (miRs) to cardiac development and disease has already been demonstrated, it has only recently been suggested that miR‐1 directs embryonic stem cells towards the mesendodermal cell lineage while inhibiting neuroectodermal differentiation at a progenitor cell stage. As an in vitro model for cardiomyogenesis we are using the rhesus monkey embryonic stem cell (RESC) line R366.4 which strongly favours neuronal differentiation leading to poor mesoderm and cardiomyocyte formation. It is aim of this study to investigate whether expression of miR‐1 is not only able to enhance cardiac differentiation in ESC lines that easily differentiate into cardiomyocytes even without specific manipulation, but also to reverse the inherent strong neuroectodermal commitment of R366.4 towards mesodermal lineages. In general, non‐viral transfection of RESCs yields poor results. We have now established efficient introduction of miRs into single cells and entire RESC colonies. Transfected colonies are differentiated via embryoid body‐formation. To follow up on progressing differentiation we analyse expression of the mesendodermal marker Brachyury, the early cardiac marker Nkx2.5 as well as neural markers. Moreover, a lentiviral vector encoding an inducible miR‐1 transgene based on the TetON‐system has been constructed and transducted into single RESCs. This approach shall enable regulation of miR‐1 expression in RESC after stable viral integration. Data analysis from this study is on‐going and preliminary results will show whether modulation of miR‐1 expression is able to reverse the commitment towards ectodermal lineage of RESCs and instead promote cardiomyocyte formation.
PP 11 Non‐human primate Embryonic Stem Cell derived cardiomyocytes for the establishment of an in vitro pharmacological screening system
Drug development requires extensive pharmacological safety studies prior to clinical application of new agents. In contrast to expensive and ethically problematic in vivo studies, data quality of existing high throughput screening assays is usually low. Embryonic stem cell (ESC) technology may allow the development of novel high throughput screening systems that could replace current primate studies for cardiovascular safety pharmacology. Based on our recent findings demonstrating robust differentiation of functional cardiomyocytes from rhesus monkey ESCs it is now aim of this ongoing study to investigate, whether on one hand non‐human Primate ESC‐derived CMs are comparable to human ESC derivatives regarding their electrophysiological properties, and whether on the other hand electrohysiological in vitro data are comparable to in vivo data. Human ESCs and ESCs of non‐human primates were cultured and differentiated using human ESC protocols. ESC‐derived CMs were analyzed by means of semi‐quantitative and quantitative RT‐PCR, immunocytology and on an electrophysiological level by multi electrode assays (MEA). We were able to transfer our established protocol for cardiac differentiation of rhesus monkey ESCs to cynomolgous ECSs. Semi‐quantitative RT‐PCR analyses demonstrated expression of marker genes typical for endoderm, mesoderm, cardiac mesoderm and CMs. Immunohistological and ultra structural studies showed expression of CM‐typical proteins and electrophysiological studies by means of multi electrode arrays (MEA) revealed evidence of functionality, electrical coupling and β‐adrenergic signaling of the generated cardiomyocytes. Electrophysiological studies on human and nonhuman primate ESCs are ongoing in order to comparatively evaluate the effect of different agents with known cardiovascular effects.
PP 12 Lentiviral transgene expression in nonhuman primate embryonic stem cells (ESCs)
Genetic manipulation of embryonic stem cells (ESCs) is frequently used to enable cell tracking after transplantation, to direct differentiation or to purify specific cell derivatives. Most conventional gene transfer technologies yield poor results on (non)human primate ESCs, especially with respect to stable transgene expression. Lentiviral vectors (LV) have been shown to effectively and stably transduce ESCs. However, different ubiquitous promoters have been used and their expression in primate ESCs has not been analyzed systematically. It is therefore aim of this ongoing study to comparatively characterize transgene expression from LV containing different ubiquitous promoters in rhesus monkey ESCs (RESCs) and their derivatives. The RESCs are transduced with SIV‐derived LV for expression of GFP under control of CMV‐, SFFV‐, PGK‐, EF1α‐ and CBA‐ promoters. The number of integrated copies are measured by qPCR. ESCs are cultured and differentiated using a standard embryoid body based protocol. GFP expression is quantified by fluorescence microscopy and FACS‐analysis in undifferentiated RESCs and their differentiated progeny.
First results suggest that the EF1α promoter leads to the strongest expression in undifferentiated cells whereas expression significantly decreases during differentiation. Although the CMV promoter appears to be a very strong promoter in differentiated cells, no visible transgene expression was observed in undifferentiated RESCs. Further promoters are currently under detailed investigation. Our results will enable a more rational decision concerning the choice of promoters for application in cells of various differentiation statuses.
PP 13 Generation of Functional Murine Cardiac Myocytes from Induced Pluripotent Stem (iPS) Cells
The recent breakthrough in the generation of induced pluripotent stem (iPS) cells, which are almost indistinguishable from embryonic stem (ES) cells, facilitates the generation of murine disease– and human patient– specific stem cell lines. The aim of this study was to characterize the cardiac differentiation potential of murine iPS cell clones in comparison to murine ES cells. MEFs derived from transgenic OG2 mice were transduced with four factors according to Yamanaka et al. Resulting reprogrammed cells were sorted by FACS based on their Oct4‐promoter dependent GFP expression. Different iPS cell clones as well as ES cells were differentiated using a standard embryoid body (EB)–based differentiation protocol. Dependent on the clone, the differentiation resulted in 50‐95% of spontaneously contracting iPS cell EBs. Analyses on molecular, structural, and functional levels demonstrated that iPS cell– derived cardiomyocytes show typical features of ES cell– derived cardiomyocytes. Expression of marker genes typical for mesoderm, cardiac mesoderm, and cardiomyocytes including Brachyury, Mesp1, FOG‐2, GATA4, Nkx2.5, Tbx5, Tbx20, ANF, MLC2a, MLC2v, α‐MHC, cardiac troponin T and Cx43 in differentiation cultures of iPS cells was demonstrated by RT‐PCR and immunocytology. iPS cell cardiomyocytes displayed spontaneous rhythmic intracellular Ca2+ fluctuations with amplitudes of Ca2+ transients and functional coupling comparable to ES cell cardiomyocytes. Electrophysiological studies with multielectrode arrays demonstrated functionality and presence of the ß‐adrenergic and muscarinic signaling cascade in these cells. iPS cells differentiate into functional cardiomyocytes. In contrast to ES cells, iPS cells allow derivation of autologous functional cardiomyocytes for cellular cardiomyoplasty and myocardial tissue engineering.
PP 14 Establishment of human iPS like cells from lung fibroblasts and umbilical cord blood derived endothelial progenitor cells
Recently it has been shown that reprogramming of adult somatic cells into a pluripotent embryonic stem cell (ESC) ‐ like state can be achieved by the ectopic overexpression of different transcription factors from retroviral and lentiviral vectors.
We have now established reprogramming of adult and cord blood derived cells by lentiviral overexpression of four factors: Oct3/4, Sox‐2, Nanog and lin28. For this aim, human lung fibroblasts and human cord blood derived endothelial progenitor cells were transduced with lentiviral vectors containing the 4 pluripotency associated transgenes under the control of the EF1α promoter. Transduced cells were transferred to inactivated murine embryonic fibroblasts as feeder cells and further cultivated under culture conditions for human embryonic stem cells. After 3‐4 weeks colonies appeared that could be transferred to fresh feeders. Resulting colonies showed an ESC‐like morphology and behaved like ESCs in culture. Expression of endogenous Oct3/4, Sox2, Nanog and lin28 could be shown by RT‐PCR.
Further characterization of the resulting iPS like cells in particular regarding their differentiation potential is ongoing.
PP 15 Reprogramming of porcine somatic cells by fusion with murine embryonic stem cells
Differentiated mouse cells can be reprogrammed to a pluripotent state by cell fusion with mouse embryonic stem (ES) cells. Thus ES cell‐mediated cell reprogramming provides an opportunity to derive patient specific donor cells. In our study we used mouse RHN ES cells (Nanog over‐expression, hygromycin resistance) as the pluripotent partner to reprogram porcine fibroblasts (transgenic with human A20 and neomycin resistance). Co‐culture fusion of porcine fetal fibroblasts with mouse ES cells resulted in two double‐resistant fusion clones which displayed embryonic stem cells morphology and high proliferation rate. Endpoint‐RT‐PCR, PCR and Southern‐Blot analyses identified both porcine and murine transgenes in the hybrids, indicating the presence of both murine and porcine chromosomes. FACS analysis of the mouse‐pig hybrids indicated rapid loss of supernumerary chromosomes after release from the antibiotic selection medium. A second round of antibiotic‐selection with geneticin (encoded by porcine nuclei) eliminated the revertant diploid mouse cells and enriched polyploidy hybrids. Spectral karyotyping (SKY) analysis revealed that pluripotent mouse nuclei dominated the hybrids and that selective elimination of porcine chromosomes had taken place. Endpoint RT‐PCR analysis detected expression of porcine OCT4 transcripts in one hybrid clone, indicating reprogramming of the porcine genome. The present data suggest that besides reprogramming a selective ablation of somatic chromosomes can be found in hybrids of pluripotent ES and porcine somatic cells. Identification of the underlying mechanisms will be essential to evaluate feasibility of ES cell‐mediated reprogramming for cell replacement therapies.
PP 16 Application of pluripotent stem cell derived cardiac cells for 3D tissue engineering
Due to the large amount of cells needed in three dimensional (3D) tissue engineering, the use of stem cells always requires expensive large scale cultures and / or highly efficient cardiac differentiation protocols. Hence, we have designed a system to generate miniaturized 3D bioartificial cardiac tissue (BCT). Our bioreactor allows for mechanical, electrical, and chemical stimulation of six parallel, but independent settings, as well as for microscopical observation of tissue formation and measurement of forces developed by the artificial tissue under constant sterile conditions. The scaffold used in our system consists of liquid collagen type I and Matrigel ®. We were able to generate BCTs from neonatal rat cardiomyocytes (NRCMs) as a test system, as well as from murine induced pluripotent stem (iPS) cell‐derived cardiomyocytes. Rat BCTs contracted spontaneously, showed an organized tissue structure and a high contractility with maximum forces of up to 2.4 mN. Using murine iPS cell‐derived cardiomycytes, we were able to produce contractile BCTs with high expression levels of cardiac markers demonstrated by RT‐PCR and immunohistochemistry; but also markers for pluripotency like Oct 3/4 and Nanog were detected. Thus, to enhance the functionality of the BCT, a selection system is needed to eliminate undifferentiated stem cells as potential sources for teratoma formation, but also cells of non‐cardiac lineage. We introduced a lentivirally mediated cardiac specific puromycin resistance into mouse iPS cells; subsequently, selected iPS cell‐derived cardiomyocytes will be used for 3D tissue engineering in our bioreactor system.
Hematopoietic Stem Cells
PP 17 Rational design of Toll‐like receptor 1 and 2 agonists and antagonists as immunomodulating agents
Toll‐like receptors (TLRs) have been shown to be involved in the recognition of pathogens by the innate immune system. The ligands for most of the 13 TLRs have been identified, representing predominantly distinct bacterial or viral components. TLR2 forms heterodimers either with TLR1 or with TLR6 to attain specificity for a given stimulus, mainly by lipoproteins with the unusual amino acid S‐[2,3‐dihydroxypropyl]‐cysteine (Dhc). The cellular response induced by synthetic lipopeptides was shown to be dependent on the chirality of Dhc, the number and length of fatty acids.
To study the influence of the peptide moiety on activity of synthetic TLR 1 and TLR 2 ligands, a series of Pam3Cys‐lipopeptides was synthesized. These lipopeptides, differing in one amino acid in its sequence position, were investigated for biological activity. The results from this structure activity relationship of lipopeptides will be discussed in relationship to the recently published crystal structure of TLR1/TLR2 heterodimers. Lipopeptides that lack biological activity provide a basis for compounds with TLR antagonistic activity.
PP 18 Cathepsin X modulates adhesive interactions in the human hematopoietic stem cell niche
Cysteine cathepsins belonging to the papain subfamily of cathepsins primarily function within endolysosomal compartments, but have also been shown to function extracellularly. These proteolytic enzymes can regulate diverse biological processes such as cell proliferation, adhesion and migration. These processes are also highly relevant in the bone marrow stem cell niche which provides a unique microenvironment for hematopoietic progenitor cell (HPC) survival and proliferation. The major components of the endosteal stem cell niche are the osteoblasts and their secreted extracellular matrix. During mobilization of HPCs several extracellular proteases such as MMP‐9 or cathepsin G are known to be released into the bone marrow. However, in mice lacking these proteases mobilization is only partially affected. Therefore cathepsin expression and secretion by different cell types of the human bone marrow was investigated. Confocal analysis revealed that cathepsin X is not only bound to the cell surface of human primary osteoblasts (pOB) but is also secreted into the cell culture medium. Protease activity assays using the cathepsin X‐specific substrate Mca‐R‐P‐P‐G‐F‐S‐A‐F‐K (Dnp) showed that cathepsin X in pOB‐conditioned medium prompted substrate conversion. In cell‐cell adhesion assays with adherent primary osteoblasts and MACS‐isolated CD34+ HPCs a significant decrease of HPC adhesion to pOBs in the presence of mature cathepsin X was observed. Adhesive interactions between osteoblasts and HSC are impaired by activated cathepsin X suggesting a role of this protease in the release of HSC from their niche during stem cell mobilization.
PP 19 Similarities and differences during the ex‐Vivo development of human Natural Killer cells from CD34+ cells from UCB, BM or mPB
Natural killer (NK) cells are lymphocytes that mature in the bone marrow (BM), derived from hematopoietic stem cell (HSC). Hematopoietic progenitor/stem cells (CD34+ cells) represent an attractive source for generation of NK cells. NK cell generation methods were important steps forward, however so far these protocols and culture conditions have not been fully optimized and are not applicable for clinical applications.
We have developed a novel, stroma cell free culture system for the ex vivo generation of NK cells from CD34+ hematopoietic progenitor cells, isolated from umbilical cord blood (UCB), bone marrow (BM) or G‐CSF mobilized peripheral blood (mPB).
Using our system, we demonstrate that the use of a very well defined serum free medium is necessary in order to generate NK cells under the same culture conditions from all the sources of stem cells. We followed the phases of development, showing a decrease of stem cell specific antigens (CD34, CD133, CD117) during the first three weeks, whereas antigens specific for NK cell differentiation (CD56, CD94, CD161, CD16. NKp44) are up regulated after initiating differentiation at day 14. We are able to differentiate the expanded progenitor cells into CD3‐/CD56+ NK cells and demonstrated that these ex vivo‐expanded NK cells efficiently lyse AML and melanoma cells.
The use of defined culture conditions enables new prospects in NK cell research as well as in the clinical use of NK cell products derived from CD34+ cells, which can be isolated from UCB, BM or mPB.
PP 20 Osteoblast‐Derived MMPs impair adhesion of hematopoietic stem cells to the endosteal stem cell niche
Hematopoietic progenitor cells (HPCs) reside within the bone marrow in the endosteal and perivascular stem cell niche. The endosteal niche is mainly composed of osteoblasts and their secreted extracellular matrix. Different isoforms of the laminin family are found within this niche which can be degraded by several matrix metalloproteinases (MMPs). In the process of mobilization several proteases contribute to the release of HPCs from their niches. However, the precise mechanism of mobilization is still unknown. The expression of MMPs by human osteoblasts was explored by RT‐PCR, Western blotting and immunofluorescence staining and revealed that MMP‐2, −8, −9, −10 and −11 are expressed. Their influence on the interaction of HPCs with osteoblasts was quantified by cell‐cell adhesion assays with labeled HPCs. After adhesion of CD34+ progenitor cells to primary osteoblasts, activated MMPs're added. These assays revealed a strong reduction of HPC cell attachment to osteoblasts after incubation with activated MMP‐2, −8, −9 and −10 compared to non‐activated MMPs and activated MMPs mixed with inhibitors. In addition the expression of laminins by RT‐PCR and immunofluorescence staining was analyzed, the effect of MMP‐degraded laminin 511/521 to HPCs was evaluated in cell‐matrix adhesion and migration assays. Proteolytic digestion of laminin‐511/521 reduced the binding of HPC to this laminin isoform. However, the MMP‐degraded laminin‐511/521 had a strong migratory effect. We provide evidence that osteoblasts‐secreted MMP‐2, −8, −9 and −10 can reduce binding of HPCs to osteoblasts. Furthermore, proteolytic degradation of laminin isoforms by MMPs might support mobilization and migration of HPC out of the niche.
PP 21 Umbilical cord blood‐derived cells with embryonic phenotype: Impact of biological variations of serum on cell‐Culture results
PP 22 Critical parameters for serum‐Free culture of human adult progenitor cells
Prospective cell therapy will require standardised, reproducible, pathogen‐free culture conditions. Along this aim, we sought to elaborate serum‐free conditions for expansion and cryo‐preservation of two types of adult human stem/progenitor cells, i.e. multipotent mesenchymal stromal cells from chorionic villi of term placenta (CV‐MSC), and endothelial outgrowth cells from umbilical cord blood (UCB‐OEC). Both cell types proliferated fast under standard culture with serum. A panel of commercial, chemically defined expansion and preservation media were compared. We report serum‐free (but not xeno‐free) conditions for culture as well as cryopreservation of CV‐MSCs; these cells proliferate significantly faster in UltraCulture/Ultroser G than under standard conditions. Flow cytometric monitoring demonstrated that CV‐MSCs in UltraCulture/Ultroser G maintained their MSC surface marker profile over many passages. However, confluent culture resulted in loss of their MSC surface marker profile. The CV‐MSCs could be cryo‐preserved in completely synthetic ‘Filoceth’ freezing medium as efficiently as in serum/DMSO. For UCB‐OECs, expansion in serum‐free chemically defined media was very modest or absent, even upon supplementation with a battery of endothelial growth factors, for elusive reasons. We performed gene arrays with UCB‐OECs to identify signaling pathways that are activated in serum conditions but not in chemically defined media. The results are presently analyzed and will be presented. In summary, we achieved efficient expansion as well as cryo‐preservation of human CV‐MSCs under serum‐free conditions. Requirements for serum‐free OEC expansion are still elusive, but gene‐array analysis may lead to identification of signaling pathways that need to be activated for OEC propagation.
PP 23 Stem cell therapy derived CD133+− bone marrow progenitor cells secrete angiogenic, chemotactic, and inflammatory cytokines
Corresponding author: Friederike Jung, University of Luebeck, Clinic of Anesthesiology, Ratzeburger Allee 160, 23538 Luebeck, Germany
The cell based therapy of ischemic heart diseases is accepted as an optional treatment in the terminal ischemic cardiomyopathy. In a multicentre study phase II patients suffering from severe ischemic heart diseases are treated with autologues bone marrow derived CD133+− endothelial progenitor cells (EPC). First results show a significant increase of left ventricular ejection fraction. As one possible reason for this improvement of heart function paracrine effects of the injected cell fraction can be taken into account. Secreted cytokines and chemokines may stimulate residing endothelial cells to angiogenesis and recruit neutrophil granulocytes and monocytes which for their part secrete angiogenic chemokines boosting the effect. Isolation of cells from bone marrow using the surface marker CD133 adresses several bone marrow stem and progenitor cells like endothelial progenitor cells (EPC), mesenchymal stem cells (MSC), and different hematopoietic progenitor cells resulting in a very heterogeneous cell fraction. We arranged a custom cytokine array (RayBiotech) including 50 cytokines and chemokines reported to be secreted by bone marrow dervied CD34+− cells, CFU‐Meg and MSCs. The dead volume of syringes from intramyocardial injection was recovered and cells were cultured. In serum‐free medium (StemSpan SFEM) the cells secreted with ELR+ CXC‐chemokines IL‐8 and NAP‐2, RANTES, MIP‐1α, MIP‐1β, the matrix metalloproteases MMP‐1 and MMP‐9, and the tissue inhibitors of metalloproteases TIMP‐1 and TIMP‐2 angiogenic, chemotatic and inflammatory cytokines. Stimulating residing cells to angiogenesis these may contribute to the improvement of left ventricular function after stem cell therapy.
PP 24 Ex vivo ovine umbilical cord blood isolation of mesenchymal stem cells
In past decades, umbilical cord blood (UCB) has been regarded as an alternative source to bone marrow cell transplantation and therapy because of its hematopoietic and mesenchymal components. However, the presence of mesenchymal stem cells (MSCs) in UCB is controversial. Ovine is an important animal model in orthopedic pre‐clinical trials. Herein, we describe the isolation of MSC from ovine UCB. The ovine UCB has been collected through intra‐uterine surgery. It was used a previous heparinized syringe and the samples was immediately processed. The mononuclear cells (MNCs) were isolated by density gradient centrifugation using Ficoll‐Paque at 2500 rpm for 30 minutes at 20°C. MNCs were washed three times with PBS and resuspended in proliferation medium consisting of 1% DMEM‐LG (Gibco), 15% FBS, 1% penicillin/streptomycin, 1% B‐anfotericin and L‐Glutamine. The culture flasks were maintained at 37°C in a humidified environment containing 5% carbon dioxide. After expansion, the cells were morphologically analyzed by inverted microscopy (NIKON ECLIPSE, TS100). After 96‐hours of incubation the non‐adherent cells and the culture medium were discarded remaining only adherent cells and culture medium was replaced every 3 days. After cell expansion were observed cells with mesenchymal or fibroblast‐like morphology. After 25 days of culture adherent cells reached 60% confluence. This study proves that the ovine UCB contains mesenchymal cells and related to a successful protocol of isolation of MSC in ovine which gives subsidizes to new pre‐clinical researches in regenerative medicine.
PP 25 Correlation between the expression of CD45 and apoptosis in myelomonocytic HL‐60 cells
Hematopoietic stem cells have the potential for multidifferentiation as well as self‐renewal. Myelomonocytic HL‐60 cells can serve as an in vitro model for multidirectional differentiation and we have investigated the relationship between differentiation and apoptosis in these cells. Treatment of HL‐60 cells with 1mM butyrate induces the expression of CD86 molecules within 48‐72 hours, indicating differentiation mainly towards the monocytic lineage. The percentage of spontaneously apoptotic cells is comparable in treated and untreated cells, as assessed by DNA fragmentation in cell cycle analysis (subG1‐fraction = 4,07 ± 0,36%; n = 6). In contrast, higher concentrations (5‐10mM) of butyrate induce apoptosis within 24‐72 hours (subG1‐fraction = 29,40 ± 2,47%, n = 6; p = 0,05). This is also evidenced by the activation of key caspases as measured by flow cytometry. The increase of caspase+ cells is paralleled by a decrease of CD45+ cells. Both caspase+ and caspase‐ cells which are CD45+ exhibit a higher cell volume (CV) and display apoptotic volume decrease (AVD) between 24 and 72 hours. In contrast, CD45‐ cells have a smaller CV and do not display apparent AVD. Hence the presence of CD45 seems to be involved in AVD. In addition 33,93 ± 14,69 % (n = 6) of butyrate (10mM) treated CD45+ cells show caspase activation to 72 hours and exhibit a strong increase of their granularity. In contrast the number of caspase+ cells is significantly higher in the CD45‐ fraction (83,86 ± 3,78 %; n = 4; p = 0,05). Interestingly, these cells do not change their granularity during butyrate treatment.
PP 26 Ex‐Vivo generation of clinical relevant amounts of NK cells from CD34+ progenitor cells for immunotherapy
Donor Natural Killer (NK) cells, displaying a KIR‐ligand mismatch with the recipient, could play a pivotal role in an improved graft‐versus‐leukaemia (GVL) response without significant graft‐versus‐host disease (GVHD) following haploidentical stem cell transplantation. Infusions of haploidentical mismatching NK cells are suggested to become an attractive approach for cancer immunotherapy. So far only limited data are available concerning the safety and clinical effects of purified NK cell infusions. Here we describe a novel stroma free cell culture system, using specific glycosaminoglycans (GAGs), for the generation of functional NK cells from umbilical cord blood (UCB) CD34+ hematopoietic progenitor cells. We can routinely expand and differentiate CD34+ cells up to 7.3 × 104 fold into CD56+/CD3− NK cells with a purity of >99%. This results in more than 1 × 1010 NK cells, using 1.5 × 105 CD34+ cells initially. These ex‐vivo generated NK cells express typical NK cell specific antigens including CD94, CD16, NKG2A, NKG2D and most interestingly Killer Immunoglobulin‐like Receptors (KIRs). We have been able to demonstrate in cytotoxicity assays that these ex vivo‐expanded NK cells not only efficiently lyse common targets as K562 tumor cells, but in addition a variety of other human haematological and solid tumor cell lines. Our findings therefore point towards the likelihood of a breakthrough in producing a pure NK‐cell product from small quantities of UCB for future cancer immunotherapy.
PP 27 Endothelialisation of poly 4‐methyl‐1‐pentene (PMP) membranes with gas exchange properties
PP 28 Impairment of endothelial cell repair in mice lacking the CXC chemokine receptor 3
Within atherosclerotic plaques, presented antigens trigger the activation of T cells in the artery. Activated T cells produce IFNγ which stimulate vascular cells to release e.g. IP‐10 and MIG. These counteract with CXCR3 and direct the migration of inflammatory cells toward sites of inflammation following injury. We postulate that endothelial progenitor cells (EPC) express CXCR3 and are attracted to the lesion site by interaction with IFNγ inducable chemokines IP‐10 and MIG. CD133+/ CD34− and CD34+/ VEGFR+ EPC express CXCR3 as determined in PCR analysis and flow cytometry. IP‐10 and MIG enhanced the migration of EPC in Boyden Chambers and their adhesion on TNFα stimulated endothelial cells in Flow Chambers.
In order to study the in vivo relevance of CXCR3, we performed an endothelial cell denudation of the common carotid artery in CXCR3−/− mice and controls. The reendothelialization process was significantly delayed in CXCR3−/− mice compared to controls. The number of circulating Sca‐1/Flk‐1 positive EPC was significantly higher in the CXCR3−/− mice compared to controls whereas on the bone marrow level the number of Sca‐1/Flk‐1 positive EPC was decreased in CXCR3−/− mice. We conclude that the T cell associated inflammatory response after vascular damage attracts CXCR3 positive EPC which appear to contribute to the restoration of the endothelium. Our results indicate a pivotal role of the CXCR3 receptor in EPC mobilization and homing.
Mesenchymal Stem Cells & Locomotor Tissue
PP 29 TGF‐β is a regulator for matrix turnover in mesenchymal stem cells
PP 30 Isolation and engineering of rat mesenchymal stem cells for tendonndon regeneration
PP 31 Stem cells show neuroectodermal features obtained from mesenchymal stem cells
Tissue‐specific stem cells, such as bone‐marrow‐derived mesodermal stromal cells (hMSCs), are thought to be lineage restricted and therefore, could only be differentiated into cell types of the tissue of origin. Several recent studies however have suggest that these types of stem cells might be able to break barriers of germlayer commitment and differentiate in vitro in cells with neuroectodermal markers. We reported about an efficient conversion of human adult bon‐marrow stem cells (hMSCs) into a neural stem cell like population (hmNSCs for hmNSCs, for human marrow‐derived NSC‐like cells). These cells grow in neurospheres‐like structures, express high levels of neuroectodermal markers, and differentiate into the three main neural phenotypes, in astroglia, oligodendroglia and in neurons. Our report focus on an expression profile with Affymetrix technology on these human MSC‐derived NSC‐like cells (hmNSCs), compared with bone marrow stem cells, as cell‐ population of origin, and compared with adult hippocampus‐derived human neural progenitor cells (hNSCs), as a neural progenitor cell control, to show differences and similarities of these NSC‐like cells. hmNSCs showed high expression of different neural and neuroectodermal genes like BAALC, GAP‐43, MAOA, NRCAM, SCGN10, SNAP25 and PDGFRα.
PP 32 P2X and P2Y Receptors in Human Mesenchymal Stem Cell Differentiation
Human adult mesenchymal stem cells (MSCs) derived from adipose tissue possess multiple lineage capacity. Although they have been shown to differentiate into adipocytes and osteoblasts, receptor expressiossion and/or their alteration during these processes is only partly understood. Purinergic 2 (P2) receptors are plasma membrane bound molecules, divided into the ligand‐gated ion channels P2X and G‐protein coupled P2Y receptors. They are activated by ligand‐binding of extracellular nucleotides which triggers intracellular signals affecting various processes including proliferation and differentiation. Here we show that some P2X and P2Y receptors are involved in the differentiation of MSCs towards the osteogenic or the adipogenic lineage. Over a period of four weeks of differentiation several P2 receptors were found to be up‐ or down‐regulated. Further investigations of P2 receptor signalling and their downstream targets are necessary to provide additional insights into the differentiation processes revealing novel options to control stem cell fate.
PP 33 Mechanical forces to β1‐integrins stimulate the expression of vascular endothelial growth factor in mesenchymal stem cells
Beside growth factors that stimulate mesenchymal stem cells to differentiate into the different lineages, data concerning the role of mechanical forces in the control of stem cells are rare. Integrin receptors on the cell surface function as mechanotransducers. Therefore, we use a technique to directly apply drag forces to the β1 integrin subunit by antibody coated paramagnetic beads in an inhomogenous magnetic filed. This technique we used to mechanically stress integrin receptors in human mesenchymal stem cells from bone marrow for 15 min with a frequency of 1 Hz. We tested the effect on osteogenic differentiation. In addition we had been interested in the expression and secretion of vascular endothelial factor (VEGF) as a typical regulating factor for vascularisation, which is secreted by osteoblasts. 48 hours after the application of forces to integrins we found a significant increase in the expression and secretion of VEGF. This effect we found when cells were cultured both in expansion medium and in osteogenic but not in adipogenic differentiation medium. In contrast, two days after the application of mechanical integrin stress we did not detect a stimulation of the expression of the typical osteogenic genes. In summary, a short mechanical stress to integrin receptors induced the production of VEGF in mesenchymal stem cells before the cells revealed markers of an osteogenic phenotype. In conclusion, mechanical forces induce a functional activity in mesenchymal stem cells, which might be of significance for angiogenesis and osteogenesis in vivo.
The work was supported by the DFG (SFB‐Transregio 37).
PP 34 High Density Co‐Culture of primary Osteoblasts with Mesenchymal Stem Cells Promotes and Facilitates Osteogenesis
Large bone defects resulting from tumor resection and trauma require the development of new and innovative treatment strategies. A promising approach is tissue engineering of bone grafts with osteoprogenitor cells such as adult mesenchymal stem cells (MSCs). However MSCs require growth factors for osteogenic induction. The aim of this study was to alternatively evaluate the osteogenic induction potential of primary isolated osteoblasts on MSCs in co‐cultures at the following ratios: 10%/90%, 30%/70% and 50%/50%. Co‐cultures were then treated with or without a specific osteogenic induction medium in monolayer and high density cultures for up to 21 days. In monolayer co‐culture, osteogenesis was only observed in treated but not in untreated co‐cultures. In contrast to this, in high density co‐cultures, ultrastructural evaluation demonstrated osteogenesis, with no significant difference between treated, untreated or pure osteoblast cultures. Immunoblotting investigation demonstrated collagen type I, β1‐Integrin, induction of the MAPKinase pathway and Cbfa‐1 production in the co‐cultures during osteogenesis. The quality of osteogenesis achieved was proportional to the amount of osteoblasts in the co‐cultures. Co‐cultures consisting of 50% osteoblasts and 50% MSC showed markedly increased osteogenesis, compared to pure osteoblast cultures. The presence of as little as 10% osteoblasts in the co‐cultures strongly increased osteogenesis compared to MSCs; treatment with the induction medium further enhanced osteogenesis in these co‐cultures. In conclusion, co‐culture of MSCs with primary osteoblasts combined with the three dimensional environment is a strong promoter of osteogenesis. This co‐culture approach combined with patient derived serum supplementation may enhance future bone regeneration strategies.
PP 35 Long‐Term Inflammatory Stimulation of Adipose Tissue‐Derived Stem Cells Induces Proliferation and Osteogenic Differentiation
Throughout whole life, bone is continually renewed: It is degraded by osteoclasts and rebuilt by osteoblasts. In chronic inflammatory diseases, this fine‐balanced system may be disturbed. In arthritis for example, increased osteoclast maturation rates promote osteoporosis. While osteoclasts derive from the hematopoietic lineage, osteoblasts develop from mesenchymal stem cells (MSC). Adipose tissue‐derived stem cells (ASC) have MSC character, as they are able to differentiate e.g. along the adipogenic, chondrogenic and osteogenic lineage and express typical MSC surface markers. Thus, they are promising candidates for regenerative medicine and tissue engineering.
This work aims at elucidating the impact of chronic inflammatory conditions on osteogenic differentiation of ASC, simulated in vitro by long‐term treatment with low concentrations of the cytokine TNF‐alpha. TNF‐alpha was found to increase ASC proliferation rates and expression of osteogenic marker gene alkaline phosphatase as well as the activity of its protein product. Additionally, calcification of the extracellular matrix could be shown. Thus, long‐term inflammatory stimulation of ASC in vitro induces osteogenic differentiation. However, we found differences between osteogenic differentiation induced by TNF‐alpha and that induced by standard osteogenic chemicals: Transcription factor ZBTB16, an upstream regulator of RUNX2, was induced 1000‐fold by the osteogenic chemicals, but remained unaffected by TNF‐alpha. Hence, different signal transduction pathways downstream TNF receptor 1 seem to be involved which will be the focus of ongoing investigations.
PP 36 Hypoxia effects on human lipoaspirate‐Derived mesenchymal stem cells differentiation potential
Human lipoaspirate‐derived mesenchymal stem cells (lMSC) are regarded as one of the most perspective sources of cells for regenerative medicine. There is the need for a adequate amount of cells keeping their undifferentiated state. We have shown earlier that cultivation lMSC at low oxygen remained its viable and expressed the same MSC‐related markers as normoxic cells while proliferating at a 2,5‐3 fold higher rate. The aim of the study was to evaluate the effects of long‐term cultivation of lMSC in low oxygen tension (5% O2) on their adipo‐, osteo‐ and angiogenic potential. Primary mesenchimal cells were obtained from human lipoaspirate and investigated up to 3‐d passages. Osteogenic differentiation was assessed after 3 weeks as to matrix mineralization revealed by alizarine red staining. Adipogenic differentiation was evaluated after 2 weeks as to adipocytes formation. Angiogenic differentiation was assessed after induction by VEGF using in vitro Angiogenesis Assay Kit. Weak matrix mineralization (both spontaneous and induced) was observed in case of hypoxic lMSC. Their ability to differentiate into adipocytes under hypoxia was lower than that in 20% O2. Angiogenic activity manifested itself in capillaries formation was not detected in case of neither normoxic nor hypoxic cells. Thus, permanent cultivation of lMSC under hypoxia allows them to keep their undifferentiated status. This data may contribute to developing protocols for the preparation of cells used in reparative technologies.
PP 37 Function of WISP proteins in human mesenchymal stem cells
The wnt1 inducible signaling pathway proteins (WISP1 2 and 3) are matrix associated, secreted proteins. Molecular data on WISP‐functions are limited but point towards antiangiogenetic and tumorsuppressive functions. Aim of this study is to elucidate WISP‐functions in the musculoskeletal system. Recombinant WISP‐Fc proteins were expressed in insect cells and purified using protein G‐sepharose. Target cells were treated with recombinant protein, total RNA was isolated and RT‐PCR analyses were performed. For WISP3 the global gene expression pattern was analysed in MSCs using the Affymetrix Chip HG‐U133‐2.0‐plus. Results were evaluated using PathwayAssist software and RT‐PCR. Affymetrix analysis identified 111 regulated transcripts (107 up, 4 down) with at least 2.0‐fold change, 23 genes were reevaluated by RT‐PCR that confirmed the array results. A group of chemokine ligands, members of the TNFSF gene‐family and a series of interferon‐induced genes, were upregulated by WISP3. Additional RT‐PCR showed upregulation of most genes already after 12 hours of treatment. The upregulation of the chemokines CXCL10 and CXCL11 strengthens the view of WISP3 as an inhibitor of angiogenic processes. The family members IFIT1, IFIT2 and IFIT3 and two genes of the 2′‐5′‐oligoadenylate synthetase act in immune response processes. Although speculative, results might provide clues for WISP3 action in vivo. Thus the role of WISP3 might be explained by activities via anti‐angiogenic, apoptotic and interferone‐responsive genes.
PP 38 Retroviral gene transfer to ovine bone marrow mesenchymal cell
Tissue engineering and gene therapeutical methods have become a promising area of pre‐clinical and clinical research. It is important to investigate the engraftment of stem cells in the injured site and prove that delivered cells were transformed in local cell lineage. For the assessment of that, it is essential the use of genetic markers. Here we describe the successful transduction of ovine bone marrow mesenchymal cells (oBMMC) by pLNPoZ retrovirus, a Moloney Murine Leukemia Virus vector carrying the reporter bacterial gene LacZ. Retroviruses were produced by PT67 packaging cell lineage and used to infect oBMMC, plus 8 μg/ml of polybrene. At the fifth day, oBMMC infection was confirmed using X‐Gal staining method. Additionally, these cells did not show distinct phenotype in cell culture after virus transduction. Our group was interested in study bone regeneration, using these cells to verify their engraftment and capacity to differentiate in bone cells in vivo.
PP 39 Enhanced Proliferation and Differentiation Capacity of Human Mesenchymal Stem Cells Cultured with Extra cellular Matrix Proteins
PP 40 Quality Control of Bone chips as an Analogous Source for Regenerative Medicine
A sufficient vertical and transversal bone level is necessary for long‐term success of enossal dental implants. The reconstruction of bone defects can be achieved by using particulated, non‐vascularized bone autografts. Particles of bone grafts are produced during the implant‐bed preparation or are created by bone ablation with surgical round‐drills and can be collected with a bone filter integrated into surgical suction pipe. So far, contradictory statements have been made about this material. In this study, bone chips from approximately 70 donors were qualitatively and quantitatively investigated, in order to detect the properties of the contained cells; in particular their ability to proliferate out of the material. The oral cavity is the only part of the body, where bone tissue cannot be obtained in a sterile manner. Nevertheless, this material would be suitable for implants and it results during operation anyway. Therefore, additionally the contaminating microorganisms were examined in detail. Most of the samples showed cell outgrowth between weeks 2 and 4. These cells were characterised on the genetic level and on the protein level to determine their lineage specific commitment. The microbial populations, consisting mainly of the Streptococceae and Staphylococceae families, show no relationship to the cell outgrowth. Taken together, bacterial contaminations have been found in all samples, but could be reduced via perioperative antibiotic treatment. The quality of the obtained cells depends on the precise place of extraction but not on the quantity and quality of the present microorganisms, making this material a useful tool in regenerative dental medicine.
PP 41 Mesenchymal Stem Cell Therapy in Osteonecrosis of Femoral Head Ovine Model: Preliminary Results
Osteonecrosis of the femoral head (ONFH) is a progressive disease that leads to femoral head collapse and osteoarthritis. The goal in treating osteonecrosis is to preserve, not to replace the femoral head. Several models of ONFH has been described and in this study, was used the sheep model with ONFH induced by absolute ethanol through core decompression. This research agrees with ethical principles in animal research adopted by bioethics commission of the School of Veterinary Medicine and Animal Science of University of São Paulo. Eight animals were used divided in two groups according the source of cells used in cell therapy. Two animals received bone marrow ovine mesenchymal stem cells, two received human dental pulp stem cells, and two animals were considered as control. For bone marrow mesenchymal cell culture, bone marrow aspirates were obtained from the iliac crest of one 1‐year‐old Santa Inês sheep. A total of 1,6 × 106 cells were used in two animals, six weeks after ONFH ethanol induced. These cells were transduced with LacZ gene by a retroviral vector for confirm the transplant successful. For the human dental pulp stem cells group, 1,8 × 107 cells were introduced in animal's femoral head. After 4 weeks, the animals were euthanized and the femoral head injected were processed for light and scanning electron microscopy analyses. At the present moment, the engraftment of cells pre injections labeled with LacZ was confirmed, and the structure of bone tissue was fixed.
PP 42 Osteointegrative effects for seven bone‐Derivates and their influence on rat mesenchymal stromal cells
The regular treatment of patients with the need for bone replacements is the use of standard‐implants of graduated size. In many cases this approach is insufficient or impossible. Particularly the skull area requires individual implants because of the unique geometry and for plastic reasons. The aim of our study was to evaluate several bone‐derivates as a basis for an implant with variable size, which is stable, bioresorbable and has osteoinductive properties. Therefore we developed an experimental three‐dimensional implant, which is composed of polymer, fibrin, bone‐derivate material and autologous mesenchymal stromal cells. We have chosen seven different bone‐derivate materials (Bio‐Oss®, Cerasorb®, Fortoss VitalTM, Nanobone®, Osteo‐Biol®, Ostim® and TriCos®), which are in clinical use and have different properties and compositions for our investigations. To examine the effects of the three‐dimensional environment onto rat mesenchymal stromal cells in contrast to a two‐dimensional environment, we have analyzed the proliferation, cytotoxicity and differentiation rate. Outcome parameters for in vitro differentiation were alkaline phosphatase (AP) induction, RT (Reverse Transcriptase)‐PCR and Immunhistochemistry of runx2, osteocalcin, osteopontin and collagen type I. All bone‐derivates point to osteoinductive properties of the composites and no influences on proliferation and cytotoxicity rate. The intensity of osteoinductive effects seems to depend heavily on composition of the bone‐derivate materials. Overall, the results of this study emphasize that all seven bone‐derivates could be incorporated into bone tissue engineering composites as carrier for mesenchymal stromal cells retaining the bioactivity of the implants.
PP 43 Differential regulation of xylosyltransferase I and II during osteogenic differentiation of mesenchymal stem cells
The clinical application of mesenchymal stem cells (MSC) has gained increasing importance during the last years. They represent attractive cell sources for tissue engineering applications, e.g. bone replacement. Proteoglycans (PGs) exhibit an important role for matrix assembly and remodeling. Nevertheless, since bone development is a highly dynamic and complex process, the regulation of the extracellular matrix (ECM) formation remains elusive. Thus, the aim of this study was to investigate the regulation of crucial PG core proteins and key enzymes involved in glycosaminoglycan (GAG) biosynthesis during different stages of osteogenesis. For one of the rate‐limiting enzymes in GAG biosynthesis xylosyltransferase I, maximal mRNA expression levels (3.89 ± 0.83‐fold increase) and elevated enzyme activities (285 ± 17 dpm/μg DNA) were observed 10 days after osteogenic induction, simultaneously to the beginning mineralization of the extracellular matrix. In contrast, the highly homologous protein XT‐II showed no specific alterations.
The differential expression of chondroitin sulfate, dermatan sulfate and heparan sulfate chains were determined by analyzing the mRNA expression of EXTL2 (α‐1,4‐N‐acetylhexosaminyltransferase), GalNAcT (β‐1,4‐N‐acetylgalactosaminyltransferase), and GlcAC5E (glucuronyl C5‐epimerase) as they represent crucial enzymes in GAG biosynthesis. Besides GlcAC5E, all key enzymes showed upregulated mRNA contents (up to 3.6‐fold) around day 10. Except for decorin, which exhibited heightened mRNA levels even in the early stages of osteogenesis, we found similar upregulated mRNA contents (up to 14.6‐fold) for all investigated PG core proteins. The tight synchronized expression profiles demonstrate the coordinated biosynthesis of the PGs and underline their importance for the formation of bone and for the osteogenic stem cell differentiation.
PP 44 Expansion and differentiation of bmMSC under FCS‐Free conditions
PP 45 Adipose derived regenerative cell transplantation: Evaluating intervertebral disc repair in a canine model
PP 46 Is Oxygen a Factor to Influence Chondrogenic Differentiation of Bone Marrow Stem Cells?
Hypoxia is prevalent in native cartilage whereas in regular tissue culture cells are maintained under normoxic conditions. Reports exist to demonstrate the selectivity of hypoxic conditions for mesenchymal stem cells (MSCs) in vitro. To examine the effect within the chondrogenic lineage, we cultured MSCs obtained from human bone marrow under normoxic (∼ 21 % oxygen) and hypoxic (∼ 4 % oxygen) conditions. We then tested in gelatine‐based hydrogels and in standard micromass cultures whether the cells were able to differentiate to a chondrogenic phenotype under different oxygen conditions. Furthermore, we analysed whether oxygen affected the undesired terminal differentiation into hypertrophic cells. Expanded MSC were embedded in gelatine gels and transfered to standard chondrogenic medium. The cells were cultured normoxically and under hypoxia respectively. Standard micromass cultures served as positive controls. After two weeks the expression of typical chondrogenic markers was analysed via realtime RT‐PCR. All chondrogenically induced cultures (hydrogel and micromass) produced typical mRNA patterns. However, no significant improvement could be observed under hypoxia. Also, the expression of the hypertrophic differentiation marker collagen type X was not influenced by oxygen. Hypoxia is not a factor that inhibits hypertrophy. Chondrogenic differentiation appears to be independent of oxygen pressure, regardless if low or high cell‐densities were used for differentiation.
PP 47 In‐Vivo Osteoprogenitor Activity Of Human Stromal Cells From Different Tissues Does Not Correlate With Expression Of POU5F1 Or its Pseudogenes
PP 48 In vitro therapy of cartilage defects Using human osteoarthritic condyles and chondrogenic spheroids as transplants
PP 49 Low ALP activity and reduced in Vivo calcification after in vitro chondrogenesis of human synovium derived mesenchymal stem cells
A current challenge in mesenchymal stem cell (MSC) ‐based cartilage repair is to solve the donor and tissue dependent variability of MSC cultures and to prevent chondrogenic cells from terminal differentiation like in the growth plate. We aimed to select the best MSC source for cell‐based cartilage reconstruction which could promise stable cartilage formation in the absence of hypertrophy and ectopic in vivo mineralization. We hypothesized that MSC from synovium (SMSC) are superior to bone‐marrow‐ (BMSC) and adipose‐tissue‐derived MSC (ATSC) since they are derived from a joint tissue. MSC were characterized by flow cytometry. MSC pellets were cultured under chondrogenic conditions and differentiation was evaluated by histology, RT‐PCR, and determination of alkaline‐phosphatase‐activity (ALP). Differentiated pellets were transplanted subcutaneously into SCID mice. BMSC, ATSC, and SMSC revealed similar COL2A1/COL10A1 mRNA levels after chondrogenic induction and collagen‐type X protein was detected in all spheroids. While all BMSC and ATSC cultures revealed ALP activity and calcified, 4 of 7 SMSC samples showed little ALP activation correlating with marginal or absent calcification of spheroids after ectopic transplantation. At elevated MMP mRNA levels, some SMSC transplants specifically lost collagen‐type II in vivo, or were fully degraded.
In conclusion, lower donor‐dependent ALP activation and reduced mineralization of SMSC‐derived heterotopic transplants surprisingly did not lead to a more stable ectopic cartilage but correlated with fibrous dedifferentation or complete degeneration of spheroids. This emphasizes that beside appropriate induction of differentiation, locking of MSC in the desired differentiation state is a major challenge for adult stem cell‐based repair strategies.
PP 50 Human Mesenchymal Stem Cells Expressing CD105 after ex vivo Replication Defective Adenovirus BMP‐2 Mediated Gene Transfer
Autologous vascularized bone grafts, allografts, and biocompatible artificial bone substitutes each have their shortcomings. Current trend is to generate bones in desired size and shape utilizing bone marrow mesenchymal stem cells (MSCs) by tissue engineering procedures. Tissue engineering integrating ex vivo gene therapy and polymer science may have clinical significance to bone regeneration application. This study aims to understand in vitro cellular differentiation post adenoviral infection. The experimental group was composed of ex vivo replication defective adenovirus BMP‐2 mediated gene transfer to the expanded human MSCs. The controls were performed using human MSCs. We tested the parameters in flow cytometry as CD 166, CD105 and CD34 post infection 2, 3, 6 and 9 days. Comparison between the experimental and control groups, there were no difference in the expression of CD 34. While CD 166 showed no significant increase in the experimental group. Both groups demonstrated less decrement of CD 105 in the experimental one in flowcytometry and western blotting study. This data evidenced that ex vivo replication defective Adenovirus mediated human BMP‐2 gene transfer to MSCs enhances the expression of CD 105 which is an accessory protein of multiple kinase receptor complexes of the TGF‐b superfamily. TGF‐b is directly implicated in vascular development and thought to control interaction between endothelial cells and smooth muscle cells. BMPs may also be involved in these processes.
PP 51 Comparisons between sources of Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord and bone marrow
PP 52 Sterilization of poly (L‐lactide‐co‐caprolactone) and the corresponding cellular response of adipose stem cells
Biodegradable polymers are increasingly being used for tissue engineering purposes. However, although it is known that some sterilization techniques may affect the physical properties of biodegradable polymers, this aspect is often overlooked. We speculate that the type of sterilization method used may influence the cellular responses by altering the surface characteristics, which can ultimately affect the clinical outcome of the tissue engineered construct. We determined the response of human adipose stem cells (ASC) cultured onto biodegradable poly(L‐lactide‐co‐caprolactone) (PLCL) sheets which had been sterilized using various methods, i.e. ethylene‐oxide, electron beam and argon glow discharge. The results showed significant differences in surface roughness, surface energy and contact angle measurements when comparing the various sterilizations. Attachment profiles and proliferation capacity were indifferent, but the production of alkaline phosphatase, indicating osteogenic differentiation of the ASC's, was significantly higher for the ethylene‐oxide sterilized PLCL sheet after 7 days in culture compared to the other PLCL groups and significantly higher than the tissue culture plastic group at 7 and 14 days. We conclude that the type of sterilization for degradable polymers should be taken into account, since it might affect, or can be used to enhance, the outcome of the tissue engineered construct.
PP 53 Co‐Culture of human BMSC with chondrocytes reduces ALP activity during chondrogenesis and prevents ectopic in Vivo calcification
Bone marrow‐derived mesenchymal stem cells (BMSC) are a promising cell source for cell‐based cartilage repair. A yet unsolved problem is the unwanted upregulation of hypertrophic markers such as alkaline phosphatase (ALP) and collagen type X during in vitro chondrogenesis of BMSC. After ectopic transplantation into SCID mice transient calcified cartilage is formed, whereas articular chondrocytes form stable ectopic cartilage without calcification. Aim of this study was to address whether articular chondrocytes have the capacity to suppress undesired hypertrophy in co‐culture with differentiating BMSC. Chondrogenic differentiation of BMSC (n = 5‐7 donors) was induced in chondrogenic medium which had or had not been conditioned with chondrocytes, or in the presence or absence of chondrocytes (50% and 33%) within the same spheroid for 6 weeks. Following in vitro differentiation, spheroids were transplanted subcutaneously into SCID mice. The gene expression ratio of COL2A1 versus COL10A1 in conditioned medium (1.53) was similar to the control group (1.42), while ALP activity was significantly reduced (p < 0.05; 1.9‐fold) in culture medium at day 42. Histology of explanted spheroids from the conditioned medium group showed markedly reduced calcification. A dose‐dependent suppression of ALP activity and in vivo calcification occurred for spheroids composed of BMSC and chondrocytes. This effect was specific for chondrocytes since synovia‐derived cells displayed no such activity. In conclusion, secretion of soluble factors by chondrocytes suppressed hypertrophy and stabilized the chondrogenic phenotype of BMSC in vivo. Current studies now focus on the identification of the active factors that can decrease or prevent BMSC hypertrophy during chondrogenesis.
PP 54 Adult murine and human Mesenchymal Stem Cell (MSC)‐Dependent Formation of Tendon‐Bone Insertions (Osteotendinous Junctions) and Tendon
We recently described the BMP2 and SMAD8‐dependent formation of tendon‐like structures in murine MSCs in vitro and in vivo and their use for regenerative strategies (Hoffmann et al., J. Clin. Invest., 2006). Here, we now assess the capacity of this system to direct the formation of entire ectopic tendon‐bone insertions by murine and human MSCs as well.
Using this system we were able to control the MSC‐dependent generation of ectopic fibrocartilaginous tendon‐bone junctions by the adenoviral modification of murine MSCs. Lentiviral modification of human MSCs (hMSCs) exhibited a similar result: hMSCs expressing both the biologically‐active Smad8ca and BMP2 generate ectopic tendon‐bone insertions, however, without fibrocartilaginous elements. By in situ hybridization and in situ histochemistry we are able to demonstrate that the modified human or murine MSCs are directly involved in the formation of these ectopic tendinous and bony elements. In addition, we observe a considerable contribution of host‐derived stem cells which are recruited into the developing ectopic tendon‐bone stuctures.
We believe that our finding may allow to control the type of osteotendinous junction needed for regenerative therapies, eventually. In addition, we were also able to induce the formation of tendon‐ligament‐like structures without bony elements. This may have considerable importance for the therapeutic replacement of tendon or ligaments as well.
PP 55 Chondrogenic Bone Marrow Stem Cell Differentiation Is Possible in Hydrogels at Low Cell Density
Cartilage has only a low regenerative potential, hence it is necessary to promote tissue engineering techniques to treat implications of degenerative processes. To avoid additional tissue damage, mesenchymal stem cells (MSCs) may represent an alternative self‐renewable cell source for repair. MSCs could be differentiated before injection into the degenerated tissue or may differentiate in situ when brought into a promotional niche. Standard models for chondrogenic differentiation are micromass cultures. In these cultures the cells are packed at high density. They are highly condensed and assemble only sparse extracellular matrix. In contrast, native cartilage consists of only one to five percent chondrocytes. Therefore the usage of micromass cultures may not be suitable for clinical applications. As an in vivo‐like alternative, hydrogels allow the embedding of cells at low densities in a matrix with high water content. Expanded human MSCs were embedded in gelatine hydrogels and cultured for about two weeks in chondrogenic medium. Micromass cultures served as standard positive controls. The expression of typical chondrogenic markers was analysed via realtime RT‐PCR. Chondrogenesis occurred in hydrogels and in micromass cultures similarly, with high cartilage‐specific mRNA expression levels. Hence, it is possible to induce differentiation to a chondrocyte‐like cell type in hydrogels even at low cell density. In addition, the gel‐embedded cells, contrary to micromass cultures, did not display condensation nor was there a gel contraction indicative for fibroblastic behaviour. Our results suggest that hydrogels with low cell density are conceivable materials for clinical applications of MSC with chondrogenic potential.
PP 56 Cell transplantation for bone regeneration: Who's the tortoise, who's the hare?
Myocard and Vessels
PP 57 In vivo Tissue Engineering of Heart Valves Using DNA‐Aptamers as Capture Molecules for Circulating Endothelial Progenitor Cells
Currently tissue engineering principles of heart valves include tissue or stem cell derived cells. Limitations of this approach include a long in vitro culture, an accompanied risk of infection and sophisticated, cost intensive infrastructures. Objective of this study is the application of stem cell technologies to create of the shelf heart valves for in vivo tissue engineering. The concept is based on high specific DNA‐aptamers immobilized on the heart valve surface as capture molecules for EPCs circulating in the blood stream.
High specific DNA‐aptamers were immobilized on glutaraldehyde‐fixed biologic tissues (porcine heart valves and bovine pericardium) via an EDC (N‐(3‐Dimethylamino‐propyl)‐N′‐ethyl‐carbodiimide hydrochloride) mediated coupling inducing a peptide bonding between tissue and aptamer. Coupled aptamers were exposed to physiologic shear stress conditions. For proof of concept, DNA‐aptamers with binding sites to an immortalized mouse EPC line were selected.
EPCs possess binding sites for species specific DNA‐aptamers. These aptamers can be directly coupled via an EDC activation of carboxyl groups to glutaraldehyde‐fixed tissue which has significantly reduced binding sites compared to non‐fixed tissue. The peptide bonding is extremely stable and withstands shear stress occuring on heart valve surfaces.
Surface immobilization of high specific DNA‐aptamers on glutaraldehyde‐fixed and non‐fixed biologic tissues enables manufacturing of an of the shelf heart valve for in vivo endothelialization of fixed tissues. Furthermore this approach opens new perspectives for complete in vivo tissue engineering of non‐fixed valve matrices.
PP 58 Characterization of Endothelial Progenitor Cells (EPC) in Healthy Volunteers
Dept. Experimental and Clinical Transfusion Medicine, University Hospital Tuebingen, Germany
PP 59 Transpericardial infusion of BBMC in acute Infarction
Cardiovascular illnesses continue to be the first cause of death in Brazil. Stem cells can be applied on treating cardiovascular diseases because its capability to induct neovascularization and tissue formation. Stem cells transplantation has been applied through the intracoronary, intramyocardic and retrograde infusion techniques. We present the transpericardic technique as an alternative route for infusion of a total of 108 bone marrow mononuclear (BMMC) in 6 female health swine submitted to acute myocardic infarction (AMI) using a balloon catheter under fluoroscopy. Injection of BMMC was also done in animals free of infarct for control group. The procedures were done in accordance to the School's Bioethics Committee under the n° 750/2005. Bone marrow (BM) was sample from the iliac crest using a bone punction needle and heparinized syringes.
BMMC were separated from the BM by density gradient using Ficoll‐Paque™ Plus (Amsersham Pharmacia) and stained with Hoechst 33342 (Invitrogen). After MAI occurrence, the epicardic space was accessed by pre umbilical region at median portion using an epidural needle to inject the BMMC. Ventricles were sliced into three portions and overlaid by a scintillographic grid to determine echocardiographic regions and to collect 17 fragments of each one, and evaluated by standard histology and immunehistochemistry. Total number of BMMC in the free area and of infarct in the ventricle was 109494 ± 46505 cells/area. We believe our study show low costs, easy‐maneuver, fast application of the technique and characterizes the epicardic space as a long‐term source of infusioned cells in the cardiac therapy.
PP 60 Same retention of mononuclear bone marrow cells after intracoronary infusion with or without balloon in infarcted pig hearts
Corresponding author: Benjamin Krausgrill, Institute of Neurophysiology, Department of Internal Medicine III, University of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany
PP 61 Survival and tumor formation of undifferentiated embryonic stem cells injected into infarcted mouse hearts is dose‐Dependent
PP 62 The effect of application of G‐CSF and a CD26‐Inhibitor on stem cell homing and cardiac function after myocardial infarction
Contact: Dr. med. Hans Theiss, Medical Department I – Cardiology, University of Munich, Klinikum Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
PP 63 3D co‐culture construct of endothelial cells and cardiomyocytes; first steps towards a vascularized artificial myocardial tissue
PP 64 CCN1 enhances reendothelialisation in tissue engineered vascular constructs
PP 65 Electrical integration promotes maturation of transplanted cardiomyocytes
Electrical integration and maturation of transplanted immature cardiomyocytes are essential to enhance functional benefit and reduce arrhythmogenic risk. Yet, little is known about the time course of integration and maturation.
PP 66 Improved vascular regeneration and impeding of re‐stenosis by Shikonin based stent coatings
Center for Regeneration Biology & Regenerative Medicine
Cardiovascular diseases are one of the most common diseases in our society. When infarcts occur one state of the art treatment is to remove the stenotic plaque and to graft a stent in the affected vessel area to maintain the blood‐flow. A severe side‐effect from vascular interventions applying stents are occurring re‐stenosis where the vessel lumen is constricted again by strongly proliferating cells, mainly smooth muscle cells and fibroblasts. These cells migrate from the intima to the intraluminal side and are respd are responsible for the late‐lumen‐loss and thus the occurrence of re‐stenosis. Studies with drug‐eluting‐stents came to the result that anti proliferating agents (e.g. sirolimus) show best effects in reducing the late‐lumen‐loss but preventing also the endothelial layer from proliferation and so inhibit the rehabilitation of an intact vascular wall. In search of a selectively acting drug we focused on a pharmaceutical called Shikonin. Shikonin which is a red solid substance isolated from the roots of Lithospermum erythrorhizon has many different modes of action. Recent studies demonstrated potent effects like anti‐tumoral, antimicrobial and antifungal features as well as antiviral ones. Our investigations revealed a dose‐dependant anti‐proliferating impact of Shikonin. Shikonin inhibits proliferation of smooth muscle cells and fibroblast but not endothelial cells. Hence Shikonin is a potent candidate for an application on stents through it's selective acting on the responsible cells for re‐stenosis. The received data from the in‐vitro experiments are actually verified in an animal model. When previous data is validated a valuable tool is generated for the cardiovascular treatment.
PP 67 Isolation and Expansion of Adult Cardiac Stem Cells from Rhesus Monkey
Recently resident cardiac stem cells have been identified in human and murine hearts. Messina et al. have reported the isolation of adult cardiac stem cells (CSCs) from biopsy samples, forming self‐adherent clusters termed “Cardiospheres”. Due to their high proliferative capacity, they could provide sufficient cell numbers for regenerative therapies using autologous cells. We were now able to isolate a corresponding cell type from atrial and ventricular biopsy specimens of Rhesus monkeys. The tissue was cut into pieces, treated with 0.2% trypsin and plated onto fibronectin‐coated dishes. Outgrowing cells were harvested by trypsination after 1‐3 weeks and were grown on poly‐D‐lysin coated culture surfaces in a low‐serum medium supplemented with B27, EGF, bFGF, cardiotrophin and thrombin. These culture conditions resulted in sphere formation similar to human CSCs. Like the human CSCs, Rhesus monkey CSCs express stem cell (ABCG2) and endothelial markers (flk‐1, vWF) and appear to have the properties of adult cardiac stem cells (GATA4, FOG2, Tbx20) as determined by RT‐PCR and/or immunofluorescence analysis. They are capable of long‐term self‐renewal for up to 40 passages. However, karyotype analysis of one long‐term culture revealed extensive chromosomal abnormalities; therefore, genetic stability has to be tested before therapeutic application. As described for human CSC, we did not observe efficient cardiac differentiation into spontaneously contracting cells in vitro; the regenerative effect of Rhesus CSC in vivo after transplantation in infarcted areas of SCID mice hearts is currently under investigation. These cells could potentially be used in a large animal model investigating stem cell mediated regeneration.
PP 68 Isolation, Characterization and Cryopreservation of neonatal, porcine Cardiomyocytes
Visceral Organs
PP 69 In Vitro Fascia Model for Hernia Research
Annually 200,000 inguinal hernia and 60,000 incisional hernia are diagnosed in Germany. By congenital or acquired weak points of the abdominal wall the egression of visceral organs is possible, which can successfully be treated meanwhile by different surgical operation procedures depending upon kind and extent of the hernia. To the accepted factors of risk for the hernia development belong patient‐specific influences of the genetics, environment, nutrition and comorbidities. The weighting of these factors is very likely different with the emergence of inguinal and incisional hernia and is therefore the subject of the scientific discussion. For the design of an in vitro fascia model primary fibroblast‐like cells from porcine fascia or human inguinal and incisional hernia are isolated. Risk markers for favouring the emergence of hernia are identified by immuno histological and molecular biological characterisation of the matrix and isolated cells. Additionally cells are cultivated in a collagen matrix, set under physiological conditions like breathing by a bioreactor system. The established system is to be used on the one hand as mechanistical study model. On the other hand as bioartificial tissue structure applications as test systems for new biological materials and medicinal products seems to be possible, which could be applied for testing new hernia therapy forms.
PP 70 Investigations on the biocompatibility of a new collagen‐Based matrix for human urothelial cells
In vitro engineering of lower urinary tract tissue equivalents suitable for reconstructive surgery might require biomaterials as cell carriers. Matrices have to be biocompatible, induce tissue regeneration, and must be subject to rapid degradation in vivo. Aim of the pilot study was to prove adherence, viability, and growth pattern of human urothelial cells (HUCs) seeded on a new factory‐made bovine collagen I‐based matrix. HUCs isolated from ureter tissue were labelled with the fluorescent cell linker PKH26, seeded onto the collagen matrix, and cultivated in serum‐free medium. Cell adherence was indirectly ascertained by counting cells in culture supernatant. Growth behaviour was studied by phase contrast microscopy and cryosections of the populated matrix. Viability of HUCs was analysed with the WST‐1 assay. HUCs grown on the collagen matrix were as homogeneously spread as HUCs seeded onto standard plastic surface. At day 1 after seeding the fraction of non‐adherent HUCs was slightly increased (2.2%) compared to the controls (0.3%), whereas at day 3 both groups revealed similar rates (0,4% and 0,3%, respectively). Viability of HUCs growing on the matrix revealed 111% of the control group at day 3. The cell‐matrix constructs could be easily detached from the culture dish and were manageable with surgical instruments. The data demonstrate a good in vitro biocompatibility of the new collagen matrix. We conclude that the matrix might be well suitable for construction of cell‐matrix implants for reconstructive surgery of the lower urinary tract. Further experiments with urothelial multilayers grown on the matrix will be performed.
PP 71 Human mesenchymal stem cells for treatment of urinary incontinence in a nude rat model
Urinary incontinence is associated with damaged or decreased sphincteric myofibers. Bone marrow‐derived mesenchymal stem cells (MSCs) have the capacity to differentiate into muscle cells. Study aim was to examine myogenic differentiation of human MSCs and to monitor their integration into the urethral sphincter in a nude rat model. To induce myogenic differentiation, human MSCs in P1 were exposed to 5‐azacytidine (5‐AZA) for 24 hours. Expression of smooth muscle alpha‐ and alpha/gamma‐actin, skeletal muscle MyoD, and slow muscle myosin was examined in differentiation‐induced MSCs (P2‐P6) and native MSCs (P0‐P6) by immunocytochemistry. PKH26‐labeled MSCs were directly injected into the bladder neck of athymic rats and monitored histologically after 4, 8, 12, 28, and 56 days. Native MSCs expressed alpha‐actin, alpha/gamma‐actin, and skeletal muscle MyoD in P0 in 62%, 60%, and 73%, resp. and in P1 in 94%, 100%, and 92%, resp.; MSCs in P3‐P6 only expressed alpha‐actin (65‐84%). In MSCs exposed to 5‐AZA alpha‐actin, alpha/gamma‐actin, and skeletal muscle MyoD were identifed in P2‐P6 in 86‐97%, 81‐100% and 63‐100%, resp. There was no reactivity for skeletal slow muscle myosin in both groups of MSCs. Histology demonstrated well‐defined clusters of transplanted cells in bladder neck tissues from 4‐56 days after cell injection. The results stress the potential of bone marrow‐derived MSCs to differentiate into smooth and skeletal muscle cells. An exposure to 5‐AZA is not necessary. Survival and integration of MSCs in bladder neck tissue for up to eight weeks emphasizes the use of autologous MSCs for a cell‐based treatment modality of urinary incontinence.
PP 72 Human abdominal and gluteal fat depots: the latter is better!
Adipose tissue is not only the region of energy storage. In addition to the endocrinological role, adipose tissue is also suggested as a reservoir of mesenchymal stem cells (MSC). The goal of this study was to isolate and characterize adult stem/progenitor cells from human gluteal and abdominal adipose tissue. Adipose tissue was obtained from deep subcutaneous abdominal and gluteal fat depots of 10 comparable female patients. Histological evaluation was performed. The isolated cells were investigated by FACS analysis for expression of mesenchymal marker molecules. The proliferation capacity of the cells was analyzed using a BrdU assay. The multipotent differentiation potential into the chondrogenic, osteogenic and adipogenic lineage was assessed by histochemical analysis, immunostaining and RT‐PCR. Adult and juvenile human fibroblasts served as a control.
Histological evaluation did not show an obvious morphological difference. Moreover, no significant differences concerning the proliferation capacity and the expression of cell surface marker molecules were observed between the cell groups. The derived cells achieved the criteria of MSC: they were plastic adherent, expressed the typical CD marker molecules (CD 105, 73, 90) and were negative for CD45 and CD34 and showed a multilineage differentiation potential. Interestingly, we demonstrate that MSC from the gluteal region showed a clear significantly better differentiation capacity into the osteogenic and adipogenic lineage in comparison to cells from the abdominal tissue. Therefore, the gluteal fat depots are likely to deliver MSC of higher potential, which could prospectively be of considerable therapeutic consequence.
PP 73 Application of Epoetin alfa improves renal function during acute ischemic renal failure in an animal model
After ischemic tubular necrosis kidney function can recover. Nevertheless, acute renal failure is an independent risk factor for morbidity and mortality. The goal of this study was to investigate the effect of erythropoietin (EPO) on renal repair mechanisms and renal function in an in vivo rat model of renal ischemia. One hour after 30 min‐ligation of the A. renalis on both sides, EPO (1.000 IE/kg i.p.) was administered to male Wistar rats. A sham‐operated group and non‐operated animals served as controls. Renal function was assessed after 1, 3, 5 and 7 d post application of EPO by measurement of serum biochemical parameters (urea, creatinine) and analysis of functional parameters (perfusion flow rate, glomerular filtration rate, albumin excretion rate, fractional albumin and inulin clearance, 02‐consumption rate and fractional sodium‐, water‐, calcium, as well as glucose‐reabsoprtion rate), the latter were obtained using the model system of the isolated perfused kidney. Apoptosis was evaluated by detection of Caspase‐3 expression in the ischemic kidneys. The morphology of acute tubular necrosis was assessed by histological analysis.
Solely after application of EPO we found a population of CD133‐positive progenitor cells in peripheral blood by fluorescence activated cell sorting. Immunhistological analysis confirmed the hypothesis that CD133‐positive progenitor cells contribute to vascular structures in ischemic kidneys. This neovascularisation was enhanced after treatment with EPO. This may be one possible explanation for the functional improvement of ischemic kidneys detected under the influence of EPO in this study.
PP 74 Biological vascularized scaffold: Basis of a liver cell module
We've developed a vascularized liver module, which enables a physiological co‐culture of hepatocytes (HC) and endothelial cells (EC). Basis is a vascularized matrix which provides a blood vessel network for EC an HC co‐culture and the transport of nutrients, metabolites and gases or the removal of toxic metabolites by physiological perfusion. The used vascularized matrix is chemically acellularized and consists of a porcine jejunal segment with a maintained vascular system including an arterial inflow and venous reflux. The vascular structures are reseeded with ECs or progenitor cells (PC) from the bone marrow aspirate. After 7‐14 days hepatocytes are seeded on the matrix lumen to start the co‐culture. During the cultivation period the matrix is perfused with medium over the artery in a bioreactor system. The flow rate is controlled (sensor, computer) to simulate in vivo blood flow. The cells were characterized for the expression of liver specific markers, vitality and for metabolic activities. Human ECs/PCs were seeded successfully via the arterial inflow in the vascular bed of the matrix. Vital human HCs could be repopulated on the surface of the lumen. The culture of HCs on the matrix shows good results for vitality, conservation of liver‐specific functions and formation of cell‐matrix contacts.
Our aim's the development of a vascularized liver module with physiological liver cell functions for pharmaceutical substance screening. Furthermore the system could be enhanced with other cell types (e.g. stem cells) for special applications. A future challenge is the construction of a liver transplant to reduce transplant shortage.
PP 75 Development of a porcine large animal model for an endoscopic therapy of urethral strictures with autologous urothelial cells
To date, no tissue‐engineered based therapy of urethral defects is established. Transplanted autologous urothelial cells promote urothelial regeneration. Thus fibrosis and recurrent strictures might be reduced. We developed a large animal stricture model as pre‐stage for urethral stricture repair with autologous urothelial cells. In male minipigs urethral strictures were placed with ligation and thermocoagulation. For urinary diversion a vesicostomy was done; urothelial cells were isolated from the vesicostomy bladder tissue and expanded in complete keratinocyte serum‐free medium. Four weeks later an internal urethrotomy was performed. In the incised area autologous urothelial cells (PKH26 fluorescent dye labelled and mixed with stabilized hyaluronic acid) were applied with a catheter. Four and 8 weeks, respectively later the animals were sacrificed. The epithelial phenotype of transplanted cells was analysed via immunohistochemistry using pan‐cytokeratin (AE1/AE1). Formation of collagen type I/III was evaluated after picrosirius red staining.
Stricture formation could be detected by urethrography and was histologically confirmed. The stricture areas showed a modified collagen composition, in which collagen type I was 4.5‐fold higher expressed compared to native tissue. Transplanted autologous urothelial cells could be detected in the area of stricture resection. The labelled cells integrated in the damaged urothelium were AE1/AE3 positive. Survival and integration of implanted autologous urothelial cells in the damaged urothelium might support the regeneration of damaged urothelium. The successfully developed stricture model enables investigations on tissue engineering‐based treatment options for urethral stricture therapy.
PP 76 Central necrosis in collections of transplanted cells in muscles of nonhuman primates: implications for cell transplantation
Numerous myogenic cell transplantations implicate the direct injection of cells into the skeletal or cardiac muscles. In this case, the implanted cells form avascular collections. Since the diffusion of oxygen and nutrients from the surrounding tissue throughout the implanted cell collections may be restricted, we hypothesized that ischemic necrosis could develop. We studied this possibility in nonhuman primates. Macaca monkeys were injected intramuscularly with different amounts of myogenic cells per single site. The cell‐transplanted sites were sampled one hour later and at post‐transplantation days 1, 3, 5 and 7, and analyzed by different histological techniques. One day post‐transplantation, the largest pockets of implanted cells showed cores of massive necrosis. The peripheral layer of living cells was roughly 100‐200 micrometers. Delivering 0.1 × 106 and 0.3 × 106 myoblasts did not produce ischemic necrosis; pockets of 1 × 106, 3 × 106, 10 × 106 and 20 × 106 myoblasts exhibited respectively a mean of 7%, 13%, 45% and 65% of central necrosis. An intense macrophage infiltration took place in the muscle, invading the necrotic regions and eliminating them by post‐transplantation days 5 to 7. Therefore, the desire to create more neo‐formed muscle by delivering more cells per injection site is confronted with the fact that the acute survival of the implanted cells is restricted to the thin peripheral layer than can profit of the diffusion of oxygen and nutriments from the surrounding tissue. These observations condition the characteristics of cell transplantation based on direct injection of cells into the tissues.
PP 77 Intramuscular migration capacity of transplanted myoblasts after subcutaneous implantation: a study in nonhuman primates
The main limitation of intramuscular myogenic‐cell transplantation is the fact that the transplanted cells fuse only with the myofibers reached by the injection. This phenomenon is traditionally attributed to a “lack of migration” of the transplanted cells. However, recent observations of the author in monkeys suggest that intramuscularly implanted myoblasts fuse with myofibers following an intra‐fascicular migration, though this migration seems to be only towards the myofibers damaged by the injections. To verify the migration capacity of the implanted myoblasts, we perform an experiment in cynomolgus monkeys. Skeletal muscles of nonhuman primates were damaged by performing 100 parallel needle penetrations per cm2 with a 27G needle, 1 hour before injecting ½ ml of a cell suspension of allogeneic β‐galactosidase‐labeled myoblasts subcutaneously under the damaged region and under non‐damaged regions. Monkeys were immunosuppressed with tacrolimus. One month later, the muscle regions under the subcutaneous injections were biopsied and analyzed by histology. In the damaged regions, β‐galactosidase‐positive myofibers were observed up to 1 cm distant from the muscle surface. The distribution pattern of the β‐galactosidase‐positive myofibers followed the pattern of the previous needle trajectories. This indicates that in nonhuman primates the implanted myoblasts are able to migrate for long distances into the recipient's muscle, although to reach and to fuse with damaged myofibers. The problem is thus not a “lack of migration capacity” but rather the incapacity to diffuse throughout a non‐damaged muscle to fuse indiscriminately and spontaneously with non‐regenerating myofibers.
PP 78 Reagents for Defining the Biological Environment of Three‐Dimensional Cell Cultures
A novel system for the configuration of defined biological environments for three‐dimensional cell culture was developed. This system consists of maleimide‐ and thiol‐functionalized hydrophilic polymers, that can be modified with biofactors, such as adhesion molecules, growth factors, and extracellular matrix molecules and that subsequently can be cross‐linked in the presence of cells to form a hydrogel. The chemistry allows uncomplicated setup of three‐dimensional cell culture conditions in straightforward experimental steps. The selection of synthetic or natural polymers, such as polyvinyl alcohol and polyethylene glycol, or serum albumin, which elicit little or no cellular responses, provides an inert background for determining the effects of added specific biofactors. Different cell types, such as primary chondrocytes, mesenchymal stem cells, Madin‐Darby Canine Kidney (MDCK) cells, NIH‐3T3‐cells, and Human Umbilical Vein Endothelial Cells (HUVEC) were successfully cultivated in different gel combinations. Furthermore, the effect of a fibronectin‐derived adhesion peptide on the formation of cellular extensions in HUVEC cells is demonstrated and morphogenetic development of epithelial cell sheets in gels modified with extracellular matrix molecules is shown. Our approach provides convenient toolbox for establishing defined environments for 3‐D cell culture and thus allows to determine cellular responses to extraneous factors as well as to study cell behavior under more controlled and adaptable conditions compared to traditional three‐dimensional culture media. The hydrogel technology thus provides a versatile matrix that can be used to develop extracellular environments for tissue engineering and regenerative applications.
PP 79 The lily‐of‐the‐Valley fragrance receptor ‐ Potential in prostate cancer imaging
PP 80 Periodontal regeneration of maxilla alveolar bony defect repaired with BMP‐2 gene engineered autologus bone marrow mesenchymal stem cells
PP 81 Human stem cell sheets engineered on polyelectrolyte multilayer coatings for prospective transplantation
Transplantation of intact, dense cell sheet structures has emerged as promising alternative to cell delivery via injection or biomaterial vehicles. Using of temperature‐responsive polymer coatings has been already successfully employed for non‐enzymatic collection of dense monolayers from different cell types. We sought to develop alternative electro‐sensitive polyelectrolyte multilayer (PEM) coatings for engineering of transplantable cell sheet structures from human multipotent mesenchymal stem cells (hMSCs). As experimental stem cell types we used: adipose tissue‐derived mesenchymal stem cells (AT‐MSCs) and placenta‐derived mesenchymal stem cells (PD‐MSCs). Model PEM coatings of variable thickness (3, 6, and 9 layer pairs) were deposited as alternating layers of positively charged poly‐L‐lysine [PLL] and negatively charged hyaluronic acid [HA]. Further, chemical cross‐linking for substrate stiffening and surface functionalization with fibronectin was explored. Our initial analysis revealed that: (1) both PD‐MSCs as well as AT‐MSCs do not interact well with native, “soft” PEM substrates, (2) stiffness of the [PLL‐HA]n multilayer coating is a critical regulator for adhesion, spreading, and formation of dense sheets from hMSCs, (3) covalent affixation of PEM bound fibronectin is necessary for cell sheet integrity, (4) resulting dense stem cell sheets maintained their vitality and capacity to differentiate into osteogenic lineage. In summary, we established conditions for creation of cell sheet structures from human mesenchymal stem cells (AT‐MSCs and PD‐MSCs) that have a potential for its charge‐mediated collection in intact form for prospective in vivo transplantation, or assembling of in vitro tissue models.
PP 82 Intramyocardial Implantation of CD 133+ Stem Cells Improve Cardiac Function without Bypass Surgery
PP 83 NGFR: a new osteogenic differentiation marker in mineralizing periosteal cells
PP 84 Effect of collagen I on the behaviour of mesenchymal stem cells
Human mesenchymal stem cells (hMSCs) are good candidates for bone regeneration because they can be easily obtained and are able to differentiate to osteoblasts. Protein or peptide coatings of bone‐replacing materials can influence survival and in vivo performance of hMSCs. Collagen I, a native bone protein, might be very appropriate for betterment of synthetic implants. The goal of this study was to evaluate the effect of collagen I on hMSC proliferation, adhesion, migration and differentiation. HMSCs were cultured on collagen I‐coated surfaces. This resulted in an enhancement of their proliferation and adhesion. We estimated the amount of formed focal contacts. In hMSCs grown on collagen I, the focal contacts occupied up to 9% of the cell terrain. In order to monitor the behaviour of hMSCs on collagen I, we performed time lapse imaging and we observed that hMSCs were less migratory on collagen I. Next, we induced osteogenic differentiation of hMSCs in vitro. Our results demonstrated: firstly, that collagen I augmented hMSC differentiation and secondly, after we applied blocking antibodies or shRNA against major collagen I‐binding integrins, that the disruption of hMSC‐collagen I interactions led to reduced cell survival and matrix mineralization. Altogether, the contact of hMSCs to collagen I has positive effect on cell proliferation, adhesion and differentiation. Hence, coating with collagen I or related peptides can be implicated in the development of bone‐like biomaterials.
PP 85 Low oxygen tension reduces the osteogenic potential of rat bone marrow mesenchymal stromal progenitor cells
Low oxygen tension may modify mesenchymal stromal progenitor cells (MSC) characteristics and thus influence tissue reparation processes. Such modifications were shown as to MSC proliferation, viability and they are especially important in relation to MSC differentiation potential. There are controversial data on MSC osteogenic differentiation under hypoxia conditions. The aim of this study was to evaluate the impact of reduced oxygen tension on rat bone marrow MSC osteogenic differentiation. MSC at 1‐4 passages were cultivated either in normoxia (95% air + 5% CO2) or hypoxia and anoxia (95% gas mixture of 95%N2 + 5%CO2 and 5% or 1% O2). MSC surface markers expression was analyzed by flow cytometry. Osteogenic differentiation of MSC was determined as to alkaline phosphatase (AP) activity and calcium deposition assessed using Alizarin Red staining. The amount of cells in which both spontaneous and induced AP activity was revealed decreased with the oxygen level reduction. AP activity was significantly reduced but was still observed under anoxia, which indicated the early stages of osteogenic differentiation. MSC viability imposed limits on its further progression with calcium deposition under these conditions. Matrix mineralization was observed only in case of induced differentiation and its extent was less in hypoxia compared to normoxia. These results indicate that low oxygen tension reduces the osteogenic differentiation of MSC and probably help maintain the MSC stemness.
PP 86 Detection of cells with stem cell characteristics in human epidermis
Increased aldehyde‐dehydrogenase (ALDH) activity is a well known marker for hematopoetic stem cells. The ALDH activity can be monitored using the artificial substrate ALDEFLUOR®. Degradation of ALDEFLUOR® by ALDH activity releases a fluorophore, which can be quantified in the cells by flow cytometry. To our knowledge, there is no information about ALDH expression in epidermal stem cells. We analysed the ALDH activity of cells from epidermal cell preparations from human skin biopsies by flow cytometry. Interestingly, in our experiments ALDH positive cell populations do show a costaining with well known surface markers discussed as epidermal stem cell markers integrin beta1 and integrin alpha6. Further physiological analyses may show the stem cell activity of the ALDH/intregrin costained cells.
Central and Peripheral Nervous System
PP 87 Biodegradable nerve guide conduit with pro‐angiogenic potential
To bridge gaps of lesioned nerves after PNS injury we have started to develop a nerve guide implant made from the special gelatine‐based product NerVusion. Current implants approved for human application do not allow regeneration across gaps of more than a few centimeters in length, possibly due to insufficient blood vessel formation. The novel concept is to design an implant material that facilitates angiogenesis which in turn improves neuronal regeneration. Our tubular implant shall have an inner membrane tube and an outer pro‐angiogenic sponge layer for enhanced blood vessel formation. The NerVusion specimens were produced with defined characteristics with regard to reproducible membrane homogeneity and sponge pore diameter and physicochemical features such as mechanical stability. Preconditioned sponge materials were positively tested in vitro with regard to four parameters: biocompatibility, endothelial cell adhesion, ‐migration and ‐proliferation. Implantation onto the chick egg chorioallantoic membrane induced robust formation of blood vessels. After subcutaneous implantation of sponges into mice, immigration of cells and subsequent formation of functional vasculature became evident. Preconditioned tubes made from Nervusion were biocompatible and were sufficiently permeable to allow outgrowth of neurites and diffusion of doxycycline for reporter gene expression in transfected Neuro‐2a cells in vitro. Intraneuronal implantation in rats displayed no adverse response but long‐term implant stability in vivo.
In summary, the novel matrix based on NerVusion is expected to be a valuable component of future implants in order to improve regeneration by concomitant pro‐angiogenic stimulation.
PP 88 Comparison of adipose‐derived stem cells and bone marrow‐derived stem cells in cell transplantation therapy against brain ischemia
PP 89 Efficacy of various durations of in‐vitro predegeneration on the cell count and purity of rat Schwann cell cultures
For reconstruction of peripheral nerve defects, tubulization with artificial grafts coated with cultivated Schwann cells (SC) is a promising approach. By in vitro‐predegeneration of a nerve, efficacy of cell cultivation can be enhanced. This study aimed to improve efficacy of SC‐culture comparing three time spans of predegeneration. Sciatic nerves of 6‐8 week old Lewis rats were harvested and subjected to either 2‐day, 7‐day or 14‐day predgeneration in DMEM, 10%FCS and 1%Pen/Strep. Afterwards, tissue was dissociated in 0.125% collagenase IV and 0.25% trypsine for 24 hours and given into modified melanocyte‐growth medium. Fibroblast growth factor was added at 10ng/mL, in addition to 2μM Forskolin and 5μg/ml bovine pituitary extract. Cell count was determined after dissociation, cell purity was determined 16 hours after cell attachment by means of microscopy. Special value was set on SC to fibroblast relation. Cumulative cell count in culture was 5.8 × 104 for 2 days, 1.12 × 105 for 7 days and 1.48 × 105 for 14 days of predegeneration. Culture purity was approximately equal for 2 and 7 days of predegeneration (88% SCs, 12% fibroblasts after 2 days, 85% SCs, 15% fibroblasts after 7 days). After 14 days of predegeneration, cultures were significantly higher debased by fibroblast proliferation (57% SCs, 43% fibroblasts). The yield of cultivated rat SCs is duplicated by 7‐days in vitro predgeneration in comparison to 2‐days. After 14‐days predegeneration, culture debasement with fibroblast is significantly higher. Therefore, 7‐days in vitro predegeneration of the harvested nerve tissue is an advisable procedural method in the cultivation of rat Schwann cells.
PP 90 Guidance of axons on pre‐aligned Schwann cells on hundreds of polymer filaments for nerve regeneration
The peripheral nervous system is capable to regenerate partly because in many cases only cell processes become lesioned, whereas cells remain viable. Lesioned axons can regenerate if the continuity of the nerve tissue is preserved. Within the nerve, axonal regrowth occurs along thousands of aligned Schwann cells (SCs), so called bands of Buengner. To improve the therapeutic performance of synthetic implants used to bridge nerve gaps we have developed biohybrid bands of Buengner inside nerve guides. 15‐30 μm thick micro‐structured poly‐caprolactone (PCL) and poly‐dioxanone (PDO) filaments were produced by a melt extrusion process. Each filament had six longitudinal micro grooves. To overcome the non‐permissiveness of the polymer filament surface, different plasma treatments and subsequent coatings with a synthetic polyamine and an extracellular matrix protein were investigated. Seeding of pretreated filaments with SCs resulted in longitudinal cell alignment along the micro groove. A metabolic labeling technique revealed that SCs retained their proliferation potential under these conditions. When dorsal root ganglions were explanted onto SC‐seeded filaments, a highly oriented axonal outgrowth could be induced. Implantation of cell‐free‐polymer filaments into lesioned sciatic rat nerves resulted in complete coverage of the implant by invading cells. Currently, implantation of cell‐seeded polymer filaments are under progress. In addition, in order to foster SC immigration we analyzed SCs in vitro and found that recombinant neuregulin‐1 (NRG‐1) accelerated cell migration. Therefore, the future addition of NRG‐1 to nerve guide tubes with polymer filaments might accelerate SC recruitment from both neighboring nerve endings and in turn aid axonal regeneration.
PP 91 Alginate‐based anisotropic capillary hydrogels as scaffolds for guided axon regeneration
Unidirectional diffusion of divalent cations into a sol of sodium alginate created hydrogels with highly anisotropic structures exhibiting capillaries which were circular in cross‐section and parallel to each other. These anisotropic capillary hydrogels were introduced into a dorsal root ganglion (DRG) axon outgrowth assay in vitro to assess their capacity to promote longitudinally directed axon regeneration. Diameter and density of the capillaries were defined by the type of cation used for the gel formation process. Diffusion of barium ions created gels with a capillary diameter of 10 μm and a capillary density of 960/mm2, whereas nickel ions generated gels with a capillary diameter of 120 μm and a capillary density of 30/mm2. After gel formation, the toxic cations were exchanged by protons without destruction of the capillary structure. The removing of cations was monitored by atomic emission spectrometry. To enhance mechanical stability and decelerate biodegradation, the gels were chemically cross‐linked with an aliphatic diisocyanate. Using the DRG axon outgrowth assay, the stabilized capillary hydrogels elicited highly oriented linear axon re‐growth. It was found that axon ingrowth into capillary hydrogels was influenced by the presence of growth‐supporting cells, i.e. Schwann cells migrating from the DRG into the capillaries. Furthermore it was observed that a higher number of axons and longer axons were generated in gels exhibiting smaller capillary diameters. From these results and further in vivo spinal cord experiments it is obvious, that alginate‐based anisotropic capillary hydrogels represent a promising strategy to induce axon re‐growth following nerve injury.
PP 92 Recapitulating Organ of Corti Development in an in vitro Culture Assay
The mature organ of Corti, the auditory epithelium of the mammalian inner ear, shows a absent intrinsic regenerative capacity resulting in irreversible loss of sensory function after damage to its sensory cells. Due to the limited accessiblity within the temporal bone, it is challenging to apply common imaging and molecular biological techniques to the inner ear.
To study developmental and regenerative issues we established an in vitro model of the inner ear sensory epithelium. Isolation of murine stem cells from the postnatal organ of Corti (postnatal day 5) allowed us to grow proliferating spheres under suspension culture conditions shown by labelling with proliferation markers PCNA, Ki67 and BrdU. Transfering these spheres to adherent culture conditions resulted in monolayered epithelial patches, that exhibit characteristics of the otic sensory epithelium. Typical hair cell markers (Math1, Myosin VI and ‐VIIA) and supporting cell markers (p27Kip1, S100 and Prox1) were detected in these patches.
Reexpression of these proliferation and differentiation markers indicates recapitulation of embryonic development of the organ of Corti in our in vitro model. This model opens the avenue to analyse mRNA‐ and protein expression with quantitative methods, for example by flow cytometry. Supported by: BMBF 0313612A
PP 93 Transretinal electrical stimulation induces neuroprotective effects in a mouse model of retinitis pigmentosa
Electrical stimulation has been shown to have neuroprotective effects on ganglion cells and photoreceptors in axotomized and dystrophic retinas from Royal College of Surgeon (RCS) rats. This study determined whether electrical stimulation also has a neuroprotective effect on cells in the inner nuclear layer (INL) of retinas. We cultivated retinas from adult RCS rats on microelectrode arrays and stimulated them continuously with 20 Hz for up to six days. Afterwards, we subjected them to quantitative immunohistochemical analysis. Using TUNEL assay and antibody staining (OX42, ED1) we found that transretinal electrical stimulation (TRES) with charge densities within the range of 100 to 500 μC/cm2 resulted in a lower number of apoptotic neurons in the INL of degenerated retinas from RCS −/− rats after one day of continuous stimulation and reduced activation of migroglial cells in RCS −/− and congenic control (RCS+/+) rat retinas. The effect of electrical stimulation on apoptosis and reduced activation of migroglial cells was closely correlated with the strength and duration of the stimulation. The neuroprotective effect of TRES on neuronal cells in the INL of degenerated RCS rat retinas supports the idea that electrical stimulation may be a therapeutic option to delay the progression of retinal degeneration in patients suffering from retinitis pigmentosa.
PP 94 Mesenchymal stem cells gain multiple neuroprotective properties upon pro‐neural conversion
Specific culture conditions (suspension and serum‐free culture at low oxygen) for adult human mesenchymal stem cells (MSC) lead to epigenetic modifications of gene expression (here referred to as ‘conversion’). Neural genes as well as many neurotrophic factors are up‐regulated. Compared to genuine human neural tissue the expression of neural genes (e.g. tubulin beta3, glial fibrillary acidic protein) remains at low level, but the expression of neurotrophic factors, i.a. hepatocyte growth factor and vascular endothelial growth factor, obtains levels of functional importance on the cellular level. Culture of rodent neural stem cells (NSC) with conditioned medium from converted MSC and direct co‐culture experiments reveal distinct effects on the proliferation rate, cell survival, and differentiation potential of NSC. Additionally, converted MSC significantly protect NSC against the neurotoxin 6‐hydroxydopamine. Genome wide gene expression analysis, real‐time RT‐PCR, immunohistochemistry, and flow cytometry reveal a very high up‐regulation of F‐spondin and neprilysin upon pro‐neural conversion, two genes which are known to reduce the production or increase the degradation, respectively, of the Alzheimer's disease related amyloid beta peptide. In summary, though we do not achieve neural transdifferentiation of MSC by using our protocol, we show that MSC gain various neuroprotective properties upon pro‐neural conversion.
PP 95 Carrier matrix for siRNA‐mediated gene knock down to promote neuronal regeneration
First two authors contributed equally to this work.
Axons in the adult vertebrate central nervous system (CNS) exhibit almost no regeneration after injury, partly because of the presence of neurite outgrowth inhibitors in the CNS. The aim of this study is to enhance functional recovery and axon regrowth using siRNA in order to transiently inhibit the intracellular signalling pathway of central components into which various repulsive inputs converge. An effort concerning this objective is to find an appropriate carrier matrix for binding, stabilization, and promoting cellular uptake of siRNA.
Chitosan is a biocompatible and biodegradable material which enables a strong electrostatic binding of oligonucleotides. In this study we present the effective binding of siRNA to chitosan under formation of nanoparticles. Analysis of different kinds of chitosan‐siRNA nanoparticles using gel‐retardation assays demonstrated high stability of those complexes abrogated only after addition of competing agents. Finally, cell transfection experiments with fluorescently labelled siRNA showed efficient uptake of chitosan‐siRNA nanoparticles into different cell types which play an important role in the nervous system.
Our results therefore highlight the potential application of chitosan in siRNA‐mediated gene knock down to promote neuronal regeneration after spinal cord injury.
PP 96 Neural stem and progenitor cells from the human adult gut: A novel cell source for the treatment of neurointestinal disorders
Neural stem and progenitor cells from the enteric nervous system have been postulated as an appropriate cell pool for future cell‐based therapies against specific neurogastrointestinal disorders such as hypo‐ or aganglionosis. Recently, the generation of enteric neural progenitors from human neonatal and early postnatal gut (up to 5 years after birth) was demonstrated. In the present study, we describe the successful proliferation and differentiation of enteric nervous system progenitors isolated from human adult gut. We were able to generate proliferating neurosphere‐like bodies from adult small or large human gut tissues, which could be sub‐cultivated and maintained over several weeks in vitro, depending on the applied cell culture conditions. Spheroid‐derived cells were differentiated into a variety of neuronal subtypes and glial cells with characteristics of the enteric nervous system as demonstrated by in situ hybridization, immunocytochemistry, RT‐PCR and electrophysiological studies. Implantation experiments into intestinal organotypical slice cultures and aganglionic gut segments of fetal mice showed the integration and differentiation capacity of human progenitors. Our results demonstrate the feasibility of isolating and expanding functional enteric progenitors. These findings offer new strategies for enteric stem cell research and cell‐based therapies.
PP 97 Multipotent stem/Progenitor cells and Their derivatives promote adult rat DRG neurite outgrowth
In an attempt to support axon regeneration across CNS or PNS lesions, we are currently investigating the in vitro growth promoting properties of different cell types. Therefore, highly enriched populations of human mesenchymal stromal cells (hMSCs), normal human neural progenitors (NHNPs), immature type I astrocytes (itIACs) derived from the NHNPs as well as primary rat astrocytes (prACs) have been investigated in simple 2D cultures using freshly dissociated adult rat dorsal root ganglion (DRG) neurons.
Confluent cultures of hMSCs grow in an orientated manner, promoting the regeneration of large numbers of primary neurites from the dissociated DRG, significantly exceeding the numbers of primary neurites counted on the other investigated cell types. Neurites of dissociated DRG neurons rapidly extend highly directed neurites which follow the orientation of the long axis of the densely packed hMSCs, suggesting that these cells may not only support axon regeneration but may also influence its orientation. A random, non‐oriented outgrowth of neurites was observed from DRG plated onto PLL/laminin‐coated surfaces. Despite the hMSC‐induced induction of large numbers of neurites and the orientated tendency for neurite outgrowth, maximal overall neurite length, longest individual processes and outgrowth per neurite branches were supported best by the immature human type I astrocytes.
Therefore, the axon growth promoting property of stem/progenitor‐derived immature human type I astrocytes was found to be superior to the other entire cell types tested, suggesting that such cells may be of interest in promoting tissue repair and functional axonal regeneration in models of spinal cord injury.
PP 98 Expression of pluripotency genes in cells derived from the SVZ or olfactory bulb of the adult mammalian brain
The subventricular zone (SVZ) of the adult mammalian brain harbours Nestin/GFAP double positive cells that function as neural stem cells (adNSC). These cells divide to generate transit amplifying cells (adPCi), which in turn give rise to progenitors (adPCl) that migrate in the rostral migratory stream to their final destination in the olfactory bulb (olfB) where they terminally differentiate. We investigated co‐expression of pluripotency genes in SVZ and olfB‐derived primary cell lines, since their expression might be critical for self‐renewal and maintenance of the stem cell‐ and progenitor‐state. SVZ‐ and olfactory bulb‐derived cultures contained Neurofilament+, Nestin+ and Nestin+/GFAP+ cells, as well as few other cell types. This was similarly observed for explants from mouse, rat and human brain. After the first round of amplifiaction the cultures consisted mainly of Nestin+/GFAP+ cells. In general, the proliferation rate of early primary cultures was high. Rodent, but not human Nestin+/GFAP+ cells amplified well in culture. In all cases, cells grew in a matrix‐dependent fashion as monolayer or neurosphere cultures. E.g, rodent Nestin/GFAP double positive cells formed (i) monolayers on standard Polyornithin‐ and Matrigel‐ but not on Laminin‐matrices, and (ii) increasing concentrations of fibronectin, permitted adherent growth of all rodent and human cell lines. The stemness genes oct4 and sox2 are co‐expressed in all rodent cultures but down‐regulated with increasing passages, irrespective of their high proliferation rate. Nearly invariant expression of nanog was observed in the human cells, whereas the expression level of both oct4 and sox2 varied largely amongst the various human cell lines.
PP 99 Expression of stemness genes in neural stem cell‐like cells derived from malignant glioma
The survival rate of patients with malignant brain tumors is very poor. It is not known whether and how cells with stem cell features affect the growth of glioma or the success of chemotherapy and irradiation. We evaluated the presence of stem cell‐like cells in different types of malignant glioma and analyzed the expression of the stemness genes oct4, sox2 and nanog. Primary cultures of glioblastoma and gliosarcoma consisted of varying amounts of fibroblasts, myofibroblasts, astrocytes, neurons and other cell types. A large portion of the latter ones co‐expressed Nestin and GFAP and a varying and usually smaller portion was Nestin+, indicating the presence of NSC‐like cells in glioma‐derived primary cultures. When continuously grown in media containing FCS Nestin+/GAPF+ cells disappeared from the cultures. In contrast, growth in medium containing a serum substitute and mitogens, a condition used for the propagation of adult neural stem cells, led to progressive enrichment of Nestin+/GFAP+ cells, which self‐renewed and formed neurospheres. The proliferation rate of the NSC‐like cells, however, varied largely amongst the various primary cultures and was low for most tumor explants. Nanog RNA was nearly invariantly expressed in both serum‐deprived and un‐deprived cultures. In contrast oct4‐expression (RNA and protein level) and Sox2‐levels (protein) varied significantly amongst the different tumor cell lines, were stronger in serum‐deprived cultures and appeared highest in cell lines derived from two clinically exceptional tumors. Together this indicates that the stemness genes oct4 and sox2 might take a role in maintenance and self‐renewal of NSC‐like glioma‐derived cells.
PP 100 Neural‐Related marker expression of undifferentiated human mesenchymal stromal cells exhibits inter‐Donor variability
In the last few years several studies have reported that bone marrow‐derived mesenchymal stromal cells (MSCs) are capable of transdifferentiating to neural cell types, effectively crossing normal lineage restriction boundaries that were thought to be uncrossable. These reports evaluated the existence of neural‐related proteins mostly only after induction of the MSCs. To assess the amount of neural‐related transcripts and to determine the degree of homogeneity between donor samples, we investigated the basal expression of a range of neural‐related mRNAs of non‐differentiated MSCs obtained from 4 healthy donors. This expression analysis revealed that several of the commonly used marker genes were already expressed by undifferentiated human MSCs (e.g. nestin, Enolase2 and microtubule associated protein 1b). Furthermore, mRNA for some of the neural related transcription factors, like Engrailed‐1 and Nurr1 were also strongly detected. However, several other neural‐related mRNAs (e.g. dopamine receptor D2, Enolase2, neurofilament light and myelin basic protein) that could be identified were not expressed in all donor samples. Similarly, synaptic vesicle‐related mRNA, syntaxin could only be detected in 2 of the 4 undifferentiated donor hMSC samples. More significantly, each donor sample revealed a unique expression pattern, demonstrating a significant variation of marker expression. These results demonstrate the existence of an inter‐donor variability within human MSC samples that has not previously been described. This donor‐related heterogeneity might affect reproducibility of transdifferentiation protocols as well as contributing to the ongoing controversy about differentiation capacities of MSCs.
PP 101 Differentiation of adult stem cells towards microglial cells
Fibroblast and Skin
PP 102 Scaffold‐Based skin equivalents: In vitro ‐models to study the effects of mature dermal organization on tissue regeneration
Advanced in vitro‐generated skin models gain importance as tools in basic research as well as clinical application in regenerative medicine. Here, we present further details of an improved long‐term skin equivalent (SE) enabling studies on skin reconstruction including maintenance of epidermal stem cells and organisation of incorporated endothelial cells exhibiting tubulogenesis. Keratinocytes were grown on dermal equivalents reinforced by scaffold fibres and colonised with fibroblasts. These scaffold‐based SEs demonstrated sustained epidermal viability over 15 weeks with regular differentiation. The continuous expression of major junctional components indicated the achievement of epidermal stability and barrier function. A progressive maturation of the dermal part of the SEs became evident by a significant remodelling of the extracellular matrix (ECM) changing from an initial provisional status to an ECM with an in vivo‐like composition (containing collagen and elastic fibres). Different from the conventional collagen‐based SEs, this authentic matrix mimics native dermis and provides the microenvironment permitting longevity of label‐retaining epidermal stem cells. Furthermore, it represents a microenvironment ideal for endothelial cells, allowing their self‐organisation into numerous tube‐like structures with endothelial basement membranes confirming the endothelial potential for capillary‐like self‐assembly.
In summary, the long‐term SE presented herein, exhibits a superior epidermal architecture with renormalised differentiation including tissue homeostasis. Its authentic ECM has proven to be a crucial component for successful in vitro vasculogenesis as well as the establishment of a functional epidermal stem cell niche.
PP 103 Ex vivo expanded hematopoietic progenitor cells improve dermal wound healing by paracrine mechanisms
PP 104 Identification of Melanoma Cells with Stem Cell Properties
Cancers contain a small population of cells named “Cancer Stem Cells” (“CSCs”) that are believed to play a critical role in the development and progression of the disease. These cells have been found in several types of cancer including just recently melanoma although their characterization is still poorly known. It is also thought that CSCs drive the metastatic spread of cancer. CSCs show resistance to a number of conventional therapies and it is believed that this explains why it is difficult to completely eradicate the disease and why recurrence is an ever‐present threat. We report the isolation and the characterization of a subset of melanoma cells with stem cells properties by two different experimental approaches. The first one allowed us to isolate spheroids by using a stem cell permissive serum‐free medium. The second one allowed us to isolate a side population (SP) based on Hoechst dye exclusion. Interestingly, by comparison to the corresponding parental cell line, we particularly show that the isolated spheroids are (i) not pigmented, undifferentiated; (ii) able to get differentiated in presence of serum; (iii) in vitro more clonogenic and more chemo‐resistant; (iv) display an increased expression of certain ABC transporters, known to be involved in the multidrug resistance (MDR), as well as some specific stem cell molecular markers. Besides, the SP isolated on the basis of Hoechst dye exclusion assay, share many of the above described cancer stem cell characteristics. Selectively targeting of CSCs should definitively offer a new paradigm in both cancer therapeutics and diagnostics.
PP 105 In human fibroblasts CC‐TT transitions of p53 decrease during in vitro proliferation
The proliferation of human skin cells in vitro plays an important role in therapeutic approaches in applied biomedical sciences such as tissue engineering and biomedical analytics e.g. biocompatibility and screening of active agents. But in vitro proliferation of cells is still an artificial system compared to the in vivo situation for example due to higher proliferation rates. For autologous cell transplantation it might be important to know whether potentially existing DNA‐damages increase or decrease during in vitro proliferation. These damages could serve as a quality control marker for skin cells cultured for use in tissue engineering. A well‐known UVB‐induced mutation is the CC‐TT transition in the tumor suppressor gene p53 at codon 281/282. We established a real‐time‐PCR method using SYBR Green technology to detect and quantify these p53 mutations in human dermis ex vivo and during in vitro proliferation of human dermal fibroblasts. Therefore human skin samples were collected and isolation of fibroblasts was performed from the dermis fraction. Later DNA‐extraction was performed every new passage. To represent the situation ex vivo, DNA was extracted from pieces of the dermis. There is a decrease of p53 mutations during in vitro proliferation. These results indicate that there is no accumulation of p53 mutations during in vitro proliferation, so it might be better to extend in vitro proliferation of cells regarding autologous cell transplantation. In contrast there is a hint of an increase of p53 mutations from the ex vivo to the in vitro situation of dermal fibroblasts.
Biomaterials, Tissue Engineering & Monitoring
PP 106 Quartz Crystal Microbalance with sensitive surface coatings for perioperative bleeding monitoring
PP 107 Matrix elasticity influences the maintenance of the chondrogenic phenotype
Cells sense and respond to the mechanical properties of their environment. It has been demonstrated that matrix elasticity plays an important role not only for cell spreading and adhesion but also for cell differentiation. The aim of this study was to examine the influence of mechanical properties on the differentiation of chondrocytes cultured in monolayer. We used a 2D‐culturing‐system in which polyacrylamide gels with different percentages of BIS‐Acrylamide were coated with collagen type I. This system allows altering the matrix elasticity while leaving all other matrix‐parameters constant.
Matrices with a Young's Modulus of 5kPa, 10kPa, 40kPa and 100kPa were produced, as determined by atomic force microscopy. Porcine chondrocytes were cultivated on matrices in low density culture for up to two weeks. The differentiation of chondrocytes was monitored by measuring collagen type I and II expression. Additionally proliferation and cytoskeleton organisation was investigated.
Obvious differences between cells cultivated on the different matrices were monitored. Porcine chondrocytes grown on stiffer matrices showed a more flattened morphology with highly organised stress fibers, lower collagen type II and higher collagen type I expression when compared to cells grown on softer matrices.
Our findings indicate that chondrocytes sense the elasticity of the matrix. Maintenance of the chondrogenic phenotype is prolonged on soft substrates while proliferation is lowered on these substrates. These data might be used in the design of novel scaffolds with mechanical properties specifically tailored to guide chondrocyte differentiation in tissue engineering applications.
PP 108 Ink‐Jet printing of proteins and functional nanoparticles for automated functionalization of surfaces
Ink‐jet printing is a relatively straightforward fabrication process. The targeted material deposition avoids material spill‐over and is therefore very much applicable for processing of high‐cost materials such as biological substances. Our objective is to identify biocompatible fluids that meet the needs for a stable piezo ink‐jet printing process. We will present results concerning substrate‐activation, ink‐preparation, and the maintenance of biological functions during the ink‐jet process. Recently, ink‐jet printing technology has been used to fabricate electronic, medical, optical and polymeric devices [1, 2, 3, 4]. In contrast to classical coating techniques as spin‐coating, dip‐coating or spray‐coating printing allows for patterned material deposition. Many formats of 2‐D drawings can be rasterized into X‐ and Y‐coordinates and directly be converted into multi‐material patterns via the printing process. The physico‐chemical properties of inks determine their jettability: surface tension and viscosity are two primary chemical properties that determine printing success. The optimum viscosities for jettable fluids in piezo drop‐on‐demand printheads are 5 mPa s to 12 mPa s, surface tension has to be in the range of 24 mN/m to 33 mN/m. However, most biological materials are water‐based and exhibit very low viscosities (0.1 mPa s to 1 mPa s) and very high surface tension values (58 mN/m to 60 mN/m). In order to enable economical biofunctional substrate‐coating and to integrate substrate‐functionalization in a process capable of being fully automated we develop ink formulations containing biomolecules or (bio‐)functional components.
PP 109 Retroviral gene transfer to cells from amniotic membrane of normal embryos of Golden Retriever Muscular Dystrophy Dogs (GRMD)
Embryonic stem cells have become a promising tool to be used in cell therapy for many diseases, especially genetic ones. Duchenne Muscular Dystrophy is a progressive genetic disease that seems to be one candidate to cell therapy with embryonic stem cells. Our group has the best model to study that, a Golden Retriever Muscular Dystrophy dog, which shows the same pattern of the human disease. However, one challenge of cell transplantation is investigate the engraftment of stem cells in the injured site and prove that delivered cells were transformed in local cell lineage. For that, genetic markers should be used. Here, we describe cells derived from Amniotic Membranes (AM) of dog's embryos successfully transducted in vitro by pLNPoZ retrovirus, a Moloney Murine Leukemia Virus vector carrying the reporter bacterial gene LacZ. Retroviruses were produced by PT67 packaging cell lineage and used to infect AM cells. AM cells transduction was confirmed using X‐Gal staining method. Additionally, these cells did not show distinct phenotype in cell culture after virus transduction. Next step, these cells will be transplanted in order to study their comportment and therapeutic effectiveness in vivo.
PP 110 Molecular Imaging: Influence of SPIO‐Labeling on the Functionality of Human Adult Mesenchymal Stem Cells
PP 111 MR‐Visualization of Endothelial Progenitor Cells after labelling with SPIO in a dynamic Cell Culture System
PP 112 Development of a novel phospholipid‐based biomimetic implant surface modification for orthopedic applications
Titanium is known to be a particularly biocompatible implant material. However in some cases subsequent development of interfacial fibrous tissue leading to the isolation of the implants is observed. Phospholipid coatings on titanium implant surfaces have been intensively studied and proved to be a positive factor for cell‐implant interactions in vitro (Willumeit et al., 2007, J. Mater. Sci: mater. Med. 18:367‐380). However, the so far used adsorptive manner of the lipid transfer is not stable enough. The aim of this study was to develop a novel, covalent coating of titanium with a phospholipid biomembrane model and to investigate the behaviour of human bone derived cells (HBDC) on this modified metal surface. Octadecylphosphonic acid (OPA) was first used to form a covalent linked monolayer on surfaces of smooth titanium samples. A phospholipid (POPE) monolayer was then deposited on this support by means of Langmuir Blodgett Technique to achieve a bilayer serving as cell membrane mimic. The quality of the coating was analysed by contact angle, reflectometry and X‐ray photoelectron spectroscopy measurements. For the study of osteointegration cell adhesion, viability and differentiation of HBDC were determined. Scanning electron microscopy was employed to corroborate the results. The data show that a stable biomembrane‐like coating was created. It was observed that this coating enhances cell adhesion and proliferation and allows the cells to produce proteins fundamental for bone growth. Our results suggest the possible usefulness of stable phospholipid based metal coating for implantology.
PP 113 A specific semi‐manual device for rapid repetitive intramuscular cell implantation
Intramuscular transplantation of myogenic cells in nonhuman primates and humans requires meticulous repetitive injections. Performed with syringes operated manually throughout large regions, the procedure takes a lot of time, becoming tiring and imprecise. In order to accelerate this task and to render it more precise, we developed a semi‐manual cell injector. Diverse mechanical principles were examined to choice an optimal arrangement. Simulations were done to verify the concept before machining a functional prototype. The final prototype was able to repeatedly inject a cell suspension simultaneously through six needles or less, delivering few microlitres equally through the intramuscular trajectory of each needle. The device was tested in vivo by performing intramuscular allotransplantations of beta‐galactosidase‐labeled myoblasts in cynomolgus monkeys. The success of the graft was comparable to that of our standard methods but the procedure was 4 to 6‐fold faster. The transplantation is facilitated by several facts.
Injecting through several needles at the same time accelerates the procedure.
The operator needs to focus only in positioning the needles for each implantation, since the distance of needle penetration to reach the muscle and the distance of cell delivery into the muscle can be preset in the device.
The course of the needles into the muscle is done automatically by pushing a button.
Continuous refilling of the cell suspension for each round of injections is done automatically from a container in the device. This is the first device specifically conceived for the needs of intramuscular cell implantation.
PP 114 Raman spectroscopy as a noninvasive tool for cellular characterization
PP 115 Design of a GMP conform, disposable bioreactor for mechanically promoted engineering of cartilage
PP 116 Cell‐based improvement of neural prosthetic device
Deep brain stimulation in selected brain regions has provided remarkable therapeutic benefits for otherwise treatment‐resistant movement and affective disorders such as chronic pain, Parkinson's disease, tremor and dystonia. Recently, there are several types of neural prosthetic implants in medical use, e.g. to treat Parkinson's disease. Beside psychological side effects several responses of the brain are described in animal studies after implantation of rigid and flexible devices. For long time application the pronounced disadvantage means an encapsulation of the neural prosthetic device by astrocytes and microglia and often leads to an insufficient signalling at the brain‐device‐interface. In this study we tried to circumvent these effects by covering the surfaces of neural prosthetic devices with adult stem cells, which serve as native interfaces. We here analysed the benefit of rat pancreatic and salivary gland stem cells to improve biological and functional integration in the brain exploring an in vivo rat model. Given the fact, that these cells show long time stability and a high proliferation activity they present an alternative source of pluripotent stem cells for various applications. In vitro, we test their growth characteristics on selected flexible prosthetic surfaces and analyse the differentiation ability into neural cells. Cell‐covered electrodes will provide new possibilities for stable chronic integration of flexible multichannel implants in the brain.
PP 117 Amino‐ and carboxyfunctionalized nano‐ and microstructured surfaces for evaluating adhesion, proliferation and differentiation of primary keratinocytes
PP 118 MEA‐Based biosensors to study cellular differentiation and integration
The microelectrode array (MEA) technique provides functional insight into cellular communication by taking advantage of the fact that the complex interplay between different ion channels can be examined in an intact and controllable system. Due to their design, MEAs can be used for short term recording of cellular activity as well as for long term culturing, thus offering a well defined in‐vitro test system for monitoring and describing both acute characteristics and long term effects, e.g. developmental states/changes, tissue integration of foreign cells or chronic drug effects.
In our lab we have developed a biosensor based on chicken cardiomyocytes to routinely investigate cardiotoxic effects of substances known to produce arrhythmia or long QT syndrome in humans. Amplitude, shape and duration of the field action potential as well as rhythmic activity are important parameters for the characterization of the effects. Other biosensors based on pig cardiomyocyes, human heart slices and stem cell derived cardiomyocytes (hes‐CM) are under development. For some of the models the investigation is accompanied by patch‐clamp analysis to separate the underlying ional mechanisms. Additional valuable information of MEA based biosensors can be obtained by analyzing the signal transduction within the 8 × 8 electrode array providing knowledge about disturbances of the excitation spread or to serve as indicator for e.g. integration of stem cell derived cells into target tissue. Possible applications include integration of hes‐CMs into heart or stem cell derived neurons into brain tissue.
PP 119 Development of a threedimensional Trachea Cell Model
PP 120 Modification of biomaterial surface structures for the in vitro generation of osteochondral implants
As the fixation of engineered cartilage to bone frequently poses problems after implantation, cartilage can be generated in vitro on top of a ceramic carrier which acts as bone substitute (osteochondral implant). Until now the adhesive strength between carrier and cartilage is not sufficient to withstand high shear stresses in the human knee. Thus, the aim of this study was to investigate the influence of carrier surface structure on adhesion of chondrocytes and tissue engineered cartilage. The surface structure of hydroxylapatite carriers (Sponceram®, Zellwerk, Germany) which was rough and inhomogeneous with local defects in the untreated state was modified by grinding with plain paper in the direction of smooth or by grinding with rough polymer sheets in the direction of structured. After characterization of the surface topography with a Charged‐coupled device camera, porcine chondrocytes were expanded on top of the carriers. After two weeks, cell density was analyzed by SEM and DAPI staining. In addition, osteochondral implants were generated according to a concept by Nagel‐Heyer et al.1. The adhesive strength and the quality of the formed matrix were determined.
Proliferation of chondrocytes was increased fivefold on the rough surface of the untreated carrier and adhesion between carrier and engineered cartilage tissue was improved compared to the modified surfaces. Against this, a slight increase in the quality of the matrix (tissue organization and biomechanical parameters) could be observed when generated on top of the modified surfaces. In conclusion, this work delivered first promising results, which motivate for further studies.
PP 121 Porous composite materials chitosan – bioactive calcium compound particulate for bone tissue engineering
There are some disadvantages in the use of ceramics based on calcium compounds such as hydroxyapatite (HA), tricalcium phosphate (TCP), carbonated HA (CHA), and calcium carbonate (CC), as bone substitute materials. The main drawbacks are brittleness and difficulty to match ceramics exactly to the bone defect size and geometry. Composite materials based on chitosan (Ch) matrix reinforced by a ceramic particulate, being elastic, allows the overcoming above drawbacks. In this study, a method has been developed to fabricate porous composites Ch – various calcium materials such as HA, TCP, CHA, and CC used in both the powder and granulated state. The medium molecular weight Ch soluble in acetic acid at pH < 6,5 was used. The calcium materials were admixed to a water solution of Ch followed by the addition of a foaming agent that also increased the pH value of the solution. Consequently, the viscosity of the suspension was increased. The foamed mixture was frozen at −180C. After that it was soaked in ethanol to remove water and acetic acid. Porous structure of scaffolds was resulted from both the foaming by carbon dioxide and the removing of crystallized water. The scaffold's properties are dependent on the porosity of the foam, the quantity and the kind of powder and granulated fillers. The solubility of the foams was studied. Also, the biological tests in vitro were performed showing cells adhesion and viability, and absence of cytotoxicity.
PP 122 Human Oct3/4 promoter dependent lentiviral transgene expression for simplified monitoring of primate embryonic stem cell culture
Clinical application of pluripotent stem cell (SC) derivatives require cell numbers that cannot be obtained by conventional SC culture techniques. However, upscale of embryonic stem cell (ESC) culture is sophisticated and control of the differentiation status in large scale cultures by means of immunostaining and qRT‐PCR is complex and time‐consuming.
To solve this problem, we have established single cell clones of rhesus and cynomolgus monkey ESCs expressing eGFP under the control of a pluripotency‐associated promoter. Since establishment of stable transgenic clones is extremely inefficient in primate ESCs when using conventional nonviral transfection techniques, we have applied lentiviral vector technology. To this end, primate ESCs were transduced with a simian immunodeficiency virus based lentiviral construct containing the reporter gene eGFP under control of the human Oct4 promotor. Colonies of transduced cells were dissociated and single cell clones were seeded onto 96 well plates after FACS sorting or limiting dilution, respectively.
Immunocytology and qPCR demonstrated robust GFP expression in undifferentiated colonies of resulting cell clones. Moreover, gradual decrease of GFP expression during differentiation was observed by qPCR. This was confirmed by anti‐OCT3/4 staining, which also revealed good correlation to endogenous Oct3/4 expression on the single cell level. More detailed analyses concerning the eGFP expression pattern of the different cell clones during differentiation are ongoing.
The established transgenic cell clones represent a valuable tool for establishment of culture conditions for large scale production of primate ESC and induced pluripotent stem (iPS) cells as well as for reprogramming of somatic (non)human primate cells.
PP 123 Measurement of physiology and growth of cells in 3D multilayered osteochondral constructs under mechanical stimulation
With recent advances in 3D culture, metabolic gradients play an increasingly important role in cell culture and tissue engineering, effecting control over cell growth and differentiation via physiological gradients. Here, measurements of cell physiology and development were made in osteochondral constructs fabricated by a new method, where polysaccharide sponges are glued to hydroxyapatite bone scaffolds using a sol‐gel technique. The “glue” consists of silica‐sol embedded hydroxyapatite, thus mimicking the calcified layer in deep‐zone cartilage, and enables a solid, durable but bioresorbable connection between arbitrary polymeric or ceramic materials. The constructs were cultured under perfusion with or without mechanical stimulation in bioreactors from the novel labware system of the Biocer Gmbh, which allows for high replicate numbers. Scaffold permeability was measured with electrochemical sensors.
In spite of high porosity, diffusion under static conditions in a 4 mm scaffold is very low. Perfusion‐culture improved cell development, proliferation and tissue formation. Mechanical stimulation primarily enhanced cell nutrition in central regions by augmenting fluid movement, leading to an even distribution of tissue formation throughout the scaffold, which had an overall size of 15 × 8 mm. Cells grew throughout the sol‐gel layer, which formed a porous yet firm connection. Chondrocytic differentiation was not optimally induced by the chitosan scaffold, despite the application of TGF‐β3 and IGF. Based on the good results for nutrition, more differentiation‐active matrices with better mechanotransduction will be developed. The BioCer Labware Bioreactor‐System proved to be ideally suited for perfusion and mechanical stimulation of 3D tissue cultures in high replicates.
PP 124 Interaction of human bone derived cells with phospholipid coated porous titanium alloy surfaces of different morphologies
The successful use of titanium‐based implants for orthopaedic applications is sometimes hindered because of an imperfect interaction between the bone tissue and the metal surface. Porous titanium materials with suitable pore structure are good candidates for bone interaction, because they in principle permit cell “ingrowth” preventing loosening of the implant. However, the cell mobility into the pores is in many cases restricted, the cells prefer to grow on the surface. Recently it was observed for chondrocytes that they move into pores when the surface is coated by phospholipids [Willumeit et al., 2007; European Cells and Materials, 13:11‐25]. The objective of this study was therefore to create different phospholipid coated porous titanium alloy surfaces and to investigate the interactions of human bone derived cells (HBDC) with these biomimetic implant materials. Ti‐6Al‐7Nb sintered carriers with six different particle size fractions (from 45 to 500 μm) were coated adsorptive with two phospholipids (POPE and POPC). HBDC were used for the examination of cell adhesion, viability and differentiation after preincubation of phospholipid coated samples in cell medium for two hours. The structural details of the materials and interactions with growing cells were obtained by scanning electron microscopy. The data show that the viability of HBDC strongly correlates with the structure of the sintered materials. For the native materials the best results were achieved with grain sizes under 130 μm. Phospholipid coatings have a positive effect on cell‐implant interactions and improve the vitality of HBDC on samples with grain sizes above 130 μm.
PP 125 In‐Vivo tissue engineering of vascularised adipose tissue for breast reconstruction: long‐Term results and transplantation
Aim: A high demand exists for soft tissue reconstruction with adipose tissue. Especially tissue engineering of complex three‐dimensional tissue, in particular for breast reconstruction, requires vascularisation for its survival, with a view to transplanting it into the in vivo situation.The aim was to establish a technique for the de‐novo generation of large amounts of vascularised, stable and transplantable adipose tissue using a growth chamber in an animal model.
Methods: We examined the use of an vascularised adipose tissue flap (4% of the chamber volume) and a matrix scaffold in a growth chamber in the rat (1.7ml). Subsequently, we used the method in the pig with a growth chamber of 78ml volume and following pedicled transplantation of the new generated adipose tissue to simulate in‐situ breast reconstruction. Magnetic Resonance Angiography (MRA) assessed tissue growth and vascularisation within the chamber.
Results: At 12 weeks post‐insertion, the entire chamber was filled with new tissue and the adipose tissue was grown up to 60% of the chamber volume. The MRA was capable of monitoring vessel patency. Histology could confirm true hyperplasia and adipose precursor cell stimulation. No pathological changes have been seen. After pedicled transplantation, the newly generated tissue stayed stable in volume after 22 weeks.
Conclusion: The study demonstrated a promising method of producing significant amounts of vascularised, stable and transferable adipose tissue by stem cell stimulation that can be monitored non‐invasively by MRA. This is an important step towards development of a permanent autologous soft tissue replacement and a clinical application.
PP 126 Online monitoring of oxygen and pH during cell cultivation in multiwell plates
Cell cultivation requires defined in vitro conditions. This is especially important for stem cell cultivation because even small changes can have large effects on differentiation. Monitoring essential parameters like oxygen and pH enables optimization of culture conditions for complex differentiation processes.
Monitoring in small volumes was hitherto only possible through cumbersome microscoping and destructive one‐point staining tests. With the SDR SensorDish® Reader it is possible to monitor the two key parameters dissolved oxygen (DO) and pH non‐invasively and online in 24‐well multidishes. Optical sensors for DO or pH are located in each well and read out through the bottom by a small 24‐channel reader. This reader is placed in the incubator for continuous monitoring during the entire cultivation. Two applications of this system are demonstrated: DO of human embryonic stem cells under hypoxia was monitored during the entire cultivation. It was found that even short openings of the incubator door or media change had so far unconsidered effects on the DO within the sample. Furthermore, the SensorDish® Reader was used for online pH and DO monitoring in 3D cultures of chondrocytes, where examination by microscope is not possible. New insights regarding the cell activity at high concentrations were found.
PP 127 Manipulation of biological tissue and materials with ultra‐Short laser pulses at micro‐ and nanoscale
manipulation of single living cells, even cell organelles
perforation of the cell membrane to allow impermeable macromolecules e.g. DNA to enter the cell without chemical or viral interference
Applications of ultra‐short laser pulses offer an innovative approach to gain new insights in the field of tissue engineering and stem cell research.
PP 128 Novel Nanostructured Coatings Induce Osteogenic Differentiation of Human Mesenchymal Stem Cells
One of the design goals of the ideal bone implant‐coating is osteoinductivity, the ability to induce the osteogenic differentiation of mesenchymal stem cells (MSC). In this study, the in vitro osteoinductive potential of novel High‐Velocity Oxygen Fuel (HVOF) ‐sprayed nano‐TiO2 + 10wt%HA (HA‐TiO2) coatings as possible mechanically superior alternatives to FDA approved atmospheric plasma spray (APS) HA coatings was evaluated. Human bone marrow mesenchymal stem cells (hMSCs) were cultured in basal and osteogenic medium (hMSC‐ob) on the novel nanostructured HA‐TiO2 and reference HA, TiO2 coatings. The novel coating was evaluated for promotion and maintenance of osteogenesis both in the presence and absence of biological stimuli through: (i) proliferation; (ii) cytoskeleton organization and cell‐substrate adhesion (F‐actin/Vinculin/ Propidium Iodide); (iii) coatings‐cellular interaction morphology and growth (SEM); (iv) biochemical markers of cellular mineralization: alkaline phosphatase (ALP) activity and osteocalcin (OC) expression; and (v) mineralization (Alizarin Red) and calcein staining, from 1 to 21 days. As seen by the increased cellular metabolism and denser fluorescence intensity on cells plated on the novel surfaces (figure 1), they induced cellular growth independently of culture conditions (osteogenic vs. unsupplemented media). The nanostructured HA‐TiO2 facilitated differentiation of cells to mature mineral producing osteoblasts as seen by the increased temporal ALP activity and OC expressions with hMSC and hMSC‐ob cultures and higher calcium deposition trend (Alizarin Red and calcein fluorescence) for the nanostructured HA‐TiO2 substrate. In conclusion, these findings collectively demonstrate the osteoinductivity of the nanostructured HA‐TiO2 coatings and their potential as novel mechanically and biologically improved load bearing implant coatings.
PP 129 Peculiarities of interaction of mouse peripheral blood cells with different passages of mouse embryonic fibroblasts
In modern cellular therapy and regenerative medicine the problem is the increase of the amount of target cells by their multiplication for introduction into an organism. As the multiplication is performed out of an organism, there is the question – whether cells remain “own” after this ex vivo procedure. The interaction of the cells from mouse peripheral blood with mouse fibroblasts prepared from 13,5 days embryo was studied. Fibroblasts at 0, 2nd and 4th passages have been tested. It has been shown that when using zero passage, as compared to control, neither morphological changes of embryonic fibroblasts after addition of white blood cells, nor interaction between them took place. Loading of peripheral white blood cells onto the monolayer of 2th passage fibroblasts resulted in appearance of changes in fibroblasts' morphology along with the presence of typical cells. Changes were expressed in cells rounding, their bulge, appearance of unevenness. Further increase of fibroblasts passages number to 4 resulted in changes, the consequence of which was vivid reaction of the added white blood cells, namely rapid and radical destroy of fibroblasts by them. These reactions cannot be connected with the remains of donor plasma at the white blood cells, because leukocytes were washed before loading. The differences revealed in the interaction of fibroblasts at different passages with the cells of peripheral blood are the evidence for the necessity of studying the interaction of cells after their multiplication out of organism with the cells of the organism.
PP 130 Test of nano‐Structured titanium dioxide coatings for use as biocompatible surfaces
A series of nanostructured TiO2 coatings on glass substrates was prepared by screen printing of TiO2 pastes and subsequent sintering at 450 °C. The surface structure was controlled on the nanoscale by the diameter of the TiO2 nanoparticles in the paste, which was chosen between 15 nm and 300 nm. For comparison, compact TiO2 layers were produced using sol‐gel and dip coating techniques. The coatings were sterilized either by autoclaving or rinsing in ethanol before cells were seeded. Glass cover slips with cells from different cell lines (epithelial, fibroblast and osteogenic origin) were incubated for 48 to 72 hours and prepared for immunocytochemistry and MTT‐assay to compare adhesion, outgrowth and proliferation. Cells`re stained for cytoskelettal proteins like tubulin and actin in combination with live stain for mitochondria and viewed with epifluorescence as most of the coatings were opaque. Differences in adhesion and growing properties of various cell lines were observed. Whereas cells on compact, dip‐coated TiO2‐layers led to similar results like controls on uncoated glass, some of the nano‐structured coatings induced improved adhesion and outgrowth. Proliferation was estimated by mitochondrial activity. Evaluation of proliferation was difficult due to hindered visibility of cell density used for the test system. Quantifying DNA by BrdU assay will avoid this restriction.
In summary, the tested cell lines showed individual effects on different nanostructured TiO2 coatings. The results demonstrate the importance of a detailed knowledge of the nanostructure and its interaction with individual cell lines to pre‐estimate effects of implants on various tissues in vitro.
PP 131 Influence of oxygen pressure on Proliferation and Chondrogenic Differentiation of Human Mesenchymal Stem Cells in Fibrin Glue
Tissue engineering using biomaterials is a promising solution for cartilage replacement. The purpose of this study was to investigate whether the fibrin sealant Tissucol® provides a suitable scaffold for re‐implanting during chondrogenic replacement therapy. Pluripotent stem cells were isolated from adult human bone marrow (hMSCs), cultured and characterised by FACS (CD105+/CD106+, CD45‐/CD14‐/CD34‐), by differentiation‐assays as well as by Oct4‐expression profile. Using appropriate preparation and applying centrifugal forces leads to a reproducible large‐holed porous 3D network in which the hMSCs are homogenously distributed and that allowed hMSCs to survive throughout the period of culture in either proliferation or chondrogenic differentiation medium under normoxic (21% O2) or hypoxic (3% O2) conditions. Morphology (as determined by light‐ and electron microscopy) and proliferation (Ki67 staining) of the embedded hMSCs did not markedly vary under normoxic and hypoxic culture even after 21 days in culture. The stem cell marker Oct4 was expressed during the whole culture period. Under chondrogenic differentiation conditions, especially under hypoxic conditions, we observed rounded chondrocyte‐like cell types and a chondrogenic phenotype assessed by mRNA expression of collagen II and Alcian blue staining. hMSCs seeded into large‐holed porous preparations of Tissucol® survive, proliferate and keep their stem cell character. Furthermore, culturing the cells in corresponding medium induces chondrogenic differentiation, which could be remarkably and significantly enhanced under hypoxic conditions. This firstly qualifies Tissucol® as adequate scaffold for cartilage generation and secondly suggests benefits in emulating the bradytrophe environment of cartilage in vivo by studying chondrogenesis in vitro under hypoxic culture conditions.
PP 132 A novel collagen cell carrier for cell culture systems
The biological function of complex three‐dimensional cell culture systems strongly depends on the chemical and mechanical properties of the cell carriers employed. Numerous biocompatible materials have been modified to optimize cell attachment, integration and cellular differentiation processes in vitro and in vivo. In this study, we introduce a novel bovine collagen I‐based cell carrier which was tested in different cell culture systems. This scaffold exhibits high mechanical stability coupled with material thicknesses below 20 μm, placing it in an interesting range for the generation of complex multilayered tissue constructs. Various cell culture populations were investigated to evaluate the biocompatibility of the collagen scaffold in vitro and its impact on cell viability, proliferation and differentiation. Cell culture experiments with the human osteosarcoma cell line Saos‐2 did not show significant differences in viability and cell proliferation between cells seeded on conventional uncoated culture plates and those grown on the collagen scaffold. Differentiating murine osteoblasts and human mesenchymal stem cells strongly calcified the collagen scaffolds under osteoinductive cell culture conditions. Primary cardiomyocytes from fetal murine hearts seeded on the collagen cell carrier maintained their spontaneous contractile activity in culture over the entire 7‐day observation period. Both the mechanical characteristics and the demonstrated in vitro biocompatibility of this collagen I carrier highlight its suitability for in vitro studies and in vivo applications in basic research and in the field of Regenerative Medicine.
PP 133 Cell seeding densities affect differentiation of human adipose tissue‐Derived stem cells – Do connexins play a role?
Adipose tissue‐derived stem cells (ASC) are a promising cell type for regenerative medicine. ASC are relatively easy to isolate and propagate and could thus be utilized for stem cell therapies. However, knowledge about ASC characteristics is fragmentary. In this study, we examined the effects of seeding densities on the differentiation of ASC. ASC were seeded in different densities to control the extent of intercellular contacts. The cells were then exposed to adipogenic or osteogenic differentiation stimuli. Proliferation as well as adipogenic or osteogenic differentiation characteristics were followed for two weeks. To examine the impact of intercellular contacts, in particular connexins, on ASC differentiation, the experiments were also performed in presence of inhibitors for connexin signalling. After two weeks of cultivation, the initial differences in cell density were nearly balanced. Whereas osteogenic stimulation generally led to increased proliferation (doubled cell numbers compared to non‐stimulated cells), adipogenic stimulation led to reduced proliferative activity (ca. 30% less cells). Adipogenic differentiation was strongly dependent on the initial seeding density, in that only those cultures that were confluent from the beginning (highest seeding density) showed significant adipogenic differentiation. This is in contrast to osteogenic differentiation which was slightly increased by sparser cell densities. Connexin inhibitors did not show a significant influence on differentiation degree. Thus, primary seeding densities influenced the degree of adipogenic and osteogenic differentiation and preliminary results do not indicate an involvement of connexin signalling herein. This work was financed by EU and the Ministry of Economic Affairs, Employment and Tourism Mecklenburg‐Vorpommern.
Abstract Author Index by abstract number
Abberton K, PP 125
Abdullah, Z, PP 04
Abele, H, PP 07
Adam, S, PP 35, PP 133
Addicks, K, PP 131
Ahlers, M, OP 22, PP 46, PP 55, PP 87
Aicher, WK, OP 26, PP 07, PP 18, PP 29, PP 44
Alexander, D, PP 83
Alini, M, OP 05
Ambrósio, CE, PP 24, PP 38, PP 41, PP 109
Anderer, U, PP 48
Andersen, M, PP 95
Andreeva, ER, PP 36
Angres, B, PP 78
Anokhina, EB, PP 85
Antoniou, AS, PP 128
Arain, S, PP 126
Arnhold, S, PP 131
Baden, S, PP 42
Badke, A, OP 22
Bank, RA, PP 52
Bantleon, R, PP 110, PP 111
Bär, A, PP 63, PP 64
Bareiss, PM, PP 96
Barinov, SM, PP 121
Bastmeyer, M, OP 13
Bauer, H, PP 30
Baumgart, J, PP 127
Baumgartner, L, PP 131
Becker, B, PP 86
Becker, J‐C, PP 104
Behrends, J, PP 39
Beier, J, PP 12
Beltrão‐Braga, PCB, PP 24, PP 38, PP 41, PP 109
Benjamin, PP 61
Benz, K, OP 22, PP 46, PP 55, PP 78, PP 126
Bergemann, J, PP 105
Bianco, P, PP 47
Birgel Junior, EH, PP 24, PP 38, PP 41
Birova, B, PP 40
Bischofs, IB, OP 13
Bloch, W, PP 60, PP 131
Block, T, PP 127
Bock, C, PP 71
Boehnke, K, PP 102
Boekstegers, P, OP 33
Bohl, AC, PP 72
Bolwien, C, PP 114
Borchers, K, PP 108, PP 117
Bork, S, OP 24
Boukamp, P, PP 102
Boutter, J, PP 09
Bozkurt, A, OP 34
Branco, É, PP 59
Brenner, R, PP 31, PP 94
Brixius, K, PP 131
Broecker, E‐B, PP 104
Brook, G, PP 97, PP 100
Brook, GA, OP 34
Brunauer, R, PP 30
Brunner, S, PP 62
Buckenmaier, S, PP 118
Bühring, HJ, PP 83
Bulatova, S, PP 25
Buravkova, LB, OP 29, PP 36, PP 85
Bureau, MN, PP 128
Burger, K, PP 105
Busch, DH, PP 04
Cabral, R, PP 59
Campos, CA, PP 59
Cancedda, R, OP 15
Carmeliet, P, OP 02
Carnwath, JW, PP 15
Charbord, P, PP 47
Chen, S, PP 01
Chia Ning Chang, S, OP 37, PP 50, PP 51, PP 80
Christalla, P, OP 04
Chung, H‐Y, OP 37, PP 50, PP 51, PP 80
Claussen, CD, OP 09, PP 110, PP 111
Conrad, S, PP 66
Cooper‐White, PP 125
Csaki, C, PP 34
Cui, W, PP 122
Dahmen, U, OP 18
Dally, I, PP 119
Danker, T, PP 96
Danner, S, PP 116
Dauner, M, PP 90
David, R, PP 02, PP 62
Depping, R, PP 23
Deryabina, OG, PP 129
Deumens, R, OP 34
Dickhut, A, PP 49, PP 53
Didié, M, OP 04
Diehlmann, A, OP 24
Dienelt, A, OP 36
Dieterich, R, PP 04
Dietz, K, PP 110
Dimitrievska, S, PP 128
Ditz, C, PP 99
Docheva, D, PP 84
Dohr, G, PP 21
Döker, S, OP 04
Dolderer, JH, PP 125
Dolstra, H, PP 19, PP 26
Domogatskaya, A, OP 21
Dorn, I, OP 27
Doss, X, PP 03
Dreesmann, L, PP 87
Driller, B, OP 27, PP 39
Duchardt, F, PP 17
Duerr, M, PP 130
Dvorankova, B, OP 32
Eckstein, V, OP 24, PP 49
Egermann, M, PP 49
Eisenbeiss, W, PP 72
El‐Aouni, C, OP 33
Elvassore, N, OP 07
Emmel, J, PP 69
Enders‐Comberg, S, PP 73
Ernemann, U, PP 79
Eschenhagen, T, OP 04
Essers, M, OP 23
Essl, M, OP 26, PP 20
Everts, V, PP 52
Ewerbeck, V, PP 53
Fadeeva, IV, PP 121
Fadel, L, PP 24, PP 38, PP 41
Färber, M, PP 98
Faulhaber, J, PP 103
Fechner, N, PP 17
Fedotov, AY, PP 121
Feil, G, PP 70, PP 71, PP 75
Feldmann, C, PP 02
Felka, T, PP 29, PP 44
Fernandes, SW Han, PP 109
Ferreira, JG, PP 59
Feyerabend, F, PP 112, PP 124
Fiammengo, R, OP 25
Findlay, MW, PP 125
Finke, B, PP 112
Fioretto, ET, PP 59
Fischer, J, PP 53
Fischer, JH, PP 60
Fischer, P, PP 63, PP 64
Fischer, S, PP 27
Fischer, T, PP 60
Fomin, AS, PP 121
Franchini Ramires, JA, PP 59
Franz, W‐M, PP 02, PP 62
Franzen, R, PP 100
Frenzel, LP, PP 04
Friedrich, B, PP 83
Fritsch, D, PP 120
Fritze, O, PP 57, PP 58
Frost, P, PP 86
Fuchs, HW, PP 86
Fuhrmann, A, PP 115
Führmann, T, PP 97, PP 100
Funari, A, PP 47
Gaßner, R, PP 30
Gaetani, R, PP 67
Gaisberger, M, PP 25
Gajewski, M, PP 03
Galach, M, PP 09
Gams, E, PP 82
Gauthier, K, OP 28
Gebhard, D, PP 105
Gehring, FK, PP 106
Gerling, R, PP 124
Ghadri, J‐R, PP 103
Giacomello, A, PP 67
Globisch, F, OP 33
Goepfert, C, PP 120
Goerdt, S, PP 103
Goettler, S, PP 58
Gonçalves, LG, PP 109
Gosselin, C, PP 113
Götting, C, PP 43
Goulet, M, PP 76, PP 77, PP 113
Gregores, GB, PP 59
Grein, T, PP 130
Griessmayer, J, PP 25
Grinakovskaya, OS, PP 36
Groll, J, PP 33
Gross, G, PP 54
Grote, K, PP 103
Gruh, I, PP 16, PP 67
Grupp, L, PP 87
Grzesiak, A, PP 108
Guenther, E, PP 96, PP 118
Gustafsson, E, PP 75
Haase, A, PP 14, PP 122
Habisch, H‐J, PP 31, PP 94
Haddouti, E‐M, PP 40
Hahn, HK, OP 18
Hajosch, R, PP 87, PP 90
Halbach, M, PP 60, PP 65
Hamisch, S, PP 123
Hampel, M, PP 119
Hannes, T, PP 65
Hans Jörg, M, PP 45
Hansmann, J, PP 57, PP 119
Harmsen, MC, PP 22
Hartl, A, PP 25
Hartmann, B, OP 11
Hartmann, H, PP 95
Hasenfuss, G, PP 13
Hata, H, PP 63
Häupl, T, PP 47, PP 54
Haustein, M, PP 11, PP 13
Haußmann, S, PP 132
Haverich, A, PP 16, PP 27, PP 63, PP 64, PP 67
Hayashi, S, PP 88
Heckl, S, PP 79
Heidenau, F, PP 123
Heke, M, PP 82
Helder, MN, PP 52
Hellberg, A‐K, PP 23
Hennenlotter, J, PP 96
Hermanutz‐Klein, U, PP 110
Herr, A, PP 31
Herrmann, T, PP 93
Herten, M, PP 56
Heschel, I, OP 34
Hescheler, J, PP 01, PP 03, PP 04, PP 06, PP 11, PP 13, PP 61, PP 65
Hess, C, PP 27
Hierlemann, H, OP 11
Hilfiker, A, PP 27, PP 63, PP 64
Hillen, L, PP 97
Hindennach, M, OP 18
Hinkel, R, OP 33
Hinselmann, G, PP 17
Hinze, A, PP 101
Hippler‐Altenburg, R, PP 61
Hirsch, E, PP 62
Hirth, T, PP 108
Ho, AD, OP 24
Hoffmann, A, PP 54
Hoffmann, J, PP 83, PP 86
Hofmann, UG, PP 116
Horn, P, OP 24
Hoss, M, PP 90
Houben, R, PP 104
Hovatta, O, OP 21
Howard, K, PP 95
Huebner, N, OP 35
Ikegame, Y, PP 88
Iliev, P, PP 112
Istvanffy, R, OP 28
Iwama, T, PP 88
Iwen, A, PP 72
Jäger, M, PP 56
Jagtap, S, PP 06
Jakab, M, PP 25
Jakob, F, PP 37
Jamnig, A, PP 30
Janßen, R, PP 120
Janicki, P, PP 49
Jara‐Avaca, M, PP 13
Jatzke, S, PP 37
Jeng, L‐B, OP 37, PP 50, PP 51, PP 80
Jorgensen, C, PP 47
Jung, F, PP 23
Just, L, PP 70, PP 96, PP 132
Kalbacher, H, PP 18
Kaltschmidt, K, PP 48
Kaltz, N, PP 47
Kasten, A, PP 33
Kehlbach, R, PP 110, PP 111
Kensah, G, PP 16
Kerkis, A, PP 41
Kerkis, I, PP 41
Kerstein, A, PP 98
Kirsanova, VA, PP 121
Kjems, J, PP 95
Kleesiek, K, PP 43
Klein, C, PP 83
Klein, F, OP 13
Klein, G, OP 25, OP 26, PP 18, PP 20
Klein, HM, PP 82
Klein, J, PP 72
Kleinfeld, C, PP 40
Klein‐Hitpass, L, PP 37
Klinger, M, PP 05
Kloss, F, PP 30
Kluba, T, PP 29, PP 110
Kluger, P, PP 57, PP 117
Knaupp, M, PP 108
Knebel, G, PP 115
Knuth‐Rehr, D, PP 99
Koch, S, PP 114
Koenen, W, PP 103
Koenigsrainer, A, PP 96
Koepenik, A, OP 17
Koestenbauer, S, PP 21
Kögler, G, OP 19
Kohler, K, PP 70, PP 89, PP 93
Komlev, V, OP 15
Komlev, VS, PP 121
König, B, PP 90
Kordium, VA, PP 129
Kramer, J, PP 05, PP 39, PP 72, PP 73, PP 107
Kramer, M, PP 71
Kraus, A, PP 89
Krausgrill, B, PP 60
Kraushaar, U, PP 118
Krauspe, R, PP 56
Krenning, G, PP 22
Kriegeskorte, AK, PP 04
Kroeze, RJ, PP 52
Krönke, M, PP 04
Krug, D, PP 05
Krug, J, PP 70, PP 71
Kruse, C, PP 116
Kues, W, PP 15
Kuhn, J, PP 43
Küntscher, M, OP 11
Kupatt, C, OP 33
Kurzen, H, PP 103
Lächele, A, PP 71
Lacina, L, OP 32
Ladehoff, M, PP 98
Laggies, S, PP 54
Lakner, U, PP 95
Laliberté, T, PP 113
Landmesser, U, PP 103
Lang, H, PP 56
Lange, N, PP 04
Laschober, GT, PP 30
Lassner, F, OP 34
Lassonczyk, N, PP 100
Layer, PG, PP 09
Lazar‐Karsten, P, OP 27
Lehmann, M, PP 48
Lehnert, D, OP 13
Lehnert, H, PP 05, PP 72, PP 73
Lemos, PA, PP 59
Lepperdinger, G, PP 30
Ley, BH, PP 126
Liebau, S, PP 31
Likhacheva, LI, PP 129
Lima, EB, PP 109
Lima, R, PP 128
Limberg, W, PP 124
Lin, T‐M, OP 37, PP 50, PP 51, PP 80
Lindner, U, OP 27, PP 39, PP 72, PP 73
Linke, K, PP 74
Linke, R, PP 48
Lott, D, PP 112
Löwenheim, H, PP 92
Lubatschowski, H, PP 127
Lund, Q, PP 01
Lysenko, SP, PP 129
Mack, AF, PP 57
Mahler, B, PP 105
Maier, LS, PP 13
Maiorka, PC, PP 59
Mair, H, PP 25
Malagó, M, OP 18
Malek, A, PP 81
Mallek, A, PP 22
Mannigel, K, PP 48
Marc, H, PP 45
Marple, BR, PP 128
Martin, F, PP 48
Martin, R, OP 25
Martin, U, OP 31, PP 08, PP 10, PP 11, PP 12, PP 13, PP 14, PP 16, PP 27, PP 67, PP 122
Massow, O, PP 127
Mastrogiacomo, M, OP 15
Matis, U, PP 34
Matt, K, PP 105
Maurer, A, PP 27
Maurer, S, PP 70, PP 71
Mauritz, C, PP 13, PP 16
May, AE, OP 10
Mayer, D, OP 16
Meffert, S, OP 16
Meganathan, K, PP 06
Mehlhorn, U, PP 60
Meides, A, PP 114
Meier, M, PP 73
Menaa, F, PP 104
Menke, S, PP 13
Merkert, S, PP 122
Merkle, P, PP 130
Mertsching, H, PP 57, PP 68, PP 69, PP 74, PP 114, PP 115, PP 117, PP 119
Messina, E, PP 67
Metzger, M, PP 96
Meyer, G, OP 27
Miglino, MA, PP 24, PP 38, PP 41, PP 59, PP 109
Minger, S, OP 01
Mizuno, H, PP 88
Möckel, S, PP 98
Moder, A, PP 25
Möhle, R, PP 71
Mollenhauer, J, OP 22, PP 46, PP 55
Möller, M, PP 33
Möllers, S, OP 34
Montzka, K, PP 97, PP 100
Morrison, WA, PP 125
Muehlfriede, S, PP 115
Muffler, S, PP 102
Müller, B, PP 43
Müller, CA, PP 32, PP 40
Müller, HW, OP 06
Müller, J, PP 46, PP 55
Müller, L, PP 106
Müller, M, PP 92
Müller, P, PP 33
Müller, R, PP 91, PP 107
Müller, S, PP 10
Müller‐Ehmsen, J, PP 60, PP 61, PP 65
Munz, A, PP 83
Mutschler, W, PP 84
Nägele, T, PP 79
Nakashima, S, PP 88
Napp, LC, PP 103
Neef, S, PP 13
Nelson, P, OP 33
Neumann, B, PP 54
Neuss, S, PP 100
Nguemo, F, PP 11
Nichterwitz, S, PP 90
Nickenig, G, PP 28
Nieden, NI zur, OP 36
Niemann, H, PP 15
Niemann, R, PP 03
Northoff, H, PP 106
Notbohm, H, PP 107
Nöth, U, OP 08, PP 37
Nothelfer, K, PP 132
Nowak‐Imialek, M, PP 15
Offenhäusser, A, OP 16
Olde, DL, OP 34
Olmer, R, PP 11, PP 122
Oostendorp, R, OP 28, PP 47
Oreffo, RO, OP 14
Oser, G, OP 23
Ottomann, C, OP 11
Pagel, H, PP 73
Pallua, N, OP 34
Palmeira Sarmento, CA, PP 59
Panas, M, PP 117
Panattoni, JF, PP 24, PP 38, PP 41
Pansky, A, PP 32, PP 40, PP 56
Papadimitropoulos, A, OP 15
Paradis, M, PP 76, PP 77, PP 113
Paulitschke, M, OP 17
Pawar, K, PP 91
Pawlak, E, PP 98
Peitgen, H‐O, OP 18
Pelttari, K, PP 49
Peschel, C, OP 28, PP 47
Peters, K, PP 35, PP 133
Petit, A, PP 128
Pfannkuche, K, PP 65
Pfosser, A, OP 33
Pillekamp, F, PP 65
Pilz, G‐A, PP 07
Popov, C, PP 84
Pörtner, R, PP 120
Prante, C, PP 43
Prätzel‐Wunder, S, PP 102
Preiss, T, PP 28
Przemeck, S, PP 127
Pusch, K, PP 69
Ramchal, R, PP 112, PP 124
Raths, M, PP 61
Ratner, BD, OP 12
Rauch, N, OP 25
Reinert, S, PP 83
Reissenweber, M, OP 28
Renström, J, OP 28
Reppel, M, PP 11, PP 13, PP 65
Richard, P-L, PP 113
Richter, A, PP 116
Richter, T, PP 120
Richter, W, PP 49, PP 53
Riediger, D, PP 42
Riminucci, M, PP 47
Ritter, M, PP 25
Rodin, S, OP 21
Rohwedel, J, PP 05, PP 39, PP 72, PP 73, PP 107
Roitzheim, B, PP 40
Rolletschek, A, OP 35
Romanov, YA, OP 29
Ronda, S, PP 45
Rose, C, PP 72
Rotter, N, PP 107
Royer, L, PP 31
Ruban, TA, PP 129
Rudolph, C, PP 15
Ruhparwar, A, PP 82
Rustichelli, F, OP 15
Rychly, J, PP 33, PP 35, PP 133
Sachinidis, A, PP 01, PP 03, PP 06, PP 61
Saffrich, R, OP 24
Salamon, A, PP 35, PP 133
Sanovic, R, PP 25
Šaric, T, PP 04
Schäfer, F, PP 83
Schäfer, J, PP 71
Schäfer, R, PP 29, PP 44, PP 58, PP 110
Schaller, H‐E, PP 89, PP 125
Schandar, M, PP 68, PP 115
Schanz, J, PP 74
Scharstuhl, A, PP 46, PP 55
Schenk, A, OP 18
Schenk, K, PP 61
Schenk, R, PP 37
Schieffer, B, PP 103
Schieker, M, PP 84
Schledzewski, K, PP 103
Schlegelberger, B, PP 15
Schlegelmilch, K, PP 37
Schleicher, M, PP 57, PP 58
Schlenke, P, OP 27, PP 39
Schloßhauer, B, PP 87, PP 90, PP 95
Schmehl, J, PP 66, PP 111
Schmid, H, PP 93
Schmidberger, T, OP 22
Schmidt, M, PP 60
Schmidt, S, PP 25
Schmidt, T, PP 132
Schmidt‐Richter, I, PP 67
Schmitteckert, S, OP 35
Schnabel, S, PP 103
Schöler, H, PP 13, PP 16
Scholze, NJ, PP 32
Schomäcker, K, PP 60
Schönherr, R, PP 99
Schossig, M, PP 112, PP 124
Schrama, D, PP 104
Schreiber, TD, OP 26
Schröder, M, PP 31
Schubert, S, PP 08
Schügner, F, OP 34
Schuh, E, PP 107
Schulz, H, OP 35
Schumann, H, PP 16
Schuster, A, PP 112, PP 124
Schütze, N, PP 37
Schwanke, K, PP 08, PP 10, PP 11, PP 12, PP 13, PP 16, PP 122
Schwarz, J, PP 31
Schwarz, US, OP 13
Schwinger, RHG, PP 60
Seibold, J, PP 75
Seiffart, V, PP 54
Seitz, D, PP 123
Selent, C, PP 75
Sellhaus, B, OP 34
Semenov, O, PP 22, PP 81
Sergeeva, NS, PP 121
Shahab, S, PP 54
Shakibaei, M, PP 34
Shimono, A, OP 28
Siegel, G, PP 110
Sievers, H‐H, PP 23
Sievert, K‐D, PP 70, PP 71, PP 75
Sinis, N, PP 89
Sinn, S, PP 106
Skroch, M, PP 40
Skuk, D, PP 76, PP 77, PP 113
Skutella, T, PP 66, PP 96
Smeets, R, PP 42, PP 100
Smetana, KJ, OP 32
Smirnov, VV, PP 121
Smit, TH, PP 52
Sonntag, C, OP 25
Spanholtz, J, PP 19, PP 26
Spatz, J, OP 25
Sperling, LE, PP 09
Spitkovsky, D, PP 01
Spohn, R, PP 17
Spychaj, K, PP 69
Stachel, G, OP 33
Stark, H‐J, PP 102
Staudt, ND, PP 18
Steinhoff, J, PP 73
Steinl, C, OP 26, PP 20
Stenzel, A, PP 70
Stenzl, A, PP 71, PP 75, PP 96
Stett, A, PP 93
Stock, UA, PP 57, PP 58
Stoelting, S, PP 23
Stoll, D, PP 78
Stolzing, A, PP 101
Stopiglia, AJ, PP 59
Storch, A, PP 31, PP 94
Sturany, S, PP 78
Sturzu, A, PP 79
Sulz, G, PP 114
Sviridova, IK, PP 121
Synwoldt, P, PP 104
Szabo, P, OP 32
Täger, J, PP 89
Tajra Feitosa, ML, PP 24, PP 38, PP 41
Takimura, C, PP 59
Taylor, U, PP 15
Tempfer, H, PP 30
Templin, C, PP 103
Tepe, G, PP 111
Thedieck, C, OP 25
Theiss, HD, PP 62
Tiburcy, M, OP 04
Timothy, G, PP 45
Tobiasch, E, PP 32, PP 40, PP 56
Tordoir, M, PP 19, PP 26
Tosh, D, OP 03
Tossios, P, PP 60
Tovar, GEM, PP 108, PP 117
Tremblay, JP, PP 76, PP 77, PP 113
Tronnier, V, PP 98, PP 99
Trost, N, PP 125
Trumpp, A, OP 23
Tryggvason, K, OP 21
Tschöke, B, PP 100
Ugurel, S, PP 104
Ulmer, AJ, PP 17
Ulmer, JT, PP 68
Ulrich, C, PP 07
Utermöhlen, O, PP 04
Vallaster, M, PP 62
van Lenthe, HG, OP 20
Voß, F, PP 48
von der Ruhr, JW, PP 66, PP 111
Vonka, V, OP 32
Voros, J, PP 81
Voss, S, PP 17
Voth, V, PP 58
Wagh, V, PP 06
Wagner, KF, PP 23
Wagner, S, PP 96
Wagner, W, OP 24, PP 49
Waldhaus, J, PP 92
Walenda, T, OP 24
Walter, H, PP 63
Warstat, K, PP 07, PP 29
Weber, A, PP 108
Weber, J, PP 133
Weibezahn, K‐F, OP 35
Weidner, N, PP 91
Wein, A, OP 24
Wein, F, OP 24
Weis, J, OP 34
Weiss, B, PP 130
Wenceslau, CV, PP 24, PP 38, PP 41, PP 109
Wendel, H‐P, PP 57, PP 106
Wendler, N‐O, PP 39
Werner, N, PP 28
Wiedemann, J, PP 71, PP 75
Wiegmann, B, PP 27
Wiendieck, K, PP 99
Wiesmüller, K‐H, PP 17
Will, F, PP 127
William, H, PP 45
Willumeit, R, PP 112, PP 124
Wilson, A, OP 23
Winck, CP, PP 109
Winkel, A, PP 54
Winkler, J, PP 01, PP 03
Winnefeld, M, PP 72
Winter, M, PP 40
Wischhusen, J, PP 104
Wiskirchen, J, PP 110, PP 111
Witte, F, PP 54
Witte, T de, PP 19, PP 26
Wobus, AM, OP 35
Woelfle, M, PP 31
Wohlert, S, PP 69
Wolburg, H, PP 110
Wöltje, M, PP 42, PP 100
Wuchter, P, OP 24
Wulcko, I, PP 123
Wunderlich, S, PP 08, PP 11, PP 12, PP 16
Wurst, H, PP 78
Yamashita, K, PP 88
Yang, H, OP 30
Yo, F, PP 88
Yoshimura, S, PP 88
Zaehres, H, PP 13, PP 16
Zardo, P, PP 27
Zaruba, M‐M, PP 62
Zech, NH, PP 21
Zechel, C, PP 98, PP 99
Zeisberger, SM, PP 22
Zell, A, PP 17
Zhambalova, AP, OP 29
Ziegler, G, PP 123
Ziemer, G, PP 57, PP 58
Zimmermann, H, PP 01
Zimmermann, W‐H, OP 04, PP 16
Zippel, N, PP 32, PP 40
Zisch, A, PP 81
Zisch, AH, PP 22
Zwart, P de, PP 44
